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Abstract 
 
Oligodendrocytes myelinate axons in the CNS to increase the speed of action 
potential conduction. Myelinating oligodendrocytes develop from oligodendrocyte 
precursor cells (OPCs). OPCs can express voltage-gated sodium and potassium 
channels, and receive excitatory and inhibitory synaptic input from axons. The 
functional relevance of voltage-gated and synaptic currents in OPCs is unknown, but 
electrical signalling from axons might regulate OPC development and myelination. In 
this thesis I investigate the electrical properties of OPCs, and how signalling to these 
cells regulates their proliferation, differentiation and myelination. I studied the electrical 
properties of OPCs in different brain areas, to investigate whether their electrical 
properties differ between embryonic sites of origin (in dorsal versus ventral parts of the 
CNS), and between brain regions (white matter versus grey matter). Firstly, using a 
dual reporter mouse line to colour code ventrally- and dorsally-derived oligodendrocyte 
lineage cells, I demonstrated that oligodendrocyte lineage cells derived from different 
embryonic sites are electrically similar. However, despite having indistinguishable 
electrical properties, dorsally-derived oligodendrocytes myelinated specific tracts in the 
spinal cord. Secondly, I have shown that OPCs in different brain regions have a similar 
expression of ion channels and precursor proteins, are all mitotically active, and 
generate differentiated oligodendrocytes but not neurons. Finally, having determined 
that all OPCs apparently have similar membrane properties, I investigated whether the 
inhibitory neurotransmitter GABA can regulate OPC proliferation, differentiation and 
myelination. I found that both oligodendrocytes and their precursors respond to GABA 
via the activation of GABAA receptors. In addition, endogenously released GABA was 
found to reduce the number of oligodendrocyte lineage cells formed, reduce the 
amount of myelin per axon and increase internode length. These results demonstrate 
that GABA, presumably released from inhibitory interneurons, can regulate myelination, 
and raise the possibility that GABA could also modulate CNS remyelination. 
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Chapter 1: Introduction 
1.1 An overview of glia 
The central nervous system is composed of two main types of cell, neurons and 
glia. Neurons are the excitable cells within the CNS and were thought to be solely 
responsible for information processing. On the other hand glia, as the Greek name 
implies, were thought to be the ‘glue’ of the CNS, providing structural, metabolic and 
trophic support for the surrounding neurons. Glia can be subdivided into three main 
types: (1) oligodendrocytes which wrap myelin around neuronal axons, (2) astrocytes 
which have diverse functions within the CNS, including providing trophic support to 
neurons, buffering extracellular [K+], and taking up neurotransmitters released at 
neuronal synapses, and (3) microglia which are the resident immune cells of the brain. 
In recent years recognition of the importance of glial cells and their interactions with 
neurons has increased, especially in terms of the role of glia in the modulation of 
neurotransmission. My thesis focuses on investigating the properties of 
oligodendrocyte lineage cells and their interactions with neurons. In this chapter I will 
provide the background needed to understand the thesis: I will review the development 
of oligodendrocytes, their expression of cell surface proteins and ion channels, their 
functional roles in the CNS, and how they can be damaged in diseases. 
1.2 An overview of the function of oligodendrocytes 
The term oligodendrocyte means a cell with a few branches, and originates 
from the Greek words oligo (few), dendro (branches) and cytes (cells). The primary role 
of oligodendrocytes in the CNS is the synthesis and wrapping of layers of myelin 
around neuronal axons, which provides electrical insulation, effectively lowering the 
capacitance and increasing the resistance of the axonal membrane. Myelin is essential 
for rapid action potential conduction. Myelinated axons are wrapped by myelin in a 
series of sheaths, which are interrupted by unmyelinated segments rich in voltage-
gated Na+ channels, called the nodes of Ranvier. The nodes are essential for the 
conduction of action potentials, which sequentially activate Na+ channels in the series 
of nodes (saltatory conduction). Although myelin is one of best studied mammalian 
membranes, surprisingly little is known about the oligodendrocyte-neuron interactions 
that determine which axons are selected for myelination, and how myelination is 
initiated and regulated.  
 
16 
 
1.3 The development of oligodendrocytes 
Mature myelinating oligodendrocytes develop from glial precursors 
(oligodendrocyte precursor cells or OPCs) which express the proteoglycan NG2 and 
platelet-derived growth factor receptor α (PDGFRα) (Fig. 1.1). In addition to making 
oligodendrocytes during brain development, OPCs are also present in the adult CNS, 
where they comprise ~5% of the cells (7% in the white matter and 3% in the grey 
matter), and are the main proliferating cell type (Dawson et al., 2003). OPCs express a 
variety of cell surface receptors, and can respond to a multitude of neuronally derived 
signals including neurotransmitters, growth factors and cell adhesion ligands. In the 
following sections I will review the CNS sites of origin of OPCs, their development and 
differentiation into myelinating oligodendrocytes, and their electrical properties. 
1.3.1 Birth of oligodendrocytes 
The brain and spinal cord develop in the embryo by the process of neurulation. 
Firstly, neurulation begins with the formation of the neural plate from a thickening of the 
cells within the ectoderm. Next, the edges of the neural plate thicken to form the neural 
groove before folding inwards to form the neural tube (this process occurs at embryonic 
day 12 (E12) in mice). Finally, differentiation of the neural tube gives rise to the 
embryonic brain and spinal cord, and proliferation of the neuroepithelial cells within the 
neural tube gives rise to all of the neural cells (i.e. neurons, glia and ependymal cells). 
The notochord, a transient mesodermally-derived structure, is located ventrally to the 
developing neural tube and instructive signals released from the notochord have been 
shown to be involved in the formation of the dorsal-ventral axis in the developing CNS, 
and the specification of distinct populations of neurons within the spinal cord (Van 
Straaten et al., 1988). 
1.3.1.1 Birth of oligodendrocytes in the embryonic spinal cord 
Oligodendrogenesis within different parts of the brain and spinal cord occurs 
during the late gestational and early postnatal periods, after neuronal differentiation has 
taken place (Altman and Bayer, 1984). During development, OPCs arise from neural 
precursors located within discrete regions within the CNS. The newly generated OPCs 
proliferate and migrate long distances in order to populate the entire CNS, before 
differentiating into myelinating oligodendrocytes. In vertebrates, the majority of 
myelination occurs postnatally and is thought to continue throughout life (Fields, 2008). 
The ventral ventricular zone (VZ) of the developing spinal cord is composed of 
a series of discrete progenitor domains known as p3, pMN, p2, p1, and p0 in the 
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ventral half of the cord and dP6 to dP1 in the dorsal half (Fig. 1.2). Each progenitor 
domain contains cells expressing specific transcription factors and generates a 
characteristic subset of spinal neurons before switching to production of glial cells 
(astrocytes and/or oligodendrocytes). In the developing spinal cord oligodendrocytes 
are produced in two separate waves. Initially, from E12.5, OPCs, identified by their 
expression of PDGFRα, arise from the VZ of the pMN domain of the spinal cord (Zhou 
et al., 2001) (Fig. 1.3A). The pMN domain generates the majority (~85%) of the 
oligodendrocytes in the spinal cord (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et 
al., 2005; Tripathi et al., 2011). A change of transcription factor expression generates a 
developmental switch within the pMN domain, which initially gives rise to motor 
neurons but later generates oligodendrocytes. The pMN progenitors initially express 
the Olig2, neurogenin1 and neurogenin2 transcription factors, which results in the 
production of motor neurons. The pMN progenitors then downregulate their expression 
of neurogenin1 and neurogenin 2, and upregulate their expression of Nkx2.2. Cells that 
express both Olig2 and Nkx2.2 transcription factors develop into spinal cord 
oligodendrocytes instead of motor neurons (Zhou et al., 2001). This initial specification 
of oligodendrocytes in the embryonic spinal cord is also dependent on the ventral 
signalling molecule Sonic hedgehog (Shh) (Tekki-Kessaris et al., 2001) secreted from 
the notochord and floor plate, which is thought to induce cell type specific expression of 
Olig genes (Lu et al., 2000; Zhou et al., 2000) and to enhance the survival of 
oligodendrocytes (Davies and Miller, 2001). 
 The remainder of the oligodendrocytes within the spinal cord are thought to 
arise from more dorsal progenitor domains in the cord (Fig. 1.3A), independently of 
Shh signalling. The first evidence for the existence of alternative sources of 
oligodendrocytes, came from Nkx6.1 and Nkx6.2 double-mutant studies. Nkx6 
transcription factors are expressed in the progenitor domains of p3, pMN, p2 and p1 
(Fig. 1.2). In knockout Nkx6 spinal cords, Shh signalling from the notochord and floor 
plate fails to induce Nkx6-dependent activation of Olig2 transcription, and this 
completely blocks oligodendrocyte production in the pMN (Cai et al., 2005). 
Surprisingly however, oligodendrocytes, expressing the characteristic markers 
PDGFRα and OLIG2, continue to be produced in the dorsal spinal cord of the Nkx6-null 
mice (Cai et al., 2005). These dorsal precursors expressed the transcription factor 
Pax7, confirming their dorsal origin (Cai et al., 2005). Furthermore, some 
oligodendrocytes in wild-type mice were also found to express PAX7, indicating that 
dorsal generation of oligodendrocytes also occurs in normal development. The 
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generation of dorsal oligodendrocytes, was found to begin a couple of days later than 
that of the ventral ones (from E15 compared to ~E15.5) (Cai et al., 2005).  
Cre-lox fate-mapping experiments have also shown that the transcription factor 
Dbx1, which is restricted to ventral and dorsal progenitors in p1, p0, dP6 and dP5, 
labels a small number of oligodendrocytes (~3%) (Fogarty et al., 2005) (Fig. 1.2). 
Interestingly, these oligodendrocytes were found to transiently co-express the radial 
glial marker RC2, which suggests that these oligodendrocytes are formed from the 
direct transformation of radial glia (Fogarty et al., 2005). Finally, more recent fate-
mapping studies, with Gsh2-Cre and Msx3-Cre transgenic mice, have demonstrated 
that ~10% and ~17% of oligodendrocytes, respectively, arise from the dP1-dP2 and 
dP3–dP5 domains (Tripathi et al. (2011) and chapter 3 of this thesis).  
1.3.1.2 Birth of oligodendrocytes in the embryonic brain 
Within the developing brain, as in the spinal cord, oligodendrocytes arise from 
distinct ventral and dorsal progenitor domains within the developing brain. Recent fate-
mapping studies using Nkx2.1-Cre transgenic mice, which label neural precursors in 
the ventral regions of the telencephalon (in particular the medial ganglionic eminence 
(MGE) and the anterior entopeduncular region (AEP)), showed that OPCs first arrive in 
the cortex at ~E16 after migrating from the MGE/AEP at ~ E12.5 (Fig. 1.4) (Kessaris et 
al., 2006). This first wave of oligodendrocytes populates the whole cortex by E18, 
before being joined by a second wave of oligodendrocytes which arise from Gsh2-
expressing precursors which reside in the lateral ganglionic eminences (LGE) (Fig. 1.4) 
(Kessaris et al., 2006). Until E18, all oligodendrocyte lineage cells in the forebrain are 
ventral in origin. After E18, the percentage contribution of the ventrally-derived 
oligodendrocytes begins to decrease as they are joined by a third wave of cells 
produced by Emx1-expressing progenitors found locally in the cortex (Fig. 1.4) 
(Kessaris et al., 2006). Interestingly, the original population of MGE/AEP-derived 
precursors disappears after birth, being rapidly eliminated from the cortex and more 
gradually from all other parts of the brain. Almost no trace can be found of the initial 
Nkx2.1-derived oligodendrocyte population anywhere in the adult (Kessaris et al., 
2006). At present, it is not clear whether the Nkx2.1-derived oligodendrocyte population 
fails to survive, or just becomes diluted by the later-forming LGE- and dorsally-derived 
oligodendrocytes. Perhaps these early-forming oligodendrocytes have a specialised 
function in brain development, and are no longer required in the adult brain.  Indeed, 
the majority (∼80%) of OL lineage cells in the postnatal corpus callosum are generated 
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locally from Emx1-expressing progenitors, with the remaining (∼20%) of OPCs 
migrating in from the LGE (Tripathi et al., 2011 and chapter 3 of this thesis). 
Sonic Hedgehog signalling (Shh) has also been demonstrated to be important 
in oligodendrocyte specification in the embryonic ventral forebrain (Nery et al., 2001; 
Spassky et al., 2001; Tekki-Kessaris et al., 2001). Shh signalling however has not been 
detected within the postnatal cerebral cortex (Richardson et al., 2006), so the final 
wave of oligodendrocytes generated from the cortical Emx1-expressing progenitors is 
presumably controlled by an alternative signalling molecule. For example, fibroblast 
growth factor (FGF) can induce the generation of oligodendrocytes from cortical 
progenitor cells (Davis and Temple, 1994; Qian et al., 1997), and is perhaps involved in 
oligodendrocyte specification within the cortex.   
1.3.1.3 Are oligodendrocytes derived from different progenitors functionally 
distinct? 
Oligodendrocytes arise from dorsal and ventral progenitor populations under 
the influence of different instructive signals, however it is not known whether they are 
functionally identical or differ functionally in some way. In general, oligodendrocytes are 
morphologically distinct, with four different types of myelinating oligodendrocyte having 
been defined: types I and II, which have small cell bodies and 5-10 processes which 
myelinate small diameter axons (< 2 µm diameter), type III, which have large cell 
bodies and 1-2 processes which myelinate large diameter axons (> 4 µm diameter); 
and type IV oligodendrocytes which have large cell bodies without any processes and 
lie directly over the single large axon that they ensheath (del Rio-Hortega, 1921, 1928; 
Stensaas and Stensaas, 1968; Remahl and Hildebrand, 1990; Bjartmar et al., 1994; 
Vinet et al., 2010). Thus, these different types of oligodendrocyte myelinate different 
numbers of axons, in a manner which is highly correlated with the axon diameter. 
Those wrapping large diameter axons synthesise only one myelin internode, whereas 
other oligodendrocytes can make many internodes to myelinate several small diameter 
axons (Butt et al., 1997). Differences in the migration and maturation properties of 
dorsally- and ventrally-derived oligodendrocytes have been described in the spinal cord 
oligodendrocytes, with dorsally-derived OPCs maturing more slowly than their ventral 
counterparts (Cai et al., 2005). In addition, OPCs have been described to differ in terms 
of their ion channel expression (Karadottir et al., 2008), proliferative capacity (Rivers et 
al., 2008; Psachoulia et al., 2009; Guo et al., 2010; Simon et al., 2011), and response 
to injury (Keirstead et al., 1998). However, despite all these reported differences in the 
morphological and functional properties of oligodendrocyte lineage cells, a study by 
20 
 
Kessaris et al. (2006) revealed that if one specific developmentally-defined population 
cortical oligodendrocytes is killed, they could be replaced by the remaining population 
of oligodendrocytes. Interestingly, this replacement was sufficient to ensure the normal 
development of the animal, suggesting that in the forebrain the subpopulations of 
oligodendrocytes are functionally equivalent, as they can replace each other.  
 Chapter 3 of my thesis addresses the question of whether dorsally- and 
ventrally-derived oligodendrocyte lineage cells are functionally distinct, with the use of 
a dual-reporter mouse line in which oligodendrocyte lineage cells are labelled green or 
red, depending on their developmental origin within the embryonic brain or spinal cord. 
1.3.2 Migration of oligodendrocytes 
As a result of arising from highly restricted progenitor domains, OPCs must 
migrate long distances in order to populate the whole brain and spinal cord. OPC 
migration is guided by many soluble and membrane bound cues (Miller, 2002) to 
ensure the cells reach their final destination. In the optic nerve, the majority of OPC 
migration was found to be unidirectional, with OPCs migrating from the optic chiasm to 
the retina (Sugimoto et al., 2001). This unidirectional migration was shown to be due to 
chemorepellent signals (in particular netrin-1 and semaphorin-3a and 4f) produced by 
the optic chiasm (Sugimoto et al., 2001; Armendariz et al., 2012). Similarly, netrin-1 is 
also thought to be involved in the dispersal of OPCs from the VZ of the spinal cord 
(Miller, 2002). The soluble signalling molecule Slit, which is secreted by cells within the 
midline, also repels OPC migration by activating roundabout (Robo) receptors 
expressed on the OPCs (Liu et al., 2012). Vascular endothelial growth factor (VEGF), a 
soluble signalling molecule known to regulate angiogenesis, has been recently 
reported to promote OPC migration by reorganisation of the actin cytoskeleton within 
the leading-edge processes of migrating OPCs (Hayakawa et al., 2011). 
OPCs are often defined by their expression of the proteins NG2 and PDGFRα 
on their cell surface (Fig. 1.1), and both of these proteins have been reported to play a 
role in OPC migration. Firstly, when the external interactions of NG2 was blocked by 
the binding of an antibody to an extracellular domain of the NG2 protein, OPC 
migration was impaired (Hayakawa et al., 2011; Trotter, 2005). NG2 is known to serve 
as a co-receptor for PDGFRα (Goretzki et al., 1999) and the intracellular domain of 
NG2 contains a PDZ-binding motif which can interact with many intracellular signalling 
proteins that also contain the motif. In particular, NG2 has been found to interact with 
the PDZ-binding protein syntenin-1 which aids OPC migration (Chatterjee et al., 2008). 
Secondly, activation of PDGFRα receptors, by the growth factor PDGF-AA, enhances 
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OPC migration (and proliferation: see next section). PDGFRα is a tyrosine kinase 
receptor which activates numerous signalling pathways. A recent study has 
demonstrated that the ERK signalling pathway mediates PDGF-AA-dependent OPC 
migration (Vora et al., 2011). 
OPCs also express integrins, in a developmentally regulated fashion, which 
interact with extracellular matrix proteins including laminin and fibronectin, to regulate 
contact-mediated OPC migration (Milner and Ffrench-Constant, 1994). Interestingly, 
neurotransmitter receptor signalling has been demonstrated to regulate integrin 
function to modulate OPC migration. Gudz et al. (2006) suggested that, like in 
migrating neurons (in which the amplitude and frequency of intracellular calcium 
([Ca2+]i) fluctuations in the soma provide a signal that controls the rate of cell migration 
(Pende et al., 1994; Kumada and Komuro, 2004)), OPC motility could also be 
controlled by [Ca2+]i fluctuations. Gudz et al. (2006) provided evidence that Ca2+ 
modulates integrin-dependent OPC migration, by showing that disruption of Ca2+ 
signalling in OPCs leads to an alteration of integrin function and to a reduction of the 
cells’ movement. The distribution of integrins on the OPC cell membrane provided an 
insight into how Ca2+ signalling controls OPC motility. During the ‘migratory’ phase of 
OPC development, OPCs were found to express higher levels of the αvβ3 integrin 
receptor on the leading edge of their processes when compared with their rear 
processes (Gudz et al., 2006). This regional distribution of integrin receptors, produced 
by different recycling/endocytosis rates at the leading edge and rear of the cell, was 
controlled by [Ca2+]i. Furthermore, the neurotransmitter glutamate was shown to 
increase [Ca2+]i in OPCs and accelerate integrin-mediated OPC migration (Gudz et al., 
2006).  
The inhibitory neurotransmitter GABA can also regulate OPC migration. A 
gradient of low to high immunoreactivity for GABA has been observed from the 
ventricular zone to the cortical plate of the developing telencephalon, which may allow 
the involvement of endogenous GABA signalling in directional cortical cell migration 
(Heng et al., 2007). Like glutamate, GABAA receptor activation evokes Ca2+ transients 
in OPCs, however, these Ca2+ transients are not mediated by opening of voltage-gated 
Ca2+ channels but instead involved GABA depolarising OPCs by activating a Cl- efflux 
through GABAA receptors (the Cl- reversal potential is more positive than the resting 
potential: Lin and Bergles, 2004). The depolarisation then activates voltage-gated Na+ 
channels, which raises [Na+]i. Finally the rise of [Na+]i reverses Na+/Ca2+ exchange and 
raises [Ca2+]i (Tong et al., 2009). This unique Ca2+ signalling pathway in OPCs 
regulated their migration (Tong et al., 2009). 
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The factors described above are all thought to enhance OPC migration, but less 
is known about the factors which stop OPC migration when they reach their target 
destination. A few candidate stop signals have been described for OPCs in the optic 
nerve, which include the ECM molecule tenascin-C (Miller, 2002) and the chemokine 
CXCL-1 (Miller, 2002).   
1.3.3 Proliferation of oligodendrocytes 
OPC proliferation is regulated at least in part by signals released from neurons 
and astrocytes, in order to produce sufficient of OPCs to differentiate into myelinating 
cells and ensheath the length of neuronal axons. Several mechanisms have been 
suggested to control OPC proliferation. In culture, OPC proliferation was reported to be 
limited by an intrinsic clock, which makes OPCs undergo a finite number of divisions 
before differentiating into myelinating oligodendrocytes (Temple and Raff, 1986). This 
intrinsic clock mechanism was, however, found to be dependent on surrounding 
environmental signals, as when OPCs were cultured in the absence of exogenous 
growth factors they rapidly died (Calver et al., 1998)  
Several growth factors released from neurons act as potent mitogens for OPCs. 
Perhaps the most well studied OPC mitogen is the growth factor PDGF-AA (the active 
homodimer of PDGF-A), which binds to its receptor PDGFRα. PDGFRα receptors are 
abundantly expressed by OPCs, and become down-regulated as they differentiate into 
myelinating oligodendrocytes. Over-expression of the PDGF-A gene results in a 
dramatic increase in the number of OPCs (Calver et al., 1998), while in PDGF-A 
knockout mice the number of OPCs is dramatically reduced (Fruttiger et al., 1999). The 
mechanism by which PDGF-AA regulates OPC proliferation is thought to involve 
increased expression of delayed outward-rectifying K+ channels (Chittajallu et al., 
2005), since inhibition of K+ channels produced by glutamatergic signalling to OPCs 
reduces their proliferation (Knutson et al., 1997).  
NG2 is also thought to influence the proliferation of OPCs, in part by acting as a 
co-receptor for PDGFRα (Goretzki et al., 1999). The expression of NG2 potentiates the 
activity of growth factor receptors such as PDGFRα by enhancing ligand binding 
(Goretzki et al., 1999). When NG2 is knocked out in mice, the numbers of proliferative 
OPCs are reduced, indicating that NG2 promotes OPC proliferation (Kucharova and 
Stallcup, 2010).   
The growth factor fibroblast growth factor (FGF), which appears to be widely 
distributed throughout the embryonic CNS, also enhances OPC proliferation. FGF-
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induced OPC proliferation is thought to extend the time period over which OPCs are 
proliferative and prevent their differentiation into myelinating oligodendrocytes (Gard 
and Pfeiffer, 1993; Mayer et al., 1993). The mitogenic action of FGF on OPCs is 
regulated by developmental changes of FGF receptor expression, with FGF-3 
receptors being abundantly expressed by OPCs and downregulated as OPCs 
differentiate into myelinating oligodendrocytes (Bansal et al., 1996). Several other 
growth factors including neurotrophin-3 (NT-3) (Barres et al., 1994b), brain derived 
neurotrophic factor (BDNF) (Van't Veer et al., 2009) and neuregulin (Roy et al., 2007; 
Brinkmann et al., 2008; Taveggia et al., 2008) also act as mitogens to increase OPC 
proliferation.  
Some messengers have been reported to inhibit OPC proliferation. In particular, 
retinoic acid, glucocorticoid and thyroid hormone are all suggested to cause OPCs to 
exit the cell cycle and differentiate (Barres et al., 1994a). For example, when the 
receptor for thyroid hormone is knocked out in mice, OPCs continuously proliferate and 
fail to differentiate, resulting in altered myelination in adult optic nerves (Baas et al., 
2002). However, the mechanisms by which these molecules instruct OPCs to exit the 
cell cycle and induce differentiation are yet to be determined. 
In addition to growth factors, neurotransmitters may regulate OPC proliferation, 
OPCs receive excitatory and inhibitory synaptic input mediated by glutamate and 
GABA (Bergles et al., 2000; Lin and Bergles, 2004; Kukley et al., 2007; Ziskin et al., 
2007; Karadottir et al., 2008; Ge et al., 2009), raising the question of whether these 
neurotransmitters also regulate OPC development. So far, conflicting results exist in 
the literature on this issue. Glutamate has been suggested to block the proliferation 
and lineage progression of OPCs (Gallo et al., 1996; Yuan et al., 1998), as was shown 
earlier for neuronal precursor cells (LoTurco et al., 1995), but on the other hand 
glutamate has also been shown to promote myelin formation (Wake et al., 2011). 
Surprisingly, despite stimulating OPC migration (Tong et al., 2009), GABA has been 
reported to have no effect on OPC proliferation and differentiation (Gallo et al., 1996; 
Yuan et al., 1998). In chapter 5 I re-visit this issue. 
OPC proliferation has recently been reported to be regulated by circadian 
rhythms. It is well known that, in a variety of mammalian organs, cell cycle progression 
is under the control of circadian oscillatory mechanisms (Bjarnason et al., 1999), and 
disruption of clock-associated genes significantly affects DNA replication and cell 
division in regenerated tissues and tumours (Gery et al., 2006; Chen-Goodspeed and 
Lee, 2007). The division of adult neural progenitor cells in the neurogenic sub-granular 
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zone of the hippocampus is controlled by time-of-day regulated mechanisms. More 
neural precursors proliferate during the night time (the active period in mice), when 
compared with the day time (resting time in mice) (Guzman-Marin et al., 2007; 
Matsumoto et al., 2011). Interestingly, the number of proliferating OPCs is also 
controlled by the time of the day, however, in contrast to neuronal precursors more 
OPCs proliferate during the resting period when compared to the active period 
(Matsumoto et al., 2011). This difference in time-of-day proliferation between neuronal 
precursors and OPCs was linked to a difference in the expression of cyclin proteins.   
Voluntary physical exercise was reported to increase the number of proliferating 
OPCs in the hippocampus of mice (Matsumoto et al., 2011), and this increase was 
accompanied by an increase in the expression of c-Fos, a gene product which is 
upregulated in response to an increase in neuronal activity, indicating that OPC 
proliferation may be regulated by neuronal activity. In contrast, in a different brain 
region, the cerebral cortex, voluntary physical exercise led to an increase in the 
number of OPCs exiting the cell cycle, which was followed by enhanced differentiation 
of OPCs into oligodendrocytes (Simon et al., 2011). The evidence provided by both of 
these studies indicates that an increase in neuronal activity can influence OPC 
development. 
To summarise, many signalling molecules can regulate OPC proliferation. In 
this thesis, I investigate the proliferative capacity of OPCs in Chapter 4, and whether 
OPC proliferation can be regulated by neurotransmitters in Chapter 5.  
1.3.4 Differentiation of oligodendrocytes 
During development a large proportion of OPCs differentiate into premyelinating 
oligodendrocytes, which then differentiate further into myelinating oligodendrocytes 
(Trapp et al., 1997; Zhu et al., 2008; De Biase et al., 2010; Kukley et al., 2010). The 
differentiation of OPCs is characterised by changes in the expression pattern of 
molecular markers and a dramatic change in cell morphology. Throughout 
development, all oligodendrocyte lineage cells express SOX10 and OLIG2 (Nishiyama 
et al., 2009), but as OPCs undergo terminal differentiation, they lose expression of 
precursor proteins including NG2 and PDGFRα, and begin to express the immature 
marker O4, followed by PLP, galactocerebroside and myelin basic protein (MBP) 
(Nishiyama et al., 2009) (Fig. 1.1). Morphometric analysis by single cell dye-filling has 
revealed that premyelinating oligodendrocytes have larger somas and longer 
processes which cover a greater area, when compared with OPCs (Kukley et al., 
2010). Mature myelinating oligodendrocytes possess fewer processes than both 
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premyelinating cells and OPCs, but clearly show 1-60 myelin sheaths (internodes) (Fig. 
1.1).   
As OPCs differentiate, the changes in expression of molecular markers and cell 
morphology are also accompanied by a loss of synaptic connections and a change in 
ion channel expression (Kukley et al., 2010). These changes in ion channel expression 
within the oligodendrocyte lineage are described in detail in section 1.4 below.  
From birth, OPCs are more or less evenly distributed throughout the brain   
(Nishiyama et al., 1996; Dimou et al., 2008; Rivers et al., 2008), and continue to 
produce myelinating oligodendrocytes long into adulthood (Rivers et al., 2008; 
Psachoulia et al., 2009). However, not all OPCs differentiate into myelinating 
oligodendrocytes: a large proportion of these cells persist as OPCs in the adult, where 
they represent 5% of the cells in the brain (Dawson et al., 2003). In order to maintain a 
constant number of OPCs and produce new oligodendrocytes, OPC divide 
asymmetrically giving rise to one OPC and one differentiating cell (Sugiarto et al., 
2011; Zhu et al., 2011a). When OPCs divide asymmetrically NG2 expression becomes 
polarised and segregates onto the surface of the cell that remains an OPC, and is lost 
from the other cell which then differentiates (Sugiarto et al., 2011; Zhu et al., 2011a). In 
addition, OPCs can also divide symmetrically giving rise to two new NG2 expressing 
OPCs (Zhu et al., 2011a).  
As mentioned above, OPCs are reported to possess an intrinsic clock which 
results in OPCs undergoing a finite number of divisions before differentiation (Temple 
and Raff, 1986). This intrinsic clock mechanism for regulation of OPC differentiation 
was found when OPCs were cultured in the absence of other cell types. In contrast, 
when OPCs are cultured in the presence of neurons, an intrinsic timer may not be 
responsible for the initiation of differentiation, instead the density of OPCs may be vital, 
since OPCs need to reach a critical density before differentiation occurs (Rosenberg et 
al., 2008). In fact, if OPCs reached a sufficient density they could even differentiate and 
myelinate axons fixed with paraformaldehyde (Rosenberg et al., 2008). This evidence 
suggests that spatial constraints may be able to induce OPC differentiation.  
Several molecular signals have been reported to instruct OPCs to exit the cell 
cycle and differentiate. These include messengers such epidermal growth factor (EGF) 
(Sugiarto et al., 2011), retinoic acid, glucocorticoid and thyroid hormone (Barres et al., 
1994a), and the neurotransmitter glutamate (Gallo et al., 1996; Yuan et al., 1998). 
However, the question of how proliferating OPCs rapidly switch to postmitotic 
oligodendrocytes that synthesise myelin remained unanswered until recently, when it 
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was discovered that differentiating OPCs express a series of microRNAs (miRNAs) 
which provide a hitherto unrecognised level of gene expression control. miRNAs are 
small, noncoding RNA molecules expressed by many eukaryotic organisms. These 
miRNAs are generated from longer hairpin-loop RNA sequences, which are trimmed by 
successive cleavages by the miRNA processing enzymes Drosha and Dicer1, and 
incorporated into an RNA-induced silencing complex (RISC) (Bartel, 2004). When the 
mitogen PDGF-AA was withdrawn from OPCs, this induced the expression of specific 
miRNAs (Dugas et al., 2010; Zhao et al., 2010). These miRNAs efficiently attenuated 
the expression of the PDGFRα protein and downregulated the responsiveness of 
OPCs to PDGF-AA, which was followed by a change in OPC gene expression to 
promote differentiation (Dugas et al., 2010; Zhao et al., 2010). This new finding 
provides a link between the signalling molecules which regulate OPC development and 
the changes in gene expression required for their differentiation. 
1.3.5 Survival of newly formed oligodendrocytes  
OPC cell number is controlled by regulating both cell proliferation and cell 
death. The final number of oligodendrocytes is thought to be regulated by competition 
for local survival factors (Barres et al., 1992; Barres and Raff, 1994). In addition, only 
OPCs that make the appropriate contacts with axons are thought to survive and initiate 
myelination (Trapp et al., 1997), suggesting that axon derived signals are also 
important for oligodendrocyte survival. Quantitative analysis of OPC proliferation and 
cell death reveals that as many as 50% of newly formed oligodendrocytes die during 
normal development (Barres et al., 1992). In vitro, both PDGF-AA and insulin-like 
growth factors can rescue newly formed oligodendrocytes from cell death (Barres et al., 
1992). Increasing the amount of available PDGF-AA in the postnatal optic nerve 
reduced oligodendrocyte death by up to 90% (Barres et al., 1992), indicating that 
competition for survival factors likely contributes to the death of oligodendrocytes.     
Ultimately, the number of oligodendrocytes generated must be directly matched 
to the number of axons that require myelination. Accordingly, increasing experimentally 
the number of axons results in an increase in the number of oligodendrocytes that 
survive (Burne et al., 1996). In addition, oligodendrocytes can form multiple myelin 
internodes. Therefore, both the generation of the correct number of oligodendrocytes 
and the coordination of the number of internodes formed requires the presence of 
precise temporal and spatial cues. At present, surprisingly little is known about the 
neuron-glial interactions which exist to control the process of myelination.  
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1.3.6 Myelination 
In the CNS, oligodendrocytes wrap axons with multiple layers of compact 
myelin (Fig. 1.5). The myelin membrane contains a high percentage of lipids, of which 
cholesterol is the major constituent. In addition to lipids, myelin also contains an array 
of proteins which include myelin basic protein (MBP), proteolipid proteins (PLP/DM20), 
myelin oligodendrocyte glycoprotein (MOG), the 2', 3'-cyclic nucleotide 3'-
phosphodiesterase (CNPase) and myelin associated glycoprotein (MAG) (Dubois-
Dalcq et al., 1986) (Fig. 1.1). Myelin has a high electrical resistance so, because of the 
multiple membrane layers wrapped around axons, it lowers the capacitance of the 
axon. This, in turn, reduces the current flow through the internodal membranes, making 
it easier to charge the internodal membrane, thus facilitating rapid saltatory conduction 
from node to node. 
The process of myelination requires the formation of small gaps in the myelin 
sheath, referred to as the nodes of Ranvier (Fig. 1.6). These are highly complex 
structures, of 0.5-1 µm in length, which allow ion influx into the axon to generate the 
action potential. Early in the process of myelination, an axo-glial junction forms 
between the distal, uncompacted loops of myelin and the axolemma, which gives rise 
to the paranode that separates the node from the juxtaparanode (Fig. 1.6) (reviewed by 
Salzer, 2003). Each of these domains contains specific membrane proteins which are 
highly organised. The paranode contains the axonal protein contactin-associated 
protein (Caspr) and contactin which form complexes with the glial 155 kDa isoform of 
neurofascin, that generate septate-like junctions between the myelin and the axon 
(Sherman and Brophy, 2005). The juxtaparanodes lie just under the compact myelin 
sheath immediately adjacent to the paranodes and have high densities of voltage-
gated K+ channels and neuron-glial-related nodal axonal cell adhesion molecules 
(NrCAMs), Caspr2 and TAG-1 (Fig. 1.6). These cell adhesion molecules form a 
complex and interact with TAG-1, which is expressed by the oligodendrocyte cell 
membrane (Poliak et al., 2003). The nodes of Ranvier are the sites for action potential 
regeneration, and are therefore highly enriched in voltage-gated Na+ channels. The 
Na+ channels are clustered and anchored at the nodes via interactions with several 
cytoskeletal/scaffolding proteins, including transmembrane neurofascin-186 and 
NrCAM (which interact with extracellular matrix proteins), and intracellular ankyrin-G 
and βIV spectrin (Fig. 1.6). Concentration of Na+ channels at the nodes allows for the 
action potential to be regenerated at each node, as it propagates from one node to the 
next by saltatory conduction. 
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The processes of myelination and node formation must be tightly linked, 
however the precise mechanistic relationship between the two events is unclear. These 
processes could be coordinated by axons, by myelinating glia, or by a mixture of both. 
Substantial evidence suggests that interactions with myelinating glia are vital for the 
assembly of nodal domains in the axon. Na+ channels and ankyrin G, which are 
diffusely expressed on axons cultured in the absence of glia, cluster in the presence of 
glia (Kaplan et al., 1997). Also, when oligodendrocytes are ablated, Na+ channel 
clustering disappears at the nodes and the protein expression at the paranodes 
becomes disrupted (Mathis et al., 2001). Additional studies in mice deficient in myelin 
glycolipid synthesis were also found to have substantial axonal paranodal 
abnormalities (Honke et al., 2002), providing further evidence that myelinating glia play 
an important role in axon domain localisation.  
The mechanisms of node assembly are best characterised in the PNS, where 
Schwann cells instead of oligodendrocytes myelinate axons. Prior to myelination, 
components of the node, paranode and juxtraparanode are diffusely expressed along 
the axon (Zhang et al., 2012). In the PNS, the first stage of node assembly occurs with 
the diffusion of NF186 along the axon surface to the node. Gliomedin is released by the 
Schwann cell, and it binds to NrCAM expressed by the Schwann cell microvilli, forming 
the NrCAM-gliomedin complex (Feinberg et al., 2010). NF186 becomes trapped via 
interactions with the NrCAM-gliomedin complex on the Schwann cell microvilli, which 
promotes the clustering of NF186 at the node (Feinberg et al., 2010). NF186 then 
recruits ankyrin G, followed by the Na+ channels and βIV spectrin which are trafficked 
to the node in transport vesicles (Zhang et al., 2012). The paranodal junctions that form 
after the adhesion molecules have already accumulated limit the diffusion of node 
components in and out of the node. Finally, the nodal components still present along 
the internodes become downregulated, reinforcing the localisation of the node 
components (Zhang et al., 2012).  
Some differences have been reported in CNS node formation. In the PNS, 
Schwann cells make contacts with the axon at two distinct sites: the developing nodes 
and the adjacent paranodal junction. At the developing and mature PNS nodes, 
axoglial contacts are formed between Schwann cell microvilli and the axon, and these 
direct contacts are necessary for the clustering of the nodal complex (Arroyo et al., 
2004). In the CNS, oligodendrocytes make contacts with the axon at the paranodal 
junction but, unlike Schwann cells, oligodendrocytes are devoid of microvilli and do not 
contact the developing node. Despite this lack of microvilli, nodes still form beyond the 
ends of the oligodendrocyte processes. Interestingly, astrocytes and OPCs are 
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reported to extend processes to nodes (Butt et al., 1999), and these could play a role 
similar to the Schwann cell microvilli in aiding the clustering and maintenance of the 
nodal complex. However, these perinodal glial processes only project to large CNS 
axons (Melendez-Vaquez et al., 2001), suggesting that they are not required for node 
formation in all CNS axons. Also, in contrast to the PNS, Ankyrin G is the first molecule 
to be recruited during node formation in the CNS, not neurofascin (Jenkins and 
Bennett, 2002).  
Oligodendrocytes myelinate axons which have diameter of at least 0.2 µm 
(Waxman and Bennett, 1972; Voyvodic, 1989), and axons which have a diameter of 
less than this normally remain unmyelinated. Furthermore, the number of layers in the 
myelin sheath is tightly correlated with the axonal diameter, increasing in proportion to 
the inner axonal diameter. The ratio of the axonal diameter to the outer diameter of the 
myelin sheath, referred to as the g-ratio, is constant, around 0.75 in the CNS, and 0.6 
in the PNS (Friede, 1972). In addition, each oligodendrocyte is capable of myelinating 
up to 60 axons (Remahl and Hildebrand, 1990), all of which may have different axonal 
diameters and subsequently require differing amounts of myelin. The strong correlation 
between axon diameter and myelin thickness points to the existence of axonal signals 
that both initiate the myelination process and determine exactly how many times the 
myelinating process wraps around the axon before compaction occurs to form the 
mature myelin sheath. Surprisingly, the processes of axonal ensheathment and myelin 
compaction are still not fully understood.   
Several studies have helped to decipher the glial-axonal interactions which 
occur during the initial stages of myelination. So far, two axonal ensheathment models 
have been described. In the original model of myelination from electron microscopy 
studies, it has been suggested that the leading edge of the myelin sheath aligns along 
the axon in a sheet-like manner, which forms the initial wrap. Then subsequent wraps 
are laid down inside the previous ones, forming a smooth surface with all the myelin 
membranes running in parallel to the long axis of the axon, reminiscent of a rolled up 
carpet (Bunge et al., 1989). More recent studies have suggested an alternative model 
of myelination, in which a narrow oligodendrocyte process spirals around the axon and, 
when sufficient wraps have been generated, the spirals then extend laterally along the 
long axis of the axon to form overlapping sheets, as described by the ‘serpent’ model 
(Sobottka et al., 2011). A recent study by Ioannidou et al. (2012), using real time 
imaging to visualise dynamic glial-axonal interactions occurring during myelination, 
demonstrated that oligodendrocyte processes initially spiral around the axon in a 
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corkscrew-like manner, similar to the ‘serpent model’ of myelination, after which the 
myelin membrane spreads out along the axon to form the myelin internode.   
Molecular studies have provided information about the signalling molecules 
regulating various stages of myelination. Many axonal-derived signals have been 
reported to regulate myelination. For example, neurons are reported to change their 
patterns of expression of axonal proteins before the onset of, and during the early 
stages of myelination (Coman et al., 2005). In particular, polysialylated neural cell 
adhesion molecule (PSA-NCAM) and the adhesion molecule L1 CAM are expressed 
on the axonal surface at the beginning of myelination, but soon disappear as axons 
become myelinated (Coman et al., 2005), suggesting that these molecules promote 
myelination. In addition to axon-derived signals regulating myelination, there has been 
much interest in the possibility that electrical activity can provide instructive signals 
which promote myelination. Initial evidence of activity-dependent myelination came 
from studies demonstrating that when neuronal action potentials are blocked by TTX, 
myelination is impaired (Barres and Raff, 1993; Demerens et al., 1996).  
In addition, neuronal activity triggers the release of several promyelinating 
factors such as PDGF-AA (Richardson et al., 1988), neurotrophin-3 (Barres et al., 
1994b), neuregulin (Roy et al., 2007; Brinkmann et al., 2008; Taveggia et al., 2008) 
and adenosine (Stevens et al., 2002). One of the most well studied promyelinating 
factors in the PNS is the growth factor neuregulin 1 (NRG1). In the developing CNS 
and PNS, the EGF-like growth factor NRG1 activates its receptors, the family of ErbB 
tyrosine kinases, on oligodendrocytes and Schwann cells, respectively (Miller, 2002). In 
the PNS, NRG1 is essential for myelination. A threshold level of axonal NRG1 type III 
is required to induce myelination by Schwann cells, and the amount of NRG1 type III 
expressed on axons determines the thickness of the myelin sheath (Michailov et al., 
2004; Taveggia et al., 2005; Brinkmann et al., 2008).  
The role of neuregulin in CNS myelination remains controversial. Some studies 
have suggested that, like the PNS, NRG1 signalling plays a role in oligodendrocyte 
differentiation and myelination in the CNS (Park et al., 2001; Sussman et al., 2005). In 
ErbB knockout mice, oligodendrocytes were unable to differentiate into myelinating 
oligodendrocytes (Sussman et al., 2005) and ensheath axons with myelin (Park et al., 
2001). In contrast, a recent study from Brinkmann et al. (2008) suggested that CNS 
myelination does not depend on NRG1. When the NRG1 gene was conditionally 
knocked out of virtually all projection neurons of the forebrain at P5 before subcortical 
myelination occurs, surprisingly, myelination proceeded normally (Brinkmann et al., 
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2008). Furthermore, to completely eliminate neuregulin signalling, Brinkmann et al. 
(2008) knocked out all of the ErbB receptors on which neuregulins act. Despite the lack 
of neuregulin signalling, myelination proceeded normally in ErbB knockout mice 
(Brinkmann et al., 2008). However, given that many other signalling pathways are 
involved in myelination, it is possible that an alternative signalling pathway could 
compensate for the lack of neuregulin signalling in the neuregulin deficient mice, to 
ensure that myelination occurs. 
As mentioned above, neuregulin regulates myelin sheath thickness in the PNS. 
Recently, fibroblast growth factor (FGF) has been reported to play a role similar to that 
of neuregulin in the PNS, to regulate the myelin sheath thickness of CNS axons. FGFs 
are a family of growth factors that activate their receptors, the family of Fgfr1-2 receptor 
tyrosine kinases, on oligodendrocytes (Bansal et al., 1996). Oligodendrocyte lineage 
cells express FGF receptors in a developmentally regulated manner. Fgfr1 is 
expressed by all oligodendrocyte lineage cells, Fgfr3 is only expressed by OPCs, and 
Fgfr2 is only expressed by myelinating oligodendrocytes (Bansal et al., 1996; Bryant et 
al., 2009). The differential expression of FGF receptors in the oligodendrocyte lineage 
raises the possibility that FGF receptor signalling may have distinct functions in OPCs 
and myelinating oligodendrocytes. Indeed, in a recent study, Furusho et al. (2012) 
knocked-out Fgfr1 and Fgfr2 receptors from all oligodendrocyte lineage cells and found 
that OPC development was unaffected but the myelin sheath thickness was altered. In 
the absence of Fgfr1 and Fgfr2 receptors, OPCs proliferated and differentiated 
normally, and produced a similar number of myelinating oligodendrocytes (Furusho et 
al., 2012), suggesting that Fgfr1/Fgfr2 receptor activation is not important for OPC 
lineage progression. In addition, axonal ensheathment and myelination were initiated at 
a similar time to that of normal mice. However, the rapid growth of myelin, normally 
occurring the second postnatal week, was severely inhibited in Fgfr1/Fgfr2 knockout 
mice (Furusho et al., 2012). Furthermore, in adulthood in the absence of Fgfr1 and 
Fgfr2 receptors, myelinating oligodendrocytes were found to transcribe fewer myelin 
genes, and the myelin sheath remained disproportionately thin relative to the axon 
diameter (Furusho et al., 2012). This study suggests that FGF receptor signalling in 
myelinating oligodendrocytes plays a vital role in regulating the thickness of the myelin 
sheath in the CNS. 
In addition to growth factors, neurotransmitters may regulate myelination, OPCs 
receive excitatory and inhibitory synaptic input mediated by glutamate and GABA 
(Bergles et al., 2000; Lin et al., 2005; Kukley et al., 2007; Ziskin et al., 2007; Karadottir 
et al., 2008; Ge et al., 2009), raising the question of whether such synaptic 
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communication between individual axons and OPCs might initiate myelin formation on 
electrically active individual axons. Interestingly, Wake et al. (2011) provided the first 
evidence for the involvement of OPC synapses in myelination, in culture. Wake et al. 
(2011) showed that glutamate release from synaptic vesicles along axons promoted 
myelination by stimulating the formation of cholesterol-rich signalling domains in 
oligodendrocytes and increasing the local synthesis of a major protein in the myelin 
sheath, MBP (Wake et al., 2011). However, the role of OPC synapses in myelination 
has yet to be demonstrated in vivo, and it is not yet known whether other 
neurotransmitters such as GABA can regulate myelination. In chapter 5 of this thesis, I 
investigate whether GABA can regulate myelination. 
Like neurons, astrocytes also release factors which can regulate myelination. 
Ishibashi et al. (2006) found that astrocytes respond to ATP released from active axons 
by releasing LIF (leukaemia inhibitory factor) which promotes myelination by mature 
oligodendrocytes. Interestingly, astrocytes release different factors depending on their 
activation phenotype. In particular, in a myelinating culture system, inclusion of normal 
quiescent astrocytes induced the formation of less myelinated fibres when compared 
with the inclusion of reactive astrocytes (Nash et al., 2011). The cytokine ciliary 
neurotrophic factor (CNTF) was found to activate astrocytes, and increase myelination. 
In the absence of astrocytes, CNTF had no promyelinating effect on oligodendrocytes, 
suggesting that, in response to CNTF, reactive astrocytes secrete a soluble factor to 
increase myelination. In contrast, CXCL10 was identified as a potential candidate 
molecule released from quiescent astrocytes to reduce myelination since, when 
CXCL10 was neutralised with an antibody, the effect of quiescent astrocytes on 
myelination was eliminated (Nash et al., 2011). Collectively, these data demonstrate 
that astrocytes may play an important role in controlling myelination.  
1.3.7 Regulation of internode length in the tuning of action potential conduction 
speed 
During development, adjustment of myelin thickness or of the internode length 
may be used to tune the conduction speed of action potentials in myelinated axons. In 
some cases in the CNS, myelination is organised to promote synchronicity of neuronal 
firing (Sugihara et al., 1993; Lang and Rosenbluth, 2003), make the action potential 
conduction velocity almost independent of the length of the axon transmitting 
information between areas (Salami et al., 2003), or adjust action potential conduction 
delays to mediate sound localization in the auditory system (Jeffress, 1948; McAlpine 
and Grothe, 2003; Seidl et al., 2010). 
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In addition to the adjustment of myelination during development, myelination 
may also change during adult life (Ullen, 2009). For example, it has been reported that 
only around 30% of corpus callosal axons are myelinated even in eight month-old mice 
(Sturrock, 1980), suggesting that there is still plenty of scope for de novo myelination of 
axons to occur throughout life. In the human brain, myelination is known to continue 
well into the third decade of life (Fields, 2008). Interestingly, magnetic resonance 
imaging data in humans have indicated that myelination can change when people learn 
motor tasks such as piano playing (Bengtsson et al., 2005) and juggling (Scholz et al., 
2009), suggesting that myelin plasticity may be involved in learning. 
The regulation of internode length provides one mechanism for action potential 
conduction speed tuning, however, the length of each internode must be within a 
certain range to achieve a high action potential conduction speed (Huxley and Stampfli, 
1949; Brill et al., 1977). Deviations from the optimum internode length lead to a 
decrease in action potential conduction velocity. Despite this, the mechanisms by 
which internode length is determined are not well understood. Recently, intercellular 
interactions between competing myelinating oligodendrocytes have been reported to 
influence the number and length of internodes. One signal regulating internode 
number, in a myelinating co-culture system, was identified to be Nogo-A (Chong et al., 
2012), which decreases the number of myelin segements per oligodendrocyte. 
Additional potent cues probably remain unidentified in oligodendrocyte membranes 
which contribute to the patterning and spatial arrangement of internodes. Additional 
signals regulating internode formation may include receptors responding to 
neurotransmitters released from axons. The effects of the neurotransmitter GABA on 
the regulation of internode length were investigated in chapter 5.  
1.4 Ion channel expression in oligodendrocytes and their precursors 
In this section I will review the main ion channels expressed in oligodendrocyte 
lineage cells, as a background to understanding signalling to these cells, and some of 
the experiments I have performed. 
1.4.1 Voltage-gated ion channels 
In chapters 3 and 4 of this thesis, I report experiments investigating voltage-
gated ion channel expression in oligodendrocyte lineage cells. 
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1.4.1.1 Potassium channels 
Oligodendrocyte lineage cells express many voltage-gated K+ channels, which 
are differentially expressed at specific stages within the oligodendrocyte lineage 
(Soliven et al., 1988, 1989; Sontheimer et al., 1989). In OPCs, depolarising voltage 
steps from the resting potential elicit rapidly activating and sustained K+ currents, due 
to the expression of A-type K+ channels and delayed rectifying K+ channels. The 
proliferative capacity of OPCs has been linked to the expression of delayed rectifying 
K+ channels, and in particular, expression of the Kv1.3 subunit is thought to promote 
the G1/S transition in the cell cycle (Attali et al., 1997; Chittajallu et al., 2002). 
Furthermore, over-expression of Kv1.3 or Kv1.4 subunits increases the proliferation 
rate of OPCs in the absence of mitogens (Vautier et al., 2004). Interestingly, the 
amplitude of voltage-gated K+ currents decreases as OPCs stop dividing and start to 
differentiate (Kukley et al., 2010), providing further evidence for a role of K+ channels in 
OPC lineage progression.  
 OPCs also express inwardly rectifying K+ currents, which are likely to result 
from the activity of ATP-sensitive K+ (KATP) channels and inwardly rectifying K+ (Kir) 
channels (Chittajallu et al., 2004). Mature oligodendrocytes predominantly express 
inwardly rectifying K+ channel currents, and small delayed outwardly rectifying K+ 
channel currents (Barres et al., 1990; Attali et al., 1997). The inwardly rectifying K+ 
channels pass little outward current when the membrane is depolarised and pass large 
currents at hyperpolarised potentials. Inwardly rectifying K+ channels act to set the 
membrane potential close to the K+ equilibrium potential, and also act to buffer K+ 
released during neuronal activity (Reimann and Ashcroft, 1999). In addition, inwardly 
rectifying K+ channels are thought to be involved in myelination, as mice with a null 
mutation in the Kir4.1 subunit of inwardly rectifying K+ channel, have hypomyelinated 
spinal cords (Neusch et al., 2001).  
1.4.1.2 Sodium channels 
Like neurons, OPCs express voltage-gated Na+ channels, but at a density much 
lower than the density of Na+ channels found in neurons. There are some 
discrepancies in data on the proportion of OPCs that express Na+ channels. Some 
studies point to a heterogeneity in the Na+ channel expression of OPCs, and define two 
classes of OPC: one type that expresses and another type that lacks Na+ channels 
(Karadottir et al., 2008). On the other hand, other studies suggest Na+ channel 
expression is a universal property of OPCs in white and grey matter regions of the 
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brain (Bergles et al., 2000; Chittajallu et al., 2004; De Biase et al., 2010; Kukley et al., 
2010).  
The expression of Na+ channels by OPCs raised the question of whether these 
cells are able to generate action potentials. Interestingly, despite the low density of Na+ 
channels and the comparatively large K+ conductance present, some OPCs in the rat 
cerebellar white matter were reported to generate action potentials on depolarisation 
(Karadottir et al., 2008). In other species and brain areas, OPCs were not reported to 
generate bona fide action potentials on depolarisation, but could generate single Na+ 
spikes that had a higher threshold for activation than action potentials in neurons, with 
amplitudes that increased with larger current injections, and which did not substantially 
overshoot 0 mV (Chittajallu et al., 2004; Ge et al., 2009; De Biase et al., 2010). It is not 
currently known whether OPCs receive sufficient depolarising input from neurons in 
vivo to generate these Na+ spikes. However, whether or not OPCs fire true action 
potentials in vivo, the Na+ influx through Na+ channels could act to amplify any 
depolarising stimuli, such as the excitatory post-synaptic currents (EPSCs) that OPCs 
receive from neurons. For example, Na+ channel activation in OPCs, in response to 
GABA-activated membrane depolarisation, can lead to Ca2+ influx though Na+/Ca2+ 
exchangers (Tong et al., 2009). This unique signalling pathway involving Na+ channels 
and the Na+/Ca2+ exchanger, was demonstrated to be important for OPC migration 
(Tong et al., 2009). 
In contrast, Na+ channel currents have not been observed in differentiating or 
mature myelinating oligodendrocytes (Barres et al., 1990; Kukley et al., 2010). Further 
evidence for the downregulation of Na+ channels during oligodendrocyte lineage cell 
maturation came from the transcriptome database published by Cahoy et al. (2008), 
which demonstrated that Na+ channel gene expression strongly decreases as 
oligodendrocytes mature.  
In chapter 3 of this thesis I investigate voltage-gated ion channel expression in 
oligodendrocyte lineage cells with different developmental origins, and in chapter 4 I 
investigate Na+ channel expression and action potential generation in OPCs in different 
brain regions. 
1.4.1.3 Calcium channels 
 Ca2+ channels play a vital role in coupling membrane depolarisation to 
changes in cell physiology. Ca2+ influx across the cell membrane can occur via many 
routes, for example Ca2+ can move into the cells through ligand-gated ion channels, 
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such as glutamate receptors (as described below) or through voltage-gated Ca2+ 
channels. Many studies have investigated the expression of voltage-gated Ca2+ 
channels in oligodendrocyte lineage cells, but they have reported somewhat differing 
results. In culture and in brain slices, respectively, Barres et al. (1990) and Tong et al. 
(2009) reported that OPCs did not express voltage-gated Ca2+ channels. In contrast, 
low and high voltage-gated Ca2+ channels are reported to be expressed by OPCs 
(Akopian et al., 1996; Fulton et al., 2010; Paez et al., 2010). In these studies Ca2+ 
channel activation was also reported to play a role in OPC process extension and 
migration (Paez et al., 2010). Ca2+ influx into OPCs via Na+/Ca2+ exchangers, instead 
of via voltage-gated Ca2+ channels, was also found to control OPC migration (Tong et 
al., 2009).  
Although Ca2+ channel expression was reported to decrease as 
oligodendrocytes mature, some low and high voltage-gated Ca2+ channels could still be 
detected in mature oligodendrocytes (Fulton et al., 2010). However, other studies 
reported that mature oligodendrocytes did not express voltage-gated Ca2+ channels 
(Barres et al., 1990). Finally, in the transciptome database for oligodendrocyte lineage 
cells, voltage-gated Ca2+ channel genes were only found to be expressed in mature 
myelinating oligodendrocytes (Cahoy et al., 2008). The reason for these apparent 
differences in Ca2+ channel expression in oligodendrocyte lineage cells is uncertain, but 
increases in the intracellular Ca2+ concentration (by whatever mechanism) could lead to 
changes in cell physiology and gene expression, which could regulate the proliferation 
and lineage progression of these cells. 
1.4.2 Neurotransmitter-gated ion channels 
Oligodendrocyte lineage cells express receptors for many neurotransmitters 
such as glutamate, GABA, ATP and acetylcholine. In this section I will review the 
expression of glutamate and GABA receptors in oligodendrocyte lineage cells, as a 
background to understanding my experiments on the excitatory and inhibitory signalling 
to these cells.  
1.4.2.1 Glutamate receptors 
Oligodendrocyte lineage cells express AMPA, kainate and NMDA receptors, 
and the expression of some of these channels are reported to change during OPC 
lineage progression.  
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1.4.2.1.1 AMPA receptors 
AMPA receptors are composed of subunits GluA1-GluA4, and they can 
assemble as either homo- or heterotetramers, with functional properties that are 
dictated by their subunit composition. The functional properties of AMPA receptors can 
be modulated by the presence of auxiliary transmembrane AMPA receptor regulatory 
proteins (TARPs) (Rouach et al., 2005). Furthermore, expression of the GluA2 subunit 
suppresses the Ca2+ permeability of AMPA receptors (Geiger et al., 1995).  
Several studies have demonstrated that glutamate, AMPA and kainate evoke 
membrane currents in oligodendrocyte lineage cells in culture (Barres et al., 1990; 
Fulton et al., 1992; Borges et al., 1994; Patneau et al., 1994; Borges and Kettenmann, 
1995; Gallo et al., 1996; Yuan et al., 1998) and in brain slices (Berger et al., 1992; 
Karadottir et al., 2005; Karadottir et al., 2008). Molecular studies have also reported 
that oligodendrocyte lineage cells express mRNA for AMPA receptor subunits (Jensen 
and Chiu, 1993; Patneau et al., 1994; Yoshioka et al., 1995; Matute et al., 1997). OPCs 
are reported to express a mixture of GluA2-lacking calcium permeable AMPA receptors 
and GluA2-containing calcium impermeable AMPA receptors (Zonouzi et al., 2011). 
This expression of neurotransmitter receptors by oligodendrocyte lineage cells sparked 
an interest in discovering the function of these channels in OPCs. The most exciting 
finding came with the discovery that AMPA receptors in OPCs are activated during 
transmission at discrete neuron-OPC synapses in the hippocampus, and that these 
synapses shared many similarities to neuronal synapses (Bergles et al., 2000), 
including the presence of action potential–evoked transmitter release that is calcium 
dependent and quantal in nature. Additional evidence from electron microscopy studies 
revealed an accumulation of synaptic vesicles at contact sites between neuronal axons 
and the processes of OPCs (Bergles et al., 2000; Lin and Bergles, 2004) in the 
hippocampus.  
Since the discovery of glutamatergic synapses between neurons and OPCs, 
several other groups have reported that OPCs receive synaptic input from neurons 
throughout the grey matter (Bergles et al., 2000; Lin and Bergles, 2004; Mangin et al., 
2008; Ge et al., 2009; Velez-Fort et al., 2010). In addition, synaptic input onto OPCs 
has been reported to occur in many white matter brain regions (Kukley et al., 2007; 
Ziskin et al., 2007; Karadottir et al., 2008), and in particular OPCs establish excitatory 
glutamatergic synapses with unmyelinated axons passing through the white matter 
(Kukley et al., 2007; Ziskin et al., 2007), which may play a role in controlling the 
development of myelination.   
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Although the physiological function of OPC synapses is yet to be determined, 
recent studies have suggested that glutamate receptor expression in OPCs is highly 
dynamic, and can be regulated by mechanisms similar to those found at neuronal 
synapses. For example, high-frequency presynaptic activity at neuron-OPC synapses 
is generates a form of long-term potentiation (LTP) that is associated with a rapid rise 
in the proportion of calcium-permeable AMPA receptors (Ge et al., 2006). In addition, 
key signalling molecules regulating glutamate receptor expression at neuronal 
synapses have recently been reported to regulate AMPA receptor expression in OPCs. 
In particular, activation of group 1 metabotropic glutamate receptors triggers an 
increase in the proportion of Ca2+ permeable AMPA receptors, whereas activation of 
purinergic P2Y receptors decreases the proportion of Ca2+ permeable AMPA receptors 
(Zonouzi et al., 2011). Furthermore, TARPs, which are an essential modulator of AMPA 
receptor expression in neurons, were also found to regulate AMPA receptor expression 
in OPCs (Zonouzi et al., 2011). 
1.4.2.1.2 NMDA receptors 
NMDA receptors are activated by two co-agonists: glutamate and glycine (or D-
serine). NMDA receptors are tetramers. GluN2 subunits (of which there are 4 types) 
bind glutamate, while the GluN1 subunit binds glycine (or D-serine). GluN3 subunits (of 
which there are 2 types) can also bind glycine (Chatterton et al., 2002). The majority of 
NMDA receptors are heterotetramers, composed of two GluN1 subunits and two GluN2 
subunits. Current flow through activated NMDA receptors is subject to a voltage-
dependent magnesium block. As a result, at the resting potential, most neuronal NMDA 
receptors barely pass any current when activated, and can only pass significant current 
when the magnesium block is removed by sufficient depolarisation, so that cations 
(sodium, potassium and calcium) can then flow through the channel (Dingledine et al., 
1999). However, receptors containing GluN3 subunits have a weaker Mg2+ block, so 
that significant current can flow at the resting potential. 
NMDA receptors were initially thought to be absent from oligodendrocyte 
lineage cells, both in culture (Barres et al., 1990; Patneau et al., 1994; Pende et al., 
1994) and in brain slices (Berger et al., 1992). The first evidence for the possible 
expression of NMDA receptors in oligodendrocytes came when Matute et al. (1997) 
reported NMDA receptor mRNA in extracts from the corpus callosum. Later, this 
molecular evidence for NMDA receptors in the white matter was confirmed by 
immunohistochemistry and patch-clamping studies, which demonstrated that functional 
NMDA receptors were expressed in oligodendrocyte lineage cells at all developmental 
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stages in the cerebellar white matter and corpus callosum (Karadottir et al., 2005). 
Furthermore, immunogold electron microscopy demonstrated the expression of GluN1 
subunits in myelin (Karadottir et al., 2005). Similarly, in the optic nerve, Salter and Fern 
(2005) reported the presence of mRNA for GluN1 and GluN2 subunits within the 
myelin, and Micu et al. (2006) reported GluN1, GluN2 and GluN3 protein expression in 
myelin by immunohistochemistry and immunoprecipitation. Activation of NMDA 
receptors in ischaemia has also been reported to induce a [Ca2+]i rise in 
oligodendrocyte lineage cells (Micu et al., 2006), raising the possibility that signalling 
through these receptors modulates oligodendrocyte lineage cell behaviour, especially 
since glutamate can alter proliferation, differentiation, and migration of OPCs (Gallo et 
al., 1996; Gudz et al., 2006; Wake et al., 2011). Oligodendrocyte NMDA receptors were 
suggested to contain GluN1, GluN2C and GluN3A subunits, and show a weak Mg2+ 
block, passing significant current even at the resting potential (Karadottir et al., 2005; 
Burzomato et al., 2010). 
As mentioned above, OPCs receive glutamatergic synaptic inputs from 
neurons. The glutamatergic synaptic current in neurons is usually made up of an AMPA 
receptor component and an NMDA receptor component. However, in OPCs, NMDA 
receptors are not thought to contribute significantly to glutamatergic synaptic currents. 
This was assessed by voltage-clamping OPCs at positive potentials (+40 mV) to 
remove the block of NMDA receptors by magnesium. At positive potentials, 
glutamatergic synaptic currents were still completely blocked by AMPA/kainate 
receptor antagonists, in both the white matter (Kukley et al., 2007) and grey matter (Lin 
et al., 2005), suggesting that glutamatergic synaptic currents in OPCs are almost 
entirely mediated by AMPA/kainate receptors.  
Many studies have investigated the functional role of NMDA receptors in 
oligodendrocyte lineage cells, but have reported somewhat differing results. NMDA 
receptor expression on oligodendrocytes has been widely reported to have a 
detrimental effect on these cells in diseases such as ischaemia (as discussed in detail 
in section 1.7 below), mediating glutamate toxicity and damage or death of 
oligodendrocyte lineage cells (Matute et al., 1997; Karadottir et al., 2005; Karadottir et 
al., 2008). However, the functional role of oligodendrocyte NMDA receptors in the 
healthy brain has recently been investigated and has given conflicting results. De Biase 
et al. (2011) examined the function of NMDA receptor expression on oligodendrocytes, 
by genetically deleting the obligatory NMDA receptor subunit GluN1. Surprisingly, 
OPCs lacking NMDA receptors exhibited normal rates of proliferation, achieved normal 
densities in grey and white matter, and matured into myelinating oligodendrocytes to 
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form the major white matter tracts of the CNS without appreciable delay (De Biase et 
al., 2011). Moreover, the majority of the characteristic physiological and morphological 
properties of OPCs were preserved in the absence of NMDA receptors, and OPCs 
continued to receive glutamatergic synaptic input (De Biase et al., 2011). The only 
observable differences after NMDA receptor deletion, were firstly, a reduction in the 
Na+ channel density in OPCs, and secondly an alteration in the subunit composition of 
AMPA receptors in OPCs (De Biase et al., 2011). In particular, a higher number of 
Ca2+-permeable AMPA receptors were found in OPCs following NMDA receptor 
deletion. The increase in Ca2+-permeable AMPA receptors in OPCs might represent an 
attempt to compensate for a reduction in Ca2+ influx through NMDA receptors when 
they are deleted from the cell.  
In another study, Guo et al. (2012) deleted the obligatory GluN1 subunit from 
OPCs and found that it did not interrupt the normal maturation and differentiation of 
OPCs. Furthermore, deletion of the GluN1 or the modulatory GluN3A subunit from 
oligodendrocyte lineage cells did not alter the clinical severity of experimental 
autoimmune encephalomyelitis (EAE) an animal model of multiple sclerosis (Guo et al., 
2012), suggesting that oligodendrocyte NMDA receptors do not significantly contribute 
to the pathophysiology of EAE. Collectively, the studies by De Biase et al. (2011) and 
Guo et al. (2012) suggested that NMDA receptor signalling in OPCs does not play a 
significant role in OPC development or myelination, and does not contribute to the 
pathology of some diseases involving oligodendrocytes, such as EAE. 
In contrast Wake et al. (2011), studying myelination of dorsal root ganglion 
neurons by OPCs, reported that glutamate release from synaptic vesicles along axons 
promoted myelination by stimulating the formation of cholesterol-rich signalling 
domains in oligodendrocytes and increasing the local synthesis of the major protein in 
the myelin sheath, MBP. Interestingly in this study, the glutamatergic signalling to 
OPCs was partly mediated by NMDA receptors and metabotropic glutamate receptors, 
(Wake et al., 2011), suggesting that NMDA receptors play an important role in activity-
dependent myelination. It is not clear why these separate studies report contradictory 
findings on the importance of NMDA receptor signalling in oligodendrocyte lineage 
cells. Perhaps these differences result from compensatory mechanisms, such as an 
upregulation of Ca2+-permeable AMPA receptors, which occur after the genetic deletion 
of NMDA receptors, to ensure that OPC maturation and myelination proceed. Thus, 
further work will be required to shed light on the functional role of NMDA receptor 
signalling at OPC synapses, and in OPC development and myelination. 
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1.4.2.2 GABA receptors 
GABAA receptors are pentameric assemblies of subunits that form a central 
anion channel. Nineteen GABAA receptor subunits have been cloned from the 
mammalian CNS (α1-6, β1-3, γ1-3, δ, ε, θ, π and ρ1-3), but the most abundantly 
expressed receptor subtype in the brain is formed from α1, β2 and γ2 subunits (Pirker et 
al., 2000). The minimum requirement for a functional channel is the expression of α 
and β subunits, which form the binding site for GABA, and in some cases γ, δ, ε and π 
subunits are also included in GABAA receptors. The principle action of the inhibitory 
neurotransmitter GABA, which is mediated by GABAA receptors, is to increase 
membrane permeability to Cl- ions. In most neurons, this leads to a net influx of Cl- and 
a hyperpolarising response, however the direction of Cl- flow depends on the 
intracellular concentration of Cl- ([Cl-]i) and HCO3- (which also permeates the channel), 
as discussed below. 
Several studies have demonstrated that GABA can evoke membrane currents 
in oligodendrocyte lineage cells (Bormann and Kettenmann, 1988; Gilbert et al., 1984; 
Kettenmann et al., 1984; Pastor et al., 1995; Barres et al., 1990; Von et al., 1991). 
However, previously GABAA receptor expression has been reported to be 
downregulated as OPCs mature into myelinating oligodendrocytes (Kirchhoff and 
Kettenmann, 1992).  I investigate GABA signalling in oligodendrocyte lineage cells in 
chapter 5 of this thesis. 
In addition to receiving glutamatergic input from neurons, OPCs also receive 
synaptic input from GABAergic interneurons in the grey matter (Lin and Bergles, 2004; 
Velez-Fort et al., 2010) and from inhibitory projection axons in some white matter tracts 
(Karadottir et al., 2008). Activation of GABAA receptors on neurons is known to induce 
either a depolarisation or a hyperpolarisation, depending on whether the reversal 
potential is more positive or more negative than the resting potential. This is partly 
determined by the [Cl-]i, which is regulated by the expression of Cl- cotransporters on 
the cell membrane, and also by the presence of HCO3- which permeates the channels 
and makes the reversal potential more positive (since EHCO3-=-20 mV). The relative 
expression of the Na+-K+-Cl- cotransporter 1 (NKCC1) which transports Cl- into the cell, 
and K+-Cl- cotransporter 2 (KCC2) which transports Cl- out of the cell, determines the 
[Cl-]i (Ben-Ari, 2002; Tyzio et al., 2011). Immature neurons maintain a high [Cl-]i 
because of their high expression of NKCC1, relative to their low expression of KCC2, 
and consequently GABA exerts a depolarising action on immature neurons, triggering 
activation of voltage-gated Na+ channels, and perhaps Ca2+ channels to elevate [Ca2+]i 
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(Ben-Ari, 2002). Similarly, activation of GABAA receptors in hippocampal OPCs induces 
membrane depolarisation, due to the high [Cl]i, and subsequent efflux of Cl- through 
GABAA receptors in OPCs (Lin and Bergles, 2004). Activation of GABAA receptors in 
OPCs also induced a transient inhibition of AMPA receptor mediated currents (Lin and 
Bergles, 2004), suggesting that GABA can somehow also regulate the efficacy of 
glutamatergic signalling in OPCs.  
The function of the GABAergic input to OPCs has yet to be determined, and so 
far contradictory results have been reported concerning the effects of GABA on 
oligodendrocyte lineage cells. On the one hand GABA has been reported to have no 
effect on OPC development (Gallo et al., 1996; Yuan et al., 1998), while on the other 
hand, GABA has been reported to induce Ca2+ transients in OPCs which can stimulate 
their migration (Tong et al., 2009). Recently, the structure of interneuron–OPC 
synapses has been reported to change during development, so that at later times the 
peak GABA concentration experienced by the OPCs is reduced (Velez-Fort et al., 
2010), suggesting that GABA signalling to OPCs may become reduced during 
development. OPCs may themselves modify the GABA concentration that they 
experience, since they are thought to express plasma membrane GABA transporters 
(Cahoy et al., 2008). In chapter 5 of this thesis, I investigate whether GABA can 
regulate OPC proliferation, differentiation and myelination. 
1.5 Adult oligodendrocyte precursor cells 
Adult OPCs were first identified in the rat optic nerve and later in other parts of 
the adult mammalian CNS (Ffrench-Constant and Raff, 1986; Wolswijk and Noble, 
1989; Engel and Wolswijk, 1996; Reynolds and Hardy, 1997; Chang et al., 2000; 
Horner et al., 2000). Like perinatal OPCs, adult OPCs express NG2 and PDGFRα, and 
(in vitro) respond to the mitogen PDGF-AA by dividing and migrating (Shi et al., 1998; 
Wolswijk and Noble, 1989). A few prominent differences have been identified when 
adult OPCs were compared to their perinatal counterparts. For example, adult OPCs 
are reported to have more extensive processes, longer cell cycle times, and slower 
differentiation (Psachoulia et al., 2009) and slower migration rates (Wolswijk and 
Noble, 1989), when compared to perinatal OPCs. However, if their intracellular levels 
of cAMP were sufficiently elevated, adult OPCs could be induced to divide as rapidly as 
perinatal OPCs (Shi et al., 1998), suggesting that adult OPCs may have the capacity to 
proliferate at a faster rate under the correct environmental conditions. 
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Due to their obvious similarities to perinatal OPCs, adult OPCs have been 
widely presumed to be glial precursors, playing a role in CNS maintenance, and 
replacing oligodendrocytes that die as a result of injury, disease or as part of the 
ageing process. However, given the significant numbers of OPC in the adult brain, 
which represent 5% of all the cells in the CNS (Dawson et al., 2003), and their 
distribution throughout white and grey matter areas, it has been suggested that they 
might also have another role unrelated to myelination. Moreover, the complex process-
bearing morphology of OPCs in vivo seems more in keeping with differentiated cells 
than immature precursors. Anatomical studies have revealed that OPCs form close 
contacts with neurons - with axons at nodes of Ranvier and in close proximity to 
synapses at neuronal cell bodies (Butt et al., 1999; Wigley and Butt, 2009). 
Furthermore, since OPCs receive glutamatergic and GABAergic synaptic input from 
neurons in both white and grey matter brain areas (Bergles et al., 2000; Lin and 
Bergles, 2004; Kukley et al., 2007; Ziskin et al., 2007; Karadottir et al., 2008; Mangin et 
al., 2008; Ge et al., 2009; De Biase et al., 2010; Velez-Fort et al., 2010), it seems 
possible that OPCs might participate in neural processing, by sensing neuronal activity 
and reporting this activity to neighbouring neurons or glia. At present, however, no 
output signal, such as neurotransmitter vesicle release, has been reported to occur in 
OPCs (Bakiri et al., 2009). Therefore, it is currently thought that signals that OPCs 
receive from neurons play an intrinsic role within the OPCs to regulate their 
proliferation, differentiation and myelination. In addition, this communication from 
neurons may also lead to an enhanced myelination of active circuits, contributing to 
circuit plasticity during adulthood. In chapter 4, I compare the properties of perinatal 
OPCs with young adult OPCs. 
1.6 Cell fate of oligodendrocyte precursor cells 
The idea that OPCs are multipotential began almost 30 years ago, with the 
discovery of a class of glial precursor - “O-2A progenitors” - that could generate 
oligodendrocytes or type-2 astrocytes in cultures of perinatal rat optic nerve cells (Raff 
et al., 1983). These O-2A progenitors expressed a range of defining molecular markers 
including NG2 and the PDGFRα, and later became known as NG2 cells or OPCs. More 
recently it was demonstrated that OPCs purified from early postnatal (P6) rat optic 
nerves could be reprogrammed into multipotent stem cells by first treating with fetal calf 
serum or bone morphogenetic proteins (BMPs) to generate type-2 astrocytes, followed 
by growth in basic fibroblast growth factor (bFGF) to generate free-floating balls of 
cells (neurospheres) containing neural stem cells (Kondo and Raff, 2000). Individual 
cells from these neurospheres could give rise to colonies containing a mixture of 
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neurons, astrocytes, and oligodendrocytes (Kondo and Raff, 2000), therefore indicating 
that OPCs are indeed multipotential in vitro. 
With the development of Cre-lox technology in transgenic mice (described in 
chapter 2), many labs investigated the cell fate of OPCs in vivo.  These studies 
demonstrated that the most common cell type generated by OPCs are myelinating 
oligodendrocytes, both in the normal and injured CNS (Rivers et al., 2008; Zhu et al., 
2008; Psachoulia et al., 2009; Kang et al., 2010; Zhu et al., 2011a). However, in 
addition to oligodendrocytes, OPCs were also found to generate protoplasmic 
astrocytes within the grey matter of the ventral forebrain and spinal cord of perinatal 
mice (Zhu et al., 2008; Zhu et al., 2011a). In contrast, when the cell fate of OPCs was 
traced in the postnatal CNS, no astrocytes were found among the progeny of OPCs 
(Rivers et al., 2008; Kang et al., 2010; Zhu et al., 2011a). These data suggest that 
there are two distinct subtypes of OPC - astrogenic and oligodendrogenic OPCs in the 
embryonic CNS, whereas only the oligodendrogenic type of OPCs exists in the post-
natal CNS. 
Following the discovery that when OPCs are exposed to the appropriate 
environmental signals they can revert to a multipotent state, giving rise to neurons, 
oligodendrocytes and astrocytes in culture (Kondo and Raff, 2000), widespread interest 
arose in the idea that OPCs could provide new neurons and glia in diseases involving 
neuronal and glial cell loss. A number of studies encouraged this idea, with the findings 
that OPCs express neuronal precursor markers such as doublecortin (DCX), which is 
expressed by migratory neuronal progenitors (Tamura et al., 2007; Guo et al., 2010). 
Furthermore, SVZ and hippocampal stem cells have been reported to express NG2 
(Belachew et al., 2003; Aguirre and Gallo, 2004) and PDGFRα (Jackson et al., 2006), 
indicating that OPCs may be neural stem cells.   
Interestingly, although Cre-lox fate mapping studies, using independent 
transgenic mouse lines (Pdgfrα-CreERT2: Rosa26-YFP mice (Rivers et al., 2008) and 
Plp1-CreT2: Rosa26-YFP mice (Guo et al., 2010), demonstrated that OPCs 
predominantly generated oligodendrocytes, in addition, new projection neurons derived 
from OPCs were reported to be added to the piriform cortex (see section 1.8.4 of this 
chapter) throughout life (Rivers et al., 2008; Guo et al., 2010). These neurons gradually 
appeared and accumulated solely in layers 2 and 3 of the piriform cortex (Fig. 1.7B), 
they acquired NeuN reactivity and they resembled piriform projection neurons 
morphologically. In addition, these neurons did not label for the cell proliferation marker 
BrdU (even after several months of BrdU exposure), suggesting that they were formed 
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by the direct transformation of a functionally distinct post-mitotic population of OPCs in 
the piriform cortex (Rivers et al., 2008; Psachoulia et al., 2009; Guo et al., 2010). 
These studies provided the most convincing evidence that OPCs may generate 
neurons in vivo.  
In contrast, using an independently generated line of Pdgfrα-CreER T2 mice, 
Kang et al. (2010) failed to detect any newly generated long-term surviving neurons, 
derived from OPCs, in the piriform cortex or elsewhere in the forebrain. The reason for 
the observed differences in the generation of neurons by OPCs remains unclear. 
However, these data suggest that new neurons are being produced (possibly from 
OPCs) in the adult piriform cortex. The anterior piriform cortex is part of the olfactory 
bulb circuit, which is known to be highly plastic with new neurons being added to the 
olfactory neuroepithelium of the nose and to the olfactory bulb, in adulthood (Young et 
al., 2007). These new neurons are generated from epithelial stem cells and from SVZ 
stem cells, respectively. Furthermore, these studies raise the question of whether 
OPCs in the piriform cortex are functionally distinct from OPCs in other brain regions. 
Indeed,  some OPCs in the piriform cortex are reported to express the neuroblast 
marker PSA-NCAM and the neural precursor markers Sox2 and Pax6 (Seki and Arai, 
1993; Hayashi et al., 2001; Nacher et al., 2002; Pekcec et al., 2006; Shapiro et al., 
2007; Bullmann et al., 2010; Guo et al., 2010), suggesting they might be a functionally 
distinct cell population.  
In chapter 4 of this thesis, I investigate whether OPCs in the piriform cortex 
have physiological properties inherently different from those in other brain regions. 
1.7 Death of oligodendrocytes in ischaemia  
Both oligodendrocytes and their precursors are damaged, leading to mental and 
physical disabilities, in conditions such as cerebral palsy (Back et al., 2001), spinal cord 
injury (Park et al., 2004), stroke (Tomimoto et al., 2003), multiple sclerosis (Werner et 
al., 2001) and the genetic leukodystrophies (Lappe-Siefke et al., 2003). Preventing 
oligodendrocyte damage is crucial to maintaining action potential transmission along 
axons.  
Ischaemia is a restriction in blood supply, which consequently restricts the 
energy supply, because the blood supplies cells with oxygen and glucose, both of 
which are indispensable for cell viability. Brain ischaemia occurs when the blood supply 
is cut-off during cardiac arrest or in stroke when the blood supply to a localised region 
of the brain is interrupted as a result of a blood clot occluding a vessel or a vessel 
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bursting. Ischaemia causes a depletion of cellular ATP and intra- and extracellular 
acidification. While there are several alternatives to glucose (such as lactate and fatty 
acids), there are no alternatives to oxygen, which is vital for driving mitochondrial 
respiration and the production of ATP by oxidative phosphorylation. The fall in 
intracellular ATP levels inhibits all ATP-dependent processes, notably the Na+-K+-
ATPase which uses 75% of all brain energy (Attwell and Laughlin, 2001). The Na+-K+-
ATPase is vital for maintaining ionic gradients within the brain, and therefore if its 
function is inhibited all ion and voltage-gradients run down. As a result, the extracellular 
K+ concentration rises, ultimately to approximately 50-60 mM in the grey matter (15 mM 
in the white matter) which evokes depolarisation (Hansen, 1985; Ransom et al., 1992), 
and triggers an initial increase in neuronal action potential firing (Hamann et al., 2005), 
followed by an cessation of action potential activity. A high extracellular K+ 
concentration also leads to an increase in neurotransmitter release from neurons and 
glia (Li et al., 1999). Both neurons and oligodendrocytes release glutamate in response 
to ischaemia, by a reversal of their sodium-dependent glutamate transporters (driven 
by the alteration of the ion gradients) (Li et al., 1999; Rossi et al., 2000). The resulting 
rise in the extracellular glutamate concentration triggers damage to neurons and glial 
cells. 
As all oligodendrocyte lineage cells express glutamate receptors, part of their 
ischaemic damage results probably from the released glutamate activating NMDA 
receptors (Matute et al., 1997; Karadottir et al., 2005; Karadottir et al., 2008;) and 
AMPA/kainate receptors (Matute et al., 1997; Fern and Moller, 2000; Tekkok and 
Goldberg, 2001; Deng et al., 2003) on oligodendrocytes and their precursors. However, 
other mechanisms and transmitters involved in the death of oligodendrocyte lineage 
cells in pathological conditions are largely unknown.  
GABAergic signalling may play a role in many pathological conditions. GABA is 
released in the white matter during ischaemia (Shimada et al., 1993) and may activate 
GABAA receptors present on oligodendrocytes and their precursors. It is currently 
unclear whether GABA release exerts a beneficial effect by limiting depolarisation 
produced by glutamate release (Lutz, 1992) or a harmful effect since Cl- influx 
facilitates water influx leading to cell swelling (Allen and Attwell, 2004). In chapter 5 of 
this thesis, I investigate GABAergic signalling to oligodendrocytes during ischaemia. 
In response to demyelinating diseases such as multiple sclerosis, adult OPCs 
are reported to divide and differentiate, providing a major source of new 
oligodendrocytes for remyelination (Levine, 1994; Gensert and Goldman, 1997; Levine 
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et al., 2001). In addition, transplantation of OPCs has been suggested as a potential 
therapeutic strategy to repair damage caused to oligodendrocytes in neurological 
diseases (Windrem et al., 2008). Importantly, the efficiency of remyelination following 
experimental demyelination is reported to decrease with age, which might be attributed 
to an age-related decline in the regenerative properties of OPCs (Sim et al., 2002). The 
factors that cause these age-related changes in OPCs are currently unknown, but they 
are likely to be related to changes in the ability of OPCs to proliferate and generate 
new oligodendrocytes as the brain ages. If these changes in OPC behaviour with age 
could be understood, it might be possible to manipulate the properties of OPCs in the 
ageing brain to improve their regenerative properties. 
1.8. The structure and function of the brain areas studied 
1.8.1 The corpus callosum  
In chapters 3 and 4, I report experiments on white matter oligodendrocyte 
lineage cells in the corpus callosum. The corpus callosum is the largest white matter 
structure in the brain, consisting of hundreds of millions of axons (Fig. 1.8). The corpus 
callosum connects and transfers motor, sensory and cognitive information between the 
left and right cerebral hemispheres. The majority of the corpus callosal fibres are 
excitatory, and originate from pyramidal cells in layers II/III and V of the cortex. These 
axons terminate on the spines of pyramidal cells in the contralateral cortex (Kumar and 
Huguenard, 2001). In addition, inhibitory fibres have been detected in the corpus 
callosum perinatally, however, these fibres disappear during development (Kimura and 
Baughman, 1997). 
The corpus callosum was studied in chapter 3, because the oligodendrocyte 
lineage cells in this region are derived from separate dorsal and ventral progenitor 
pools within the developing brain (Kessaris et al., 2006). Since it was not known 
whether oligodendrocyte lineage cells derived from dorsal and ventral progenitors are 
functionally distinct, I compared their physiological properties in the corpus callosum. 
The corpus callosum was also studied in chapter 4, firstly, in order to compare the 
properties of OPCs in this white matter area with OPCs in grey matter areas (such as 
the motor cortex and the anterior piriform cortex), and secondly so that the properties 
of OPCs could be compared at different stages of myelination (at P9 when myelination 
is beginning, and at P35 when ~70% of the fibres are myelinated (Hamano et al., 
1998)).   
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1.8.2 The cortex 
In chapters 4 and 5, I report experiments on grey matter oligodendrocyte 
lineage cells in the motor cortical area (henceforth called the motor cortex or Ctx). The 
motor cortex is located in the posterior portion of the frontal lobe (Fig. 1.8). The motor 
cortex is centrally involved in mammalian motor behaviour and the cortical control of 
movement.  Multiple long-range excitatory input pathways converge on primary somatic 
motor cortex (M1) (Weiler et al., 2008). These include corticocortical projections 
(carrying ipsi- and contralateral sensorimotor information), thalamocortical projections 
(carrying cerebellar and basal ganglionic information via the thalamic ventrolateral 
nucleus, as well as sensory and other information via multiple additional 
thalamocortical pathways) and neuromodulatory projections from brainstem and other 
areas (Weiler et al., 2008). Major outputs from M1 include projections to spinal motor 
centers, striatum, cerebellum, thalamus, subthalamus, red nucleus and pons (Weiler et 
al., 2008). All of the excitatory neurons in M1 are pyramidal neurons projecting to one 
or several of these long-distance targets (Weiler et al., 2008).  
Myelination of motor cortical axons can be detected between the second and 
third postnatal week in the rodent brain (Bjelke and Seiger, 1989), and new myelinating 
oligodendrocytes continue to be added to the cortex throughout adulthood - a process 
which can even be detected in the aged brain (Psachoulia et al., 2009; Rivers et al., 
2008).  
The motor cortex was studied in chapter 4, firstly, so that a comparison could 
be made between grey matter OPCs in this region and white matter OPCs, and 
secondly so that the properties of OPCs could be compared at different stages of 
myelination (at P9 before cortical myelination has begun, and at P35 when some fibres 
in the motor cortex have been myelinated (Bjelke and Seiger, 1989)). In addition, in 
chapters 5 and 6, a cultured cortical model of myelination was used, as described by 
Rinholm et al. (2011), in which the progress of myelination can be observed. Briefly, 
myelination develops over a period of about 2 weeks in these cultured slices (see 
chapter 5). Initially many oligodendrocyte lineage cells are visible but no myelination 
can be detected then, as neuronal processes develop, gradually myelin basic protein 
appears.  
1.8.3 The cerebellum 
In chapters 4 and 5, I report experiments on oligodendrocyte lineage cells in the 
white and grey matter regions within the cerebellum. The cerebellum is located behind 
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the cerebral cortex, and it plays an important role in the coordination, precision, and 
accurate timing of motor movements. Anatomically, the cerebellum can be divided into 
three lobes: the flocculonodular, the anterior and the posterior lobes. The latter two can 
be further divided into the central vermis and the two lateral cerebellar hemispheres. 
My experiments were carried out in the grey matter and white matter areas of the 
vermis. The cerebellar vermis is composed of a series of folia, and within each folium 
three cell layers can be distinguished: the molecular, the Purkinje and the granular 
layers (Fig. 1.9). In addition, in the first 2 postnatal weeks there is an extra outer layer 
of developing granule cells (the external granular layer). The outermost layer of the 
adult cerebellar cortex is the molecular layer, which contains two types of inhibitory 
interneuron: the stellate and basket cells. It also contains the dendritic arbors of 
Purkinje neurons and the parallel fibre axon tracts from the granule cells (Fig. 1.9). 
Both stellate and basket cells form GABAergic synapses onto the Purkinje cell. The 
middle neuronal layer is the Purkinje cell layer which contains the cell bodies of the 
Purkinje neurons (Fig. 1.9). As these cells are the sole output neurons of the cerebellar 
cortex they are central to cerebellar cortical information processing. The innermost 
neuronal layer is the granular layer which contains the cell bodies of the small densely 
packed excitatory granule cells and inhibitory Golgi cells (Fig. 1.9). OPCs can be found 
throughout all of these grey matter layers by the end of the first postnatal week. Finally, 
the white matter layer, which is primarily composed of axons, oligodendrocyte lineage 
cells and astrocytes, lies underneath the granular layer.  
There are two main afferents to the cerebellar cortex, the climbing fibres which 
make direct excitatory contact with the Purkinje cells, and the mossy fibres which 
terminate in the granular layer and make excitatory contacts with the granule cells and 
the Golgi cells (Apps and Garwicz, 2005) (Fig. 1.9). The granule cells recode mossy 
fibre information (modulated by Golgi cell inhibition) into action potentials which 
propagate along the parallel fibres that excite both the Purkinje cells and the molecular 
layer interneurons (the stellate and basket cells). 
The climbing and mossy fibre axons also form collaterals with the deep 
cerebellar nuclei (Fig. 1.9). The output from the cerebellar cortex passes along 
GABAergic axons from the Purkinje cells, which synapse onto the cells in the deep 
cerebellar nuclei, which then in turn send excitatory axons to many areas of the brain 
including the pons, the spinal cord, the red nucleus, the cortex and the thalamus. With 
the exception of the granule cells, all the cerebellar cortical neurons, including the 
Purkinje cells, make inhibitory synaptic connections with their target neurons (Apps and 
Garwicz, 2005).  
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The oligodendrocyte lineage cells in the cerebellum arise from neural 
progenitors in the fourth ventricle (Reynolds and Wilkin, 1988). Myelination of the 
axons entering and leaving the cerebellar cortex (but not within the cortex itself) begins 
at the end of the first postnatal week and continues until myelination is complete, at the 
end of the first postnatal month (Hamano et al., 1998). 
The experiments in chapter 4 were performed at P9 and P35 to compare the 
properties of OPCs when myelination is beginning and when myelination is almost 
complete. Furthermore, the properties of OPCs in the cerebellar white matter have 
been extensively studied in the rat (Karadottir et al., 2008), so I could compare their 
properties with transgenically labelled OPCs in the mouse, and subsequently with 
OPCs in other grey and white matter areas at different developmental stages. The 
experiments in chapter 5 were performed in the white matter of the cerebellum, at P7 
when OPCs reach their peak density (Levine et al., 1993), and at P12 when 
myelination has begun, in order to locate myelinating oligodendrocytes for patch clamp 
recordings. These experiments were performed in the cerebellar white matter, because 
the morphological and electrophysiological characteristics of OPCs and mature 
myelinating oligodendrocytes have been previously characterised in this region (Bakiri 
et al., 2011). 
1.8.4 The piriform cortex 
In chapter 4, I describe experiments on oligodendrocyte lineage cells in the 
piriform cortex. The primary function of the piriform cortex (which is also known as the 
primary olfactory cortex) is to process odorant information from the olfactory bulb. The 
piriform cortex is divided into the anterior (aPC) and the posterior (pPC) regions (Fig. 
1.7A). The piriform cortex has a laminar structure, with three layers and receives direct 
input from the olfactory bulb via the lateral olfactory tract (LOT) (Suzuki and Bekkers, 
2007) (Fig. 1.7B). Layer I contains many axons and dendrites, but only a few neuronal 
somata. The more superficial part (Layer Ia) receives afferent axons from the LOT, 
whereas the deeper part (Layer Ib) receives associational fibres from within the piriform 
cortex (Suzuki and Bekkers, 2007). Layer II is densely packed with the somata of 
glutamatergic principal neurons, the main cells receiving input in the piriform cortex 
(Suzuki and Bekkers, 2007). Layer III contains a lower density of neuronal somata and, 
like Layer Ib, a high density of associational fibres (Suzuki and Bekkers, 2007).  
The main input layer of the piriform cortex, layer II, contains two functionally 
distinctive types of principle neurons, semilunar cells which receive strong input from 
the olfactory bulb and superficial pyramidal cells which receive strong intracortical 
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(associative) input from fibres within the piriform cortex (Suzuki and Bekkers, 2006) 
(Fig. 1.7B). The olfactory circuit has long been known to be highly plastic, with new 
neurons being added to the olfactory neuroepithelium of the nose and to the olfactory 
bulb, in adulthood (Young et al., 2007). These new neurons are generated from 
epithelial stem cells and from SVZ stem cells, respectively. In addition, new projection 
neurons are added to layer II of the piriform cortex throughout life, and importantly 
these neurons are thought to be generated by OPCs (Rivers et al., 2008; Guo et al., 
2010). Furthermore, these new neurons generated by OPCs displayed similar 
morphologies to the principal neurons in layer II (Rivers et al., 2008; Guo et al., 2010), 
suggesting that these neurons mature and may integrate into the olfactory circuit. 
The piriform cortex appears to be the only brain region where OPCs generate 
neurons, which accumulate in significant numbers (Rivers et al., 2008; Guo et al., 
2010), raising the question of whether OPCs in this region are functionally distinct. 
Therefore in chapter 4, I compare the properties of OPCs in the piriform cortex with 
OPCs in other brain regions (including the corpus callosum and motor cortex), to 
determine whether they differ.  
1.8.5 The optic nerve 
In chapter 6 I describe experiments searching for activity-dependent nodal 
adjustments, which could affect the conduction speed of action potential propagation, 
in the optic nerve. 
The optic nerve transmits visual information from the retina to the brain. In the 
retina, the photoreceptors which absorb light, form glutamatergic synapses with retinal 
bipolar interneurons which in turn form glutamatergic synapses with retinal ganglion 
cells. Two layers of inhibitory interneurons, the horizontal and amacrine cells, modulate 
information flow through this pathway. The retinal ganglion cell axons converge to form 
the optic nerve. The majority of the retinal ganglion axons project to, and form 
synapses with the neurons in, the lateral geniculate nucleus, which in turn projects to 
the primary visual cortex of the brain. 
The oligodendrocytes in the optic nerve are derived from neural progenitor cells 
in the third ventricle, which migrate from the optic chiasm towards the retina (Ono et al., 
1997). Myelination of the optic nerve begins at the end of the first postnatal week, and 
by P21 (the age at which my experiments were performed) myelination is ~70% 
complete (Foster et al., 1982). The optic nerve was used for the experiments described 
in chapter 6, because it is a myelinated white matter tract which lacks neuronal cell 
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bodies, and therefore allows white matter and nodal plasticity to be studied without any 
confounding effects from neurons. 
1.8.6 The spinal cord 
In chapter 3 I describe experiments on white matter oligodendrocyte lineage 
cells in the spinal cord. The spinal cord is the main pathway for information connecting 
the brain and peripheral nervous system. In cross-section, the outermost region of the 
spinal cord consists of motor and sensory axons, the majority of which are myelinated 
(~12-40% of axons are unmyelinated in the adult mammalian spinal cord (Chung and 
Coggeshall 1983; Chung et al., 1985)). These axons transmit information either up or 
down the spinal cord (Fig. 1.3B). The innermost region at the centre of the spinal cord 
contains the cell bodies of motor neurons, ascending sensory neurons, and 
interneurons (Fig. 1.3B). The spinal cord can be divided into segments based on the 
origins of the spinal nerves, which include the cervical, thoracic, lumbar, sacral and 
coccygeal nerves. Each segment of the spinal cord is associated with a pair of ganglia, 
called dorsal root ganglia, which are situated just outside of the spinal cord.  
Somatosensory information is transmitted up the spinal cord via the dorsal 
column-medial lemniscus tract and the anterolateral system. These sensory pathways 
transmit information from sensory receptors located in the peripheral nervous system to 
the thalamus and cerebral cortex. In both pathways, primary sensory neuron cell 
bodies are found in the dorsal root ganglia, and their central axons project into the 
spinal cord. The corticospinal tract serves as the motor pathway for upper motor 
neuronal signals coming from the cerebral cortex and transmits information to 
motorneurons projecting to the periphery, which regulate fine movements by distal 
muscles. The spinal cord begins to myelinate at the end of the first postnatal week and 
myelination is complete by the end of the first postnatal month (Hamano et al., 1996).  
The spinal cord was studied in chapter 3, because the oligodendrocyte lineage 
cells in this region are derived from separate dorsal and ventral progenitor pools (Cai et 
al., 2005; Fogarty et al., 2005). Currently, it is not known whether oligodendrocyte 
lineage cells derived from dorsal and ventral progenitors are functionally distinct, so I 
compared their physiological properties in the spinal cord. 
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1.9 Aims of thesis 
The experiments performed in this thesis had the following aims: 
1. The experiments in Chapter 3 investigate functional differences between 
oligodendrocyte lineage cells, in the same region of the CNS (brain or spinal 
cord) that are derived from dorsal and ventral progenitor populations. I used a 
dual reporter mouse line in which OLs are fluorescently labelled green or red, 
depending on their developmental origin, and I patch-clamped dorsally- and 
ventrally-derived OLs and compared their electrophysiological and 
morphological properties to investigate whether they are functionally distinct. 
2. The experiments in Chapter 4 investigate whether OPCs in different brain 
regions have similar properties. OPCs were originally assumed to be a 
homogenous class of cell, but have since been subdivided according to their 
electrical properties, gene expression profiles, proliferation rates, response to 
injury and their capacity to generate different cell types including neurons. To 
better understand the diversity of OPCs, I patch-clamped OPCs to investigate 
their expression of voltage-gated ion channels, their proliferative capacity and 
their cell fate in different brain regions. 
3. The experiments in Chapter 5 investigate the properties of GABA-evoked 
currents in oligodendrocyte lineage cells, and how GABAergic signalling 
regulates their proliferation, differentiation and myelination. 
4. The experiments described Chapter 6, describe other less developed research 
projects I performed during my PhD. In this chapter, I investigate nitric oxide 
signalling to oligodendrocyte lineage cells and activity-dependent nodal 
plasticity. 
The results of each chapter are assessed in a discussion section within each 
chapter. In chapter 7, a global summary is provided and future directions for 
carrying on this work are suggested. 
Figure 1.1. Oligodendrocyte lineage cell development. 
Oligodendrocyte lineage cells are derived from proliferative neural progenitor cells, 
which lack expression of NG2 and PDGFRα, but some of these progenitors express 
OLIG2 (proliferation is indicated by red arrows). As the neural progenitors differentiate  
into proliferative oligodendrocyte precursor cells (OPCs) they express the precusor 
markers NG2 and PDGFRα, as well as the oligodendrocyte lineage cell markers OLIG2 
and SOX10. As OPCs exit the cycle cell and undergo terminal differentiation, they lose 
expression of NG2 and PDGFRα, and begin to express the immature marker O4, 
followed by PLP, galactocerebroside (GalC), myelin associated protein (MAG), 
2’,3’-cyclic nucleotide 3’-phosphodiesterase, myelin oligodendrocyte glycoprotein 
(MOG) and myelin basic protein (MBP).  The differentiation of OPCs is also accompa-
nied by a change in morphology. Premyelinating cells have longer processes which 
cover a larger area, when compared with OPCs. Myelinating oligodendrocytes have 
numerous processes which are aligned with the axons that they myelinate.
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Figure 1.2. Progenitor domains in the embryonic spinal cord
Schematic diagram illustrating the progenitor domains in the embryonic spinal cord 
which generate the oligodendrocyte lineage cells, astrocytes and neurons. The 
transcription factors expressed by the progenitor cells in each domain are indicated. The 
majority (~85%) of the oligodendrocytes in the spinal cord originate from the pMN 
domain. A small number of oligodendrocytes also originate from the p1 and p0 domains. 
Later in development, OPCs arise from more dorsal domains, such as dP1-dP6. 
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Figure 1.3. Origins of oligodendrocytes in the spinal cord
A. In the mouse spinal cord ~85% of the oligodendrocyte lineage cells are generated 
from the pMN domain in the ventral ventricular zones at ~E12.5 (red arrows). At about 
~E15, a second wave of oligodendrocytes is generated from more dorsal progenitor 
regions (green arrows). B.  A schematic diagram of the adult spinal cord showing grey 
matter regions (coloured grey) and white matter regions (coloured white). The dorsal 
funiculus (DF) contains the cortical spinal tract (CST), fasciculus gracilis (FG) and 
fasciculus cuneatus (FC) white matter tracts. The ventral funiculus (VF) is located in the 
ventral part of the spinal cord. The lateral funiculus (LF) contains the rubrospinal white 
matter tracts (RST).  
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Figure 1.4. Progenitor domains in the telencephalon
In the telencephalon,oligodendrocytes are produced in three waves. Firstly, the 
ventral-most progenitors in the medial ganglionic eminence (MGE), expressing the 
transcription factor Nkx2.1, produce oligodendrocytes from about E12.5 (1). Next, 
progenitors in the lateral ganglionic eminence (LGE), expressing the transcription factor 
Gsh2, generate oligodendrocytes a few days later (2). The last wave of oligodendrocytes 
are produced from cortex-derived precursors, expressing the transcription factor Emx1, 
mainly after birth (3).
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Figure 1.5. Myelin sheaths enwrapping axons
An electron micrograph showing myelinated axons in the corpus callosum of an adult 
mouse. Axons are surrounded my multiple layers of myelin. (Image provided by Kaylene 
Young). 
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Figure 1.6. Node of Ranvier in the CNS
Diagram displaying the molecular composition of the domains at the node of Ranvier, 
with one adjacent myelin sheath shown on the right (another exists to the left of the 
node). The nodes of Ranvier are the sites for action potential regeneration, and are 
therefore highly enriched in voltage-gated Na+ channels (Nav1.6), which are clustered 
and anchored at the nodes via interactions with axonal neurofascin-186 (NF186), 
neuron-glial-related nodal axonal cell adhesion molecule (NrCAM), ankyrin-G and βIV 
spectrin. The paranode contains the axonal protein contactin-associated protein (Caspr) 
and contactin which form complexes with the glial 155 kDa isoform of neurofascin, which 
form of the septate-like junctions between the myelin and the axon. The juxtaparanodes 
lie just under the compact myelin sheath immediately adjacent to the paranodes and 
have high densities of voltage-gated K+ channels (Kv1) and NrCAMs, Caspr2 and 
TAG-1.
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Figure 1.7. Structure of the piriform cortex
Schematic diagram of the location and anatomy of the piriform cortex (PC). A. 
Ventrolateral aspect of the rat brain, showing the olfactory bulb (OB), lateral olfactory 
tract (LOT) and the locations of the anterior (a) and posterior (p) PC. A coronal slice of 
the aPC, taken between the arrows, shows the laminar structure illustrated 
schematically in (B). B. The three main layers of the PC, with superficial and deep 
sublaminae (a and b, respectively). At the left is a schematic representation of the 
density of neuronal somata in each layer, showing the high density of mainly principal 
cells in Layer II and a lower density of neurons in Layers I and III. Schematic diagrams 
of the dendritic trees of the two main types of Layer II principal cells (SP, superficial 
pyramidal; SL, semilunar) and one type of Layer III principal cell (DP, deep pyramidal) 
are shown in grey. Schematic diagrams of the dendritic trees of four types of GABAergic 
interneurons are shown in black (B, bitufted; G, neurogliaform; H, horizontal; M, 
multipolar). 
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Figure 1.8. Coronal section of the mouse forebrain 
The corpus callosum is the largest white matter tract in the brain which connects the 
right and the left hemispheres. The majority of the corpus callosal fibres are excitatory, 
and originate from pyramidal cells in layers II/III and V of the cortex. They terminate on 
the spines of pyramidal cells in the contralateral cortex. The motor cortex  (consisting of 
the primary motor cortex (M1) and secondary motor cortex (M2), highlighted by the 
regions inside the black dotted lines) is located above the corpus callosum in the 
posterior portion of the frontal lobe, and is centrally involved in mammalian motor 
behaviour and the cortical control of movement. Both of these brain regions were 
studied in this thesis.
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Figure 1.9. Simplified organisation of the cerebellar cortex.
The diagram shows the cytoarchitecture of the cerebellar cortex in a single folium of the 
cerebellar vermis. Each folium is composed of 3 layers (the molecular layer, the Purkinje 
layer and the granular layer). The white matter is located beneath the granular layer and 
the deep cerebellar nuclei are embedded in the white matter. Oligodendrocyte lineage 
cells are located thoroughout the cerebellar cortex, both myelinating oligodendrocytes in 
the white matter and OPCs in the molecular and granular layers. The cerebellar cortex 
recieves two types of excitatory afferent. The mossy fibres orginate from the brain stem, 
spinal cord and cortex, and contact the granule cells, deep cerebellar nuclear cells and 
Golgi cells (not represented here). Climbing fibres from the inferior olive directly synapse 
with the Purkinje cells, and also send collaterals to the deep cerebellar nuclei and the 
Golgi cells (not represented here). The granule cells, through their parallel fibre axons, 
excite Purkinje cells, which are the sole output of the cerebellar cortex and send inhibi-
tory synaptic connections to the deep cerebellar nuclear neurons. The parallel fibres 
also excite three types of inhibitory interneuron: the stellate and basket cells (not shown 
here) which inhibit the Purkinje cells and the Golgi cells that inhibit the granule cells. The 
deep cerebellar nuclei send excitatory axons to the motor system and the thalamus.
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Chapter 2: Methods 
This chapter explains the general methods used for experiments throughout the 
thesis. Further details of the specific methods used are provided in each results 
chapter. 
2.1 Slice and tissue preparation 
2.1.1 Preparation of cerebellar slices 
Sprague-Dawley rats, aged postnatal day 6-12 (P6-12), were used for the 
preparation of cerebellar slices for the experiments in Chapter 4 and 5. Animals were 
killed by cervical dislocation followed by decapitation. The head was immediately 
immersed in ice-cold oxygenated slicing solution, contained the following (in mM): 126 
NaCl, 24 NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, 2 MgCl2, 10 D-glucose, Na-
kynurenate 1 (to block glutamate receptors during the slicing process), pH 7.4 (bubbled 
with 95% O2/5% CO2). The skin was removed and the skull was opened by cutting 
between the eyes, followed by lateral cuts on both sides of the head from the anterior 
to the posterior. The excised region of the skull was lifted and the brain was removed 
and placed in ice-cold oxygenated slicing solution. To obtain parasagittal slices of the 
cerebellar vermis, the cerebellum was separated from the rest of the brain by making 
cuts through, and removing the inferior colliculus and the spinal cord. The cerebellar 
hemispheres on either side of the vermis were also removed to isolate the vermis. The 
cerebellum was mounted on one of these parasagittal cut surfaces on the stage of a 
vibrating tissue slicer (Vibratome) using superglue. The tissue was also stabilised using 
an agar block attached to the Vibratome stage. The cerebellum was immersed in ice-
cold oxygenated slicing solution throughout the slicing process. The cerebellar slices 
were cut at a thickness of 225 µm, and placed in oxygenated slicing solution at room 
temperature until they were used for recording. 
2.1.2 Preparation of forebrain slices 
Coronal forebrain slices were made from transgenic mice (aged P2-P40) in 
which GFP or tdTomato is expressed in oligodendrocyte lineage cells (Gsh2-
Cre:Sox10-GFP/tdTom mice (Tripathi et al., 2011)  were used in chapter 3, Sox10-GFP 
mice (Kessaris et al., 2006)  or Pdgfrα-GFP mice (Hamilton et al., 2003) were used in 
Chapters 4-6); these mice are described in detail below. Animals were killed and the 
brains were removed as described in section 2.1.1. Coronal sections of the forebrain 
were obtained by firstly removing the cerebellum to provide a flat surface by which to 
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attach the remaining forebrain to the slicing stage, and to ensure that the slices were 
prepared in the coronal plane. The forebrain was mounted on the stage of the 
Vibratome using superglue and stabilised using an agar block. The two hemispheres 
were separated by making a cut down the midline of the forebrain, and 225 µm slices 
were made in ice-cold oxygenated slicing solution. The slices were placed in 
oxygenated slicing solution at room temperature until they were used for recording. 
2.1.3 Preparation of spinal cord slices 
Msx3-Cre:Sox10-GFP/tdTom and Gsh2-Cre:Sox10-GFP/tdTom mice (Tripathi 
et al., 2011) in which GFP or tdTomato is expressed in oligodendrocyte lineage cells 
(as explained below), aged P6–P14, were used for the preparation of the longitudinal 
spinal cord slices used in chapter 3. Animals were killed as described in section 2.1.1. 
The spinal cord was removed by cutting the skin from the back of the head to the 
caudal end of the spine and peeling back the skin. The vertebral column was cut 
between the first vertebra and the skull, and then cuts were made along both sides of 
the vertebral columns, before making a transverse cut through the sacral region of the 
vertebral column. The intact spinal cord was then removed from the vertebrae by 
pulling the meninges at the cervical end. The meninges were removed by cutting along 
the midline of the spinal cord and then peeling the meninges back along the whole 
length of the cord. The spinal cord was transversely cut into separate ~1 cm segments 
before mounting on the stage of the Vibratome with superglue. The spinal cord 
segments were then sliced longitudinally at a thickness 150–160 µm in ice cold 
oxygenated slicing solution. The slices were placed in oxygenated slicing solution at 
room temperature until they were used for recording. 
2.1.4 Isolated optic nerve preparation 
Sprague-Dawley rats, aged P21-28, were used for the preparation of isolated 
optic nerves for the experiments in Chapter 6. After cervical dislocation, and removal of 
the skin surrounding the skull, a cut was made behind the eyeball to transect the optic 
nerve as distally as possible. The brain was removed as described in section 2.1.1, 
however as the brain was lifted from the skull the optic nerves were drawn through their 
optic canals, before transecting them at the optic chiasm. The isolated optic nerves 
were then placed in oxygenated slicing solution at room temperature until they were 
used for recording. 
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2.2 Solutions 
2.2.1 Extracellular solutions 
Brain slices and isolated tissue were perfused with solutions mimicking 
cerebrospinal fluid. For the experiments in chapter 3, HEPES-buffered solution was 
used, whereas for the experiments in chapters 4-6, bicarbonate-buffered solution was 
used. HEPES-buffered solution contained the following (in mM): 144 NaCl, 2.5 KCl, 2.5 
CaCl2, 1 MgCl2, 10 HEPES, 1 NaH2PO4, and 10 D-glucose, pH 7.4 (adjusted with 
NaOH). Bicarbonate-buffered solution contained the following (in mM): 126 NaCl, 24 
NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, 1 MgCl2, 10 D-glucose, pH 7.4 (bubbled with 
95% O2/5% CO2). The HEPES-buffered solution was oxygenated with 100% oxygen, 
maintained at room temperature, and the solution was applied to the recording 
chamber using a gravity-fed perfusion system at a rate of 6-10 ml/min. The 
bicarbonate-buffered solution was applied to the recording chamber by a peristaltic 
pump at a flow rate of 4 ml/min, and additionally it was passed through a heating block 
(in which the temperature was controlled by adjusting the current through a series of 
resistors attached to the heating block) to adjust the temperature to 33 ± 2°C.   
For the experiments in chapter 5, ischaemic conditions were mimicked in vitro 
by inhibiting glycolytic and mitochondrial ATP production by removing glucose and O2, 
and pharmacologically blocking ATP production. The bicarbonate-buffered solution 
described above was amended by replacing glucose with sucrose (7 mM), bubbling the 
solution with 95% N2/5% CO2 instead of 95% O2/5% CO2, and iodoacetate (2 mM) was 
added to block glycolysis and antimycin (25 µM) to block oxidative phosphorylation 
(Allen et al., 2005). 
2.2.2 Intracellular solutions 
Whole-cell patch clamping experiments in chapters 3-6 were performed using 
different intracellular solutions appropriate for each experiment. In general, a potassium 
gluconate based solution was used to record from OPCs in both voltage- and current-
clamp modes, whereas a caesium gluconate based solution was used to record from 
mature oligodendrocytes, to increase their membrane resistance and thus increase the 
cells’ electrical space constant. All internal solutions contained a fluorescent dye 
(Lucifer yellow, Alexa Fluor 488 or Alexa Fluor 568 were used depending on the 
genetically encoded florescent label expressed by the patch clamped cell) in order to 
visualise their morphology and allow post-recording immunohistochemistry. All of the 
internal solutions used are described in Table 2.1, and in each chapter. 
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2.3 Preparation and maintenance of organotypic slices 
Sox10-GFP mice (in which GFP is expressed in oligodendrocyte lineage cells 
(Kessaris et al., 2006)), aged P8, were killed as described in section 2.1.1. Brains were 
removed (as described in section 2.1.1) and placed into ice-cold Earle’s Buffered 
Saline Solution (EBSS; Invitrogen) containing 10 mM HEPES (Invitrogen), with the pH 
set to 7.3. Coronal forebrain slices (of thickness 325 µm) were prepared as described 
in section 2.1.2 in ice-cold sterile EBSS containing HEPES. Each forebrain slice was 
then plated onto an insert (Millipore) within a 6 well plate, containing 1 ml of medium 
composed of 50% Minimal Essential Medium (MEM), 23% Earl’s Balanced Salt 
Solution (EBSS), 25% horse serum, penicillin (25 units/ml) and streptomycin (25 µg/ml) 
all from Gibco-Invitrogen, and 1.125% nystatin (12.5 units/ml), 36 mM glucose and 5 
mM Tris base all from Sigma-Aldrich. The slices were maintained for up to 14 days in 
at 37°C in a humidified atmosphere with 5% CO 2, and the medium was replaced every 
3-4 days. 
2.4 Mechanical and optical set-up for electrophysiology 
All experiments were performed with an Olympus BX51W upright microscope 
equipped with a halogen lamp and filter sets for fluorescence microscopy, mounted on 
a fixed stage with a microscope-moving table. Cell were visualised with 10x and 40x 
water immersion objectives using differential interference contrast (DIC) optics. Filter 
sets (Glen Spectra and Chroma; components listed below in brackets) were used to 
visualise transgenically labelled eGFP [ET500/20X (500nm excitation), T515LP (515nm 
dichroic), ET535/30M (535nm emission)] and tdTomato cells [XF1067 (560nm 
excitation), XF2029 (595nm dichroic), XF3081 (645 nm emission)], or cells filled with 
Lucifier yellow [D425/40X (425nm excitation), 460DCLP (460nm dichroic) D540/50M 
(540nm emission)], Alexa Fluor 488 [ET500/20X (500nm excitation), T515LP (515nm 
dichroic), ET535/30M (535nm emission)] and Alexa Fluor 568 [560AF55 (560nm 
excitation), 595DRLP (595nm dichroic), 645AF75 (645 nm emission)]. A video camera 
(COHU, 2700 series) was attached to the microscope so that cells could also be 
visualised on a TV monitor. 
The microscope and recording chamber were mounted on a vibration isolation 
table to reduce movements which could affect recordings. A grounded Faraday cage 
surrounded the microscope and recording chamber to reduce electrical noise. All other 
metallic surfaces were also grounded by low-resistance cables connected to the patch-
clamp amplifier’s ground, to reduce any remaining electrical noise. 
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2.5 Pipettes and electrical set-up 
Patch pipettes were made from thick-walled filament-containing borosilicate 
glass capillaries (outer diameter 1.5 mm, inner diameter 0.86 mm, type GC150F-10 
from Harvard Apparatus) using a two-step vertical (Narishige PC-10) or a four-step 
horizontal (Sutter instruments P-97) puller. Pipettes were filled with an appropriate 
intracellular solution (described in section 2.22 and the individual results chapters). 
Recording electrodes had resistances of between 5-8 MΩ for recording from 
oligodendrocyte lineage cells and 2-4 MΩ for recording from neurons. 
The recording electrode was inserted into the pipette holder of a patch-clamp 
headstage (Axopatch CV202AU, Axon Instruments), which was attached to and 
controlled by an electrical micro-manipulator (SM1, Luigs and Neumann) attached to 
the pipette holder. Both the electrode in the pipette holder and the bath electrode were 
a silver wire/silver pellet coated with silver chloride (AgCl). The external and internal 
solutions (section 2.2) also contained chloride ions which are reversibly exchanged 
with the electrode via the following reaction: 
 
Ag + Cl- ↔ AgCl + e- 
  
To ensure that Cl- exchange was maintained, both the silver wire and bath 
electrode were regularly chlorided by placing them in a solution containing chloride ions 
(10% bleach, NaOCl). The majority of membrane currents were recorded at a sampling 
rate of 10 kHz, except for spontaneous synaptic currents which were recorded at 1 
kHz, with an Axopatch 200B amplifier.  Data were collected using pClamp 9 (Axon 
Instruments) or Axoscope 9 (Axon Instruments), and analysed off-line using Clampfit 9 
(Axon Instruments).  
2.6 Patch-clamp recordings 
All patch-clamp recordings were performed in the conventional whole cell 
configuration (Hamill et al., 1981; Edwards et al., 1989). Firstly, the patch electrode 
was lowered into the bath, while at the same time a 5 mV voltage step (of duration 200 
ms) was applied to monitor the resistance of the recording electrode before and after 
contacting the cell membrane. Additionally, while lowering the patch electrode towards 
the cell membrane, positive pressure was applied (through a 1 ml syringe attached to 
perfusion tubing) to prevent the tip of the recording electrode from becoming blocked 
by debris from either the external solution or the brain slice. Secondly, when the patch 
electrode came into contact with the cell membrane, gentle suction was applied to form 
2.1 
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a high resistance seal (typically 1-10 GΩ) between the cell membrane and the patch 
electrode, so the electrode was in the cell-attached mode (Fig. 2.1A). Thirdly, after 
formation of a high resistance seal in the cell-attached mode, compensation of the 
pipette capacitance was made, and the holding potential was adjusted to -60 mV which 
is close to the cell’s resting membrane potential. Finally, the whole-cell configuration 
was achieved by applying further gentle suction to rupture the section of membrane at 
the tip of the patch electrode. The whole-cell configuration allows the diffusion of ions 
between the patch electrode and the cell cytoplasm, and electrical access to the 
interior of the cell (Fig. 2.1B). 
2.7 The electrical circuit for whole-cell patch-clamp recording in 
spatially compact cells  
The cell membrane, which is composed of a lipid bilayer and embedded 
proteins, is an electrical insulator. In contrast, the extracellular and intracellular 
solutions are composed of salt solutions which are excellent conductors of current. This 
combination of the cell membrane (an insulator) and the surrounding intra- and 
extracellular solutions (conductors) forms a capacitor, which can store charge. The 
charge stored (Q) is proportional to the applied voltage (V), Q=CV, where capacitance 
(C) is a measure of the ability of the membrane to store charge. The physical 
dimensions of the membrane are important for determining the capacitance: the more 
membrane, the more charge can accumulate, therefore capacitance is proportional to 
membrane surface area. Importantly, capacitors prevent instantaneous changes in 
voltage which affects both the conduction of electrical signals in biology and 
electrophysiology recordings. For example, in excitable cells, local changes in 
membrane potential, such as an action potential travelling along an axon, are subject to 
a delay in propagation due to the time needed for charging of the cell membrane, 
therefore limiting the speed of action potential propagation. Similarly, during whole-cell 
voltage-clamp recordings, a step change in desired membrane potential can only be 
produced after the charging time of the membrane capacitance. The current flowing 
through a capacitor (C) is proportional to the rate of voltage change (∆V) with time (∆T): 
  	 ∆∆ 
In addition to being a capacitor, the cell membrane is also a conductor due to 
the presence of ion channels in the membrane which allow the passage of charged 
ions. Currents flowing through these ion channels can charge or discharge the 
2.2 
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membrane capacitance and therefore cause variations in membrane potential. The 
electrical circuit equivalent of a cell in the whole cell configuration is represented by a 
capacitor (the membrane capacitance Cm), and a resistor (the membrane resistance 
Rm) connected in parallel, both connected in series with the patch electrode (electrode 
series resistance Rs) (Fig. 2.2A). 
The current flow (I) through this circuit in response to a voltage step (Vs), can 
be predicted by (Tessier-Lavigne et al., 1988): 
	
      . 1 
  /
 	  
where t is the time after the onset of the voltage step, and τ, the decay time constant of 
the current transient, is: 
    	      
At the onset of the voltage step (t=0), the cell capacitance is uncharged and the 
voltage across it is zero. Consequently, just as the voltage step is applied, the voltage 
across the series resistance is the applied voltage step, and the initial current flowing 
allows the calculation of the series resistance (from equation 2.3 at t=0) as: 
 
  	 	
  0 
When the current reaches a steady state (t=∞), the cell capacitance is fully 
charged and no current flows through it, and then the membrane resistance can be 
determined from the voltage step and the current at t=∞, by rearranging equation 2.3 
with t=∞: 
 	 	
  ∞   
Substituting Rs from equation 2.5 gives: 
  	  		
  0  	
  ∞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The membrane capacitance can be calculated by rearranging equation 2.4 to give: 
    	      
Substituting Rs from equation 2.5 and Rm from equation 2.4 gives: 
    			
  0   		
  0  	
  ∞ 
The time constant (τ), was obtained by fitting the current transient with a single 
exponential using Clampfit 9. An example of a fitted capacity transient for an electrically 
compact cell, such as an oligodendrocyte precursor cell, which can be represented by 
a single-compartment model (Fig. 2.2A), is shown in Fig. 2.2B. The current change at 
t=0 was obtained by extrapolating the exponential back to the time of the voltage step. 
2.8 The electrical circuit for whole-cell patch-clamp recordings in 
cells with complex morphology  
Cells with more complex morphology, such as mature oligodendrocytes and 
neurons, do not conform to a single compartment model. For example the thin long 
myelinating processes of mature oligodendrocytes, or the complex geometry of 
neurons with a soma, an axon and large branching dendritic trees, may cause a lack of 
voltage uniformity. The degree of voltage non-uniformity in neurons has been analysed 
by Major (1993), who showed that the voltage control in the dendrites of CA1 pyramidal 
cells was very poor. A similar problem is expected to occur in the long processes of 
mature oligodendrocytes. Cells with complex morphologies need to be represented by 
two or more compartments (Fig. 2.3A and B). In these more complex cells the capacity 
transient cannot be fitted satisfactorily with a single exponential, but equation 2.5 can 
still be used for the initial amplitude of the current response to a voltage step in order to 
calculate the series resistance (equation 2.5). An approximation of the cell membrane 
resistance was obtained by taking the difference of the input resistance calculated at 
t=∞ and the series resistance (although this measurement includes the axial resistance 
of the processes linking distant membrane areas to the soma). 
2.9 Series resistance and its compensation 
In whole-cell patch-clamp experiments the electrode resistance leads to voltage 
errors. This voltage error is due to the electrode and the membrane resistance being in 
series in an electrical circuit, which results in a voltage drop across the electrode’s 
2.8 
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resistor when current flows through the cell membrane. The higher the series 
resistance of the electrode, the larger the voltage drop, which results in the cell not 
being clamped at the voltage applied to the top of the patch electrode. For example, 
using Ohms law (V=I·R), for a series resistance (Rs) of 10 MΩ and a current flowing of 
1 nA, the voltage error would be 10 mV. In my experiments Rs was typically between 
10-20 MΩ, and the largest currents passed were typically 100 pA, giving a maximum 
voltage error of ~2 mV. Data were excluded if Rs increased significantly throughout 
recordings or if Rs was greater than 25 MΩ.  The series resistance can also be partially 
compensated for, using a positive feedback circuit in which a signal proportional to the 
measured current is used to increase the command potential applied to the pipette, to 
compensate for the voltage drop across the patch electrode. The Rs compensation 
allows for more accurate control of the cell voltage, nevertheless it is impossible to 
reach 100% compensation for Rs. A low electrode series resistance is also desirable 
because the combination of Rs and the cell capacitance acts as a filter, slowing down 
changes in the membrane voltage applied to the cell and measured currents.  
2.10 Liquid junction potential and its compensation 
A potential difference (the junction potential) exists at the interface between two 
solutions with different compositions. For example, in whole-cell patch-clamp 
experiments when the patch electrode is placed in the bath, a junction potential exists 
at the tip of the electrode because the ionic composition of the internal solution inside 
the electrode differs from the external solution in the bath. However, this junction 
potential disappears in the whole cell mode when the pipette contents diffuse into the 
cell. The junction potential depends on the diffusion coefficients of the anions and 
cations present in each solution (which depends on their molecular weight and charge, 
which affects the mobility of ions). In particular, for my solutions, the principal ions 
responsible for generating the junction potential are K+, Na+, Cl- and gluconate-. K+ ions 
diffuse out of the patch electrode more quickly (DK=1.99x10-9 m2 s-1) than Na+ ions 
(DNa=1.36x10-9 m2 s-1) diffuse in, and gluconate ions (DGluconate= 1.06x10-9 m2 s1) diffuse 
out more slowly than chloride ions diffuse in (DCl=1.99x10-9 m2 s-1) (Robinson and 
Stokes, 1965), so the patch electrode potential becomes more negative than the bath 
potential (Fig. 2.4). The junction potential can be measured experimentally, as 
described below.  
In order to measure the junction potential, an agar bridge was used (containing 
4 M NaCl) to connect the bath solution to the reference electrode, to avoid changes in 
the reference electrode potential following a change in the external solution. Junction 
potentials were then measured by comparing the zero current voltage value obtained 
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when both the patch electrode and bath contained the same solution (when there is no 
junction potential), to the value obtained when the bath solution was that used for 
experiments. The junction potential was measured to be -10 mV for my K-gluconate 
and Cs-gluconate based internal solutions, and all of the voltage data have been 
adjusted accordingly (i.e -10 mV was added to all of the voltages measured with the 
patch clamp). 
2.11 Voltage-gated ion channel analysis 
In order to reveal and quantify voltage-gated currents, the passive components 
of current responses evoked by voltage steps can be removed from the data. The 
current response to a hyperpolarising voltage step with no active components, which 
only contained the capacity current and an ohmic leak conductance, was selected. This 
passive current is proportional to the size of the voltage step, and was linearly scaled 
according to the size of the voltage steps applied. This linearly scaled passive 
component was then subtracted from all of the current responses evoked by voltage 
steps, which revealed voltage-gated Na+ and K+ channel current responses evoked by 
depolarising voltage steps.  
2.12 Optic nerve recordings 
To make recordings from the axons in the optic nerve, suction electrodes were 
used. Thick walled capillary glass was shaped by heat to a 45° angle approximately 5 
mm from the end of the capillary. The angled opening of each suction electrode was 
then fire-polished to the correct size to allow the nerve to be positioned inside the 
electrode securely during the recording, but without damaging it. Both of the suction 
electrodes contained an Ag/AgCl wire and extracellular recording solution, but one was 
used for stimulation whilst the other was used for recording (Fig. 2.5).   
Compound action potentials were recorded from optic nerves by firstly drawing 
both ends of the optic nerve into the two suction electrodes, by applying slight negative 
pressure using syringes attached to the other end each glass capillary. The optic nerve 
was then stimulated via one suction electrode attached to a stimulator, and the 
compound action potential was recorded through the second electrode.  
2.13 Using transgenic mice to label and trace neural cells 
The transgenic mouse lines that were used for the work described in this thesis 
are listed below. 
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2.13.1 Transgenic mice expressing fluorescent constructs  
Pdgfrα-H2BGFP knock-in mice (Hamilton et al., 2003), referred to as Pdgfrα-
GFP mice, were purchased from Jackson Laboratories (line B6.129S4-Pdgfra 
tm11(EGFP)Sor /J). These mice have a histone-GFP fusion gene knocked into the 
Pdgfrα locus, resulting in nuclear labelling of PDGFRα-expressing cells, including 
OPCs. This transgenic line was maintained as a heterozygous breeding colony and 
was genotyped using the primers specified in table 2.2. Sox10-GFP mice were also 
used (see below). 
2.13.2 Cre transgenic mouse lines 
Emx1-iCre, Gsh2-iCre (Fogarty et al., 2005; Kessaris et al 2006) and Msx3-iCre 
(Tripathi et al 2011) transgenic mice are PAC transgenic mice that express a 
constitutively active form of improved Cre (iCre) recombinase in Emx1-, Gsh2- and 
Msx3- expressing cells, respectively. These transgenic lines were maintained as 
heterozygous breeding colonies and were genotyped by PCR amplification of their 
genomic DNA, to detect the presence of the iCre coding sequence, using primers 
specified in table 2.2. 
Pdgfrα-CreERT2 transgenic mice (Rivers et al., 2008) express a tamoxifen 
inducible form of Cre recombinase under the regulation of the Pdgfrα gene promoter.  
This PAC (Phage Artificial Chromosome) transgenic mouse line was maintained as a 
homozygous breeding colony. 
2.13.3 Reporter mouse lines (transgenic mice that contain loxP sites) 
Rosa26-YFP transgenic reporter mice (Srinivas et al., 2001) were maintained 
as a homozygous breeding colony.  Following Cre-mediated recombination, cells within 
these mice will express the yellow fluorescent protein (YFP) under the regulation of the 
ubiquitous Rosa26 promoter. 
Sox10-GFP transgenic reporter mice (Kessaris et al., 2006) express a PAC 
DNA construct containing the targeting construct Sox10-lox-GFP-poly(A)-lox-DTA 
driven by the Sox10 promoter. In the absence of Cre, these mice express enhanced 
GFP (eGFP) in all Sox10+ cells, and their GFP was used as a general marker of 
oligodendrocyte lineage cells. Following recombination by Cre, the eGFP sequence is 
removed, and the diphtheria toxin A chain (DTA) is expressed in the recombined cells.  
Expression of the active component of the diphtheria toxin results in the targeted 
ablation of the recombined cells. For experiments reported here, these mice were 
74 
 
maintained as a heterozygous breeding colony and were not crossed with any Cre-
expressing line, so the diphtheria toxin was not expressed. Mice were identified 
(genotyped) as being positive for the Sox10-GFP transgene by exposing the P0-P4 
pups to a UV light source – the positive pups fluoresced.  
Sox10-GFP/tdTom dual reporter mice express a PAC DNA construct containing 
the targeting construct Sox10-lox-GFP-pA-lox-tomato-pA driven by the Sox10 promoter 
(Tripathi et al., 2011). In the absence of Cre, these mice express enhanced GFP 
(eGFP) in all Sox10+ cells. Following recombination by Cre, the eGFP sequence is 
removed, and the cells instead turn on the expression of the red fluorescent protein, 
tandem-duplicated tomato (td-Tom). The generation of the Sox10-GFP/tdTom dual 
reporter mice will be described in more detail in Chapter 3. 
Tau-mGFP transgenic reporter mice (Hippenmeyer et al., 2006) contain a lox-
pA-lox-mGFP-IRES-NLS-LacZ-pA targeting cassette in exon 2 of the Tau genomic 
locus.  Following recombination by Cre, these mice express a membrane targeted form 
of GFP under the control of the Tau promoter, directing its expression within the central 
nervous system to differentiating/differentiated oligodendrocytes and neurons. This 
transgenic line was maintained as a heterozygous breeding colony and mice were 
genotyped by PCR using primers that identify the GFP coding sequence (Table 2.2) 
2.13.4 Cre mediated recombination 
The Cre-lox system is a genetic tool used to produce site and cell 
specific recombination events in genomic DNA. It was discovered in P1 
bacteriophages, which use this mechanism to circularize and facilitate replication of 
their genomic DNA when reproducing as part of their life cycle (Sternberg and Hamilton 
1981). This system is now artificially reproduced in the cells of transgenic mice and 
requires co-expression of two components: loxP sites (specific DNA sequences) within 
the target DNA sequence, and expression of the enzyme Cre recombinase, which 
recognises and catalyses the recombination and excision of DNA between the loxP 
sites (Sternberg and Hamilton, 1981). This system allows the labelling and tracing of 
specific cell types with visible proteins, the deletion of genes of interest or the targeted 
ablation of whole populations of cells.   
Mice expressing the constitutive form of Cre (section 2.13.2) were crossed with 
one of the reporter mouse lines (see 2.13.3) to generate double heterozygous mice for 
experimental use. In cells that express Cre, the enzyme recombines the loxP sites 
within the reporter transgene, forming a circular region of DNA (Abremski and Hoess, 
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1984). The DNA between the loxP sites is then excised (Orban et al., 1992). This 
recombination event is permanent within the cell and all of its progeny (Fig. 2.6). 
2.13.5 CreERT2 mediated recombination 
Mice expressing a tamoxifen-inducible form of Cre (Pdgfrα-CreERT2) (see 
2.13.2) were crossed with one of two reporter mouse lines: Rosa26-YFP or Tau-mGFP 
(see 2.13.3). Cre recombination does not spontaneously occur in adult 
CreERT2/reporter double transgenic mice, as Cre is bound to the estrogen receptor 
(ERT2), and held inactive in the cell cytoplasm (Metzger et al., 1995). When tamoxifen, 
an estrogen analogue, is administered to double heterozygous mice, tamoxifen will 
bind to the ERT2 allowing Cre to translocate from the cytoplasm to the nucleus. In the 
nucleus, activated Cre recognises sequences in the DNA that correspond to lox-P sites 
and recombines the lox-P sites, excising the DNA sequence was between them. When 
tamoxifen is withdrawn Cre is again inactive.     
Tamoxifen was administered orally to CreERT2/reporter mice. 40 mg/ml 
tamoxifen in corn oil was sonicated for 40 minutes and administered by oral gavage 
into the stomach.  Adult mice received 300 mg/kg body weight of tamoxifen daily for 4 
consecutive days. Kaylene Young performed the tamoxifen administration.   
2.13.6 Genotyping of transgenic mice 
Genomic DNA was extracted from a tissue biopsy and used for PCR 
amplification. The primers used for genotyping each transgenic mouse line were 
designed to specifically amplify only stretches of DNA within the targeting construct 
(see Table 2.2). PCR genotying was performed by Ulla Dennhey, Sabrina Pacheco, 
Kaylene Young, Huiliang Li or Richa Tripathi. Alternatively, where stated, mice were 
identified visually by GFP fluorescence under a UV light source between P0-P4.  
2.13.7 In vivo and in vitro EdU labelling of dividing cells  
5-ethynyl-2’-deoxyuridine (EdU) (Invitrogen) is a thymidine analogue that is 
incorporated into the DNA of cells as they undergo DNA replication as part of the cell 
division process. EdU was administered to mice either by subcutaneous (s.c.) 
injections (for mice ≤ P10) or via the drinking water (for mice ≥ P20) by Kaylene Young. 
EdU was also added to the organotypic slice medium, at a concentration of 10 µM to 
quantify the percentage of dividing cells in vitro. For s.c. injections, EdU was dissolved 
to 1mg/ml w/v in PBS and each pup was injected with 50µl at 7:30am, 10:30am, 
1:30pm, 4:30pm and 7:30pm for 5 consecutive days. Alternatively EdU was dissolved 
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in the drinking water (0.3 mg/ml) which was available ad libitum replaced every 2-3 
days.   
2.14 Immunohistochemistry 
2.14.1 Perfusion fixation, tissue collection and freezing  
Tissue sections were prepared by Richa Tripathi or Kaylene Young for the 
immunohistochemistry experiments in chapters 3 and 4, respectively. Briefly, mice 
were anaesthetized with pentobarbitone (2ml/kg body weight), and an incision was 
made at the base of the sternum extending along the base of the rib cage and then up 
the side of the body through the ribs allowing the rib cage to lift up. The diaphragm and 
connective tissue around the heart were dissected away and a small incision was 
made in the atrium. A needle connected to a peristaltic pump containing 4% 
paraformaldehyde (wt/vol, PFA, Sigma, in PBS) was inserted into the apex (left 
ventricle). 4% PFA was delivered at a rate of 5 ml/minute until there was no blood 
exiting the right atrium. Brains were removed and sliced into 2 mm coronal slices using 
a rodent brain matrix (Agar Scientific).  Brain slices were immersion fixed in 4% PFA in 
PBS at 4ºC overnight (except for PDGFRα immuno-labelling where tissue was 
immersion fixed for 45’ at room temperature), cryoprotected in 20% (w/v) sucrose in 
PBS at 4ºC for 6 hours before embedding in Optimal Cutting Temperature medium 
(Tissue Tek).  Frozen tissue was stored at -80ºC.  Cryosections (30 µm) were collected 
and immunohistochemistry performed on floating sections as described by Tripathi et 
al. (2011).  
2.14.2 Antibody labelling 
To label acute slices or organotypic slice cultures, slices were fixed in 4% 
paraformaldehyde in PBS for 1 hour, then rinsed three times (for 10 minutes) in PBS 
followed by preincubation in 0.5% Triton and 10% goat serum in PBS for 6-8 hours at 
room temperature. The slices were then incubated with primary antibodies for 36 hours 
at room temperature with slight agitation, rinsed in PBS three times (for 10 minutes), 
and then incubated with secondary antibodies for 3 hours before being rinsed again in 
PBS 3 times (for 10 minutes). All primary and secondary antibodies used in this thesis 
are listed in tables 2.3 and 2.4. Slices were then incubated with DAPI to label nuclei 
(300 nM in PBS, Molecular Probes) for 20 minutes, and rinsed in PBS three times (10 
minutes), before finally mounting slices on a microscope slide with Citifluor 
(glycerol/PBS, Citifluor), covered with a 0.17 mm thick glass cover slip, and sealed with 
nail varnish (Boots, UK).  
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2.14.3 EdU detection 
Following fixation, acute slices were washed once with PBS and subsequently 
incubated for 20 minutes in 0.8% (v/v) Triton X-100 in PBS, on an orbital shaker, at 
21ºC.  The slices were again washed in PBS before EdU detection with the Click-iT 
EdU Alexa Fluor-647 Imaging Kit (Invitrogen).  Each slice was immersed in ~120µl of 
Click-iT developing cocktail, prepared according to the manufacturer’s instructions and 
incubated for 45 minutes at 21ºC, in the dark.  Slices were washed once with PBS 
before continuing with immunohistochemistry (see section 2.14.2).   
For cryosections, EdU developing was performed immediately following 
immunohistochemistry, as some antibodies failed if the order was reversed.  Sections 
were incubated at 21ºC for 15 minutes in PBS / 0.5% triton-x100.  The reagents 
provided in the Click-iT EdU Alexa Fluor-647 Imaging Kit were combined according to 
the manufacturer’s instructions. Floating cryosections were transferred into the 
developing cocktail and incubated in the dark at 21ºC, for 40 minutes.  Sections were 
then washed three times in PBS. Cell nuclei were visualized by post-staining with 
Hoechst 33258 (1:1000; Sigma). All sections were coverslipped using fluorescent 
mounting medium (DAKO). 
2.14.4 Confocal imaging and set up 
Fixed slices were imaged with a confocal laser scanning microscope (LSM). 
The confocal microscope was either a Zeiss LSM 510 or a Zeiss LSM 710. Images 
were taken with x10, x20, x40 or x63 oil DIC objectives. 
All imaging with multiple wavelengths was carried out with sequential scans, in 
order to minimise ‘bleed through’ from one channel to another. The argon laser line 488 
nm was used to excite eGFP and Alexa Fluor 488 containing antibodies, the 458 nm 
laser line of the argon laser was used for tdTomato, Alexa Fluor 555, and Alexa Fluor 
568 containing antibodies, and the 633 laser line was used for Cy5, Alexa Fuor 633 
and Alexa Fuor 647 containing antibodies. The ultraviolet laser 364 nm laser line was 
used for the detection of DAPI. Scanning of areas of interest in slices was done in the 
x-y and z directions, and averaged 2-6 times depending on the signal. The size of the z 
stack largely depended on the region of interest from (15-90 µm depth), taken in 
continuous 0.2 µm sections. The gain and offset settings were initially chosen for each 
set of images in an experiment depending on the signal intensity being detected, and 
the settings were kept constant for all slices within an experiment.   
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2.15 Data analysis and statistics 
Data are presented as mean ± sem. Statistical significance was normally 
assessed with 2-tailed Student’s t-tests. T-tests were either paired, to analyse whether 
responses in a single cell changed after drug application, or unpaired when comparing 
the mean responses between different groups of cells. A correction procedure 
equivalent to the Holm-Bonferroni method was used when making multiple 
comparisons (for N comparisons in a given experiment, the most significant p value is 
multiplied by N, the 2nd most significant by N-1, the 3rd most significant by N-2, etc; 
the resulting corrected p values are significant at the 5% level when less than 0.05). 
Two-sample Kolmogorov-Smirnov tests were used to compare distributions.  
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Figure 2.1. Schematic diagram of patch clamp configurations. 
A. Seal formation, where the patch electrode comes into contact with the cell membrane 
and forms a high resistance seal. Very little current flows into the cell because of the high 
resistance of the membrane patch. B. Whole-cell configuration, where the membrane 
beneath the patch electrode is ruptured by application of gentle suction. The whole-cell 
configuration allows the diffusion of ions between the patch electrode and the cell 
cytoplasm, and electrical access to the interior of the cell. Vs is the voltage step applied 
to the patch electrode, Cm is the cell capacitance, Rs is the series resistance of the 
patch electrode, and Rm is the resistance of the cell membrane.
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Figure 2.2. Electric circuit and capacity transient analysis for spatially compact 
cells. 
A. Electric circuit model for spatially compact cells, such as oligodendrocyte precursor 
cells (OPCs). B. The top black trace displays the current response to a 5mV voltage 
pulse in a spatially compact OPC. The top red trace displays a single exponential fit to 
the current waveform. The bottom trace displays the applied voltage step. The series 
resistance (Rs) is calculated by the peak current recorded when the voltage pulse was 
applied (I(t=0)), the membrane resistance is calculated by measuring the current at 
t=∞, when the membrane is fully charged, as described in the text associated with 
equations 2.5 and 2.7.
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Figure 2.3. Electrical circuits of cells with complex morphology. 
A. Electrical circuit model for a neuron. The dendrites are treated as an extra electrical 
compartment, where Ri is the intracellular resistance along the dendrites B. Electrical 
circuit model for a mature oligodendrocyte. Each myelinated process (Ri) is treated as a 
series of electrical compartments. In these more complex cells the capacity transient 
could not be fitted satisfactorily with a single exponential, but the initial amplitude of the 
current response to a voltage step was measured to calculate the series resistance as 
in Fig. 2.2, and the steady state input resistance was also measured.
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Gluconate- ion 
Chloride- ion 
Sodium+ ion 
Potassium+ ion 
[KGlu] = 130 mM 
[NaCl] = 4 mM 
[NaCl] = 126 mM 
[NaHCO3] = 26 mM 
[KCl] = 2.5 mM 
Figure 2.4. Liquid junction potential. 
A potential difference (the junction potential) exists at the interface between two 
solutions with different compositions. When the patch electrode is placed in the bath a 
junction potential exists at the tip of the electrode because the ionic composition of the 
internal solution inside the electrode differs from the external solution in the bath. This 
junction potential does not exist in whole-cell mode because the electrode solution 
diffuses into the cell. The junction potential present with the electrode in the extracellular 
solution depends on the diffusion coefficients of the anions and cations present in each 
solution (which depends on their molecular weight and charge, which affects the mobility 
of ions). For my solutions the principal ions responsible for generating the junction 
potential are K+, Na+, Cl- and gluconate-, all of which are represented here. 
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Figure 2.5. Optic nerve compond action potential (CAP) set up. 
CAPs were measured using suction electrodes. Optic nerves were drawn into recording 
and stimulating electrodes. Both recording and stimulating electrodes were filled with 
external solution and Ag/AgCl chlorided wires.The optic nerve was then simulated via 
the electrode attached to a stimulator, and the compound action potential was recorded 
through the second electrode. Earth electrodes made of Ag/AgCl pellets were placed in 
the external bath solution.
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Figure 2.6. Cre-lox transgenics. 
Cre-mediated recombination of loxP sites in GeneA-Cre/GeneB-eGFP double 
transgenic mice. In the absence of Cre, eGFP is not expressed by the GeneB-eGFP 
reporter mouse. When GeneA-Cre transgenic mice are crossed with GeneB-eGFP 
reporter mice, in cells expressing Cre, the Cre will bind to the loxP sites recombining and 
excising the loxP-flanked stop sequence of DNA. The removal of the sequence of DNA 
between the loxP sites by Cre then switches on the expression of the eGFP reporter 
gene.   
X
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 Concentration of main ion (mM) 
K gluconate solution Cs gluconate solution 
K-gluconate 130 n/a 
Cs-gluconate n/a 130 
NaCl 4 4 
HEPES 10 10 
BAPTA 10 10 
CaCl2 0.5 0.5 
Na4GTP 0.5 0.5 
Mg2ATP 4 4 
Lucifer yellow n/a 2 
Alexa Fluor 488 or 568 0.1 n/a 
pH adjusted to 7.3 with KOH CsOH 
 
Table 2.1. Composition of the internal solutions used for the experiments described in 
this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
Transgenic mouse line Genotyping primers 
Pdgfrα-CreERT2 mice 
 
CAGGTCTCAGGAGCTATGTCCAATTTACTGAACGTA/G
GTGTTATAAGCAATCCCCAGAA 
 
Pdgfrα-GFP mice  
 
ACGAAGTTATTA GGT CCC 
TCGC/CCCTTGTGGTCATGCCAAAC 
Gsh2-Cre mice 
 
TTGGCGCGCCTGTGAAGCGTTGGACAGAGGCCC/AG
GTACAGGAGGTAGTCCCTC 
 
Msx3-Cre mice 
 
GAAACCTGGACTCTGAGACTGGG/GGCTGTCCAATAA
CCGAAGACG 
 
Emx1-Cre mice 
 
GCCAAGGATGACTCTGGGCA/GCGGTGGCCAAAGAAG
CGATTCCG 
 
Tau-mGFP reporter 
mice 
 
TTC CCCTGAAGTTCATCTGCACCAC/TCGTTGGGGTC 
  GCTC   
 
Sox10-GFP/tdTom 
reporter mice 
 
GCCACGAGTTCGAGATCGAG/GGCTTCTTGGCCATGT
AGATGG 
 
Table 2.2. The genotyping primers used for the experiments described in this thesis. 
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Primary Antibody Supplier Dilution 
Rat anti-PDGFRα  
 
BD Pharmingen 1:400 
Guinea pig anti-SOX10  
 
Gift from M.Wegner 1:2000 
Mouse anti-NeuN 
 
Chemicon 1:500 
Mouse anti-PSA-NCAM IgM 
 
Chemicon 1:1000 
Rabbit anti-Ng2 
 
Chemicon 1:500 
Rabbit anti-Olig2 
 
Chemicon 1:1000 
Rat anti-myelin basic protein (MBP) Chemicon 1:200 
Chicken anti-200kD neurofilament heavy (NF200) 
IgY 
Abcam 1:1000 
Rabbit anti-ankyrin G Santa Cruz 1:400 
Mouse anti-APC/CC1 IgM Calbiochem 1:50-1:100 
Rabbit anti-GFP serum Synaptic Systems 1:1000 
Rat anti-GFP IgG2a Nacalai Tesque 1:3000 
Mouse anti-glial fibrillary acidic protein (GFAP) Sigma 1:2000 
Rabbit anti-somatostatin (SST) Peninsular 
laboratories 
1:100 
Rabbit anti-neuropeptide Y (NPY) Insight 1:1000 
Rabbit anti-parvalbumin  Chemicon 1:1000 
Mouse anti-calbindin Swant 1:1000 
Rabbit anti-calretinin  Swant 1:1000 
Mouse anti-reelin  Gift from A. Goffinet 1:2000 
Rabbit anti-Iba1  Synaptic Systems 1:1000 
Rabbit Ki67 polyclonal Novacastra 1:200 
Rabbit cleaved caspase 3 Cell signalling 1:200 
 
Table 2.3. Primary antibodies used for the experiments described in this thesis, their 
dilution and supplier. 
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Secondary Antibodies Supplier Dilution 
Donkey anti-rabbit 647 Molecular Probes 1:1000 
Goat anti-mouse IgG 568  Molecular Probes 1:200-
1000 
Goat anti-mouse IgM 488 Molecular Probes 1:1000 
Goat anti-rat 555 Molecular Probes 1:200-500 
Goat anti-rat 350 Molecular Probes 1:200 
Goat anti-rabbit 568 Molecular Probes 1:200 
Goat anti-rabbit 633 Molecular Probes 1:200 
Goat anti-chicken  IgY CY5.5 Abcam 1:200 
 
Table 2.4. Secondary antibodies used for the experiments described in this thesis, their 
concentration and supplier. 
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Chapter 3: Dorsally- and ventrally-derived oligodendrocytes 
have similar electrical properties but myelinate preferred tracts 
3.1 Introduction 
Oligodendrocytes are generated from both dorsal and ventral germinal regions 
of the embryonic neural tube, under the influence of different inductive signals (see 
chapter 1.3.1). In the developing spinal cord, most OPCs arise from the ventral 
ventricular zone (VZ) under the influence of Sonic Hedgehog (SHH), but a minority are 
generated from the dorsal VZ in a SHH-independent manner (possibly under the 
influence of Wnt, FGF and BMP signalling). In the developing forebrain too, OPCs arise 
from both the ventral and the dorsal VZ. Since the discovery of both dorsally and 
ventrally derived populations of OL lineage cells in the brain and spinal cord, an 
important question has been whether they are functionally identical or specialised in 
some way. In order to visualise dorsally and ventrally derived OLs, I used a dual 
reporter mouse line in which OLs are fluorescently labelled green or red, depending on 
their origin in the VZ (see Chapter 2.13).  In both the spinal cord and corpus callosum I 
patch-clamped dorsally- and ventrally-derived OLs, at different developmental stages 
of the oligodendrocyte lineage, and compared their electrophysiological and 
morphological properties to investigate whether they are functionally distinct. 
3.2 Methods 
Transgenic mice generation  
An OL lineage-specific dual reporter mouse line Sox10-lox-eGFP-STOP-lox-
tdTomato (referred to as Sox10-GFP/tdTom) was generated by PAC (Phage Artificial 
Chromosome) transgenesis by Richa Tripathi (see methods, chapter 2 section 2.13). 
This line was designed to label Sox10-expressing OPCs and differentiated OLs 
constitutively with enhanced GFP or conditionally (in the presence of Cre recombinase) 
with tandem-duplicated Tomato (tdTom).  
A 120 kb fragment of the Sox10 genomic PAC (Phage Artificial Chromosome) 
(RP21-427-F18) was used, which includes 60 kb upstream and 50 kb downstream 
of Sox10 (Fig. 3.1A). The genomic region spanning exons 3–5 was replaced by loxP-
eGFP-polyA-loxP-tdTomato-frt-Cmr-frt (Fig. 3.1A) by homologous recombination 
in Escherichia coli bacteria (Lee et al., 2001). The chloramphenicol resistance cassette 
(Cmr), inserted to allow selection of correctly recombined clones in bacteria, was 
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removed by transient activation of Flp recombinase with arabinose (Fig. 3.1A) before 
pronuclear injection into mouse embryos. In the absence of Cre recombinase, only 
eGFP is expressed since the polyA4 cassette directs the cleavage of the RNA 
transcript upstream of the tdTom. Ten founders were generated by pronuclear 
injection, eight of which transmitted the transgene in roughly Mendelian ratios and 
expressed eGFP strongly in the expected pattern. One male founder was used to 
establish a line for further study.  
These Sox10-GFP/tdTom mice were crossed to Gsh2-iCre, Emx1-iCre lines 
(Kessaris et al., 2006), or to a Msx3-iCre line. In Sox10+ cells that express Cre 
recombinase, the eGFP-polyA cassette is removed, activating expression 
of tdTom instead (Fig. 3.1A).  
Brain and spinal cord slices  
 Coronal forebrain slices (225 µm thick) were prepared from P9-12 Gsh2-
Cre:Sox10-GFP/tdTom mice (in which dorsally derived cells are green and ventrally 
derived cells are red) and longitudinal spinal cord slices (150-160µm thick) were 
prepared from P6-14 Msx3-Cre:Sox10-GFP/tdTom mice (in which dorsally derived OL 
cells are red, and ventrally derived cells are green). Slices were superfused at room 
temperature (~23°C) with HEPES-buffered solution, c ontaining (mM) 144 NaCl, 2.5 
KCl, 2.5 CaCl2, 10 HEPES, 1 NaH2PO4, and 10 glucose, pH 7.4 (adjusted with NaOH). 
Patch clamp recordings  
Whole-cell recordings were made from OPCs and OLs that expressed GFP or 
tdTom. OPCs were distinguished from differentiated OLs by morphology (OPCs are 
bipolar or stellate cells, OLs have long processes aligned with axons) and by the 
change in membrane current induced by changing the cell membrane potential from 
−110 to +30 mV in 20 mV steps. The steady-state I–V plots are approximately ohmic 
(linear) with mild outward rectification for mature OLs and more outwardly rectifying for 
OPCs (see Fig. 3.4 and 3.5). Electrodes were pulled from thick-walled borosilicate 
glass to a resistance of 6–9 MΩ and filled with a K-gluconate-based solution containing 
the following (in mM): 130 K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 BAPTA, 4 
MgATP, 0.5 Na2GTP, and 2 K-Lucifer yellow (or 0.052 Alexa Fluor 568), pH 7.3 
(adjusted with KOH). Drugs (NMDA 60 µm, kainate 100 µm, and GABA 100 µm) were 
applied in the superfusion solution.  
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Antibody labelling   
Cryosections were prepared and labelled as described in detail in chapter 2, 
section 2.14. 
Cell counts  
For cell counts in the corpus callosum, at least three sections per animal were 
examined. For cell counts in the dorsal funiculus, three sections at each spinal level 
(cervical, thoracic, and lumbar) were examined. This was because the corticospinal 
axons are still extending caudally during early postnatal development. For cell counts in 
the rubrospinal tract and ventral funiculus, three sections at cervical level only were 
examined. Data are quoted as mean ± SEM (n = number of mice). The length of the 
cervical spinal cord (C1–C8) was measured in fixed, dissected spinal cords at P13 (5.3 
± 0.4 mm) and P67 (8.0 ± 0.1 mm). 
Tract tracing  
The anterograde tracer biotinylated dextran amine (BDA, Invitrogen) was used 
to label the corticospinal tract (CST) and the rubrospinal tracts (RSTs) in Msx3-
Cre:Sox10-GFP/tdTom mice (Hossain-Ibrahim et al., 2007). The mice (P51–P64) were 
anesthetized and the skull opened. Then, 10% (w/v) solution of BDA in 0.1 M PBS was 
injected using stereotactic apparatus in the right primary motor cortex (4 sites, 0.4 µl at 
each site) and the right red nucleus (2 µl at one site) to label the CST and RST, 
respectively. The mice were humanely killed 12 days after BDA injection (P63–P72, 
referred to as P67). 
Statistics  
This is described in detail in chapter 2, section 2.15. 
3.3 Results 
3.3.1 Generation of SOX10 GFP/tdTom dual reporter mice 
An OL lineage-specific dual reporter mouse line Sox10-lox-eGFP-STOPlox-
tdTomato (referred to as Sox10-GFP/tdTom) was generated by PAC transgenesis (Fig. 
3.1A and chapter 2 section 2.13) (Tripathi et al., 2011). This line was designed to label 
Sox10-expressing OPCs and differentiated OLs constitutively with enhanced GFP 
(Zhang et al., 1996) (e.g., Fig. 3.1B,E) or conditionally (in the presence of Cre 
recombinase) with tandem-duplicated Tomato (tdTom) (Shaner et al., 2004). In the 
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absence of Cre, 96% ± 0.2% (n=3 mice) of SOX10-immunoreactive cells also 
expressed GFP in the corpus callosum at P12/13 (Fig. 3.1H). In P10–P13 spinal cord 
white matter, 86 ± 4% (n=4 mice) of SOX10+ cells were GFP+ (Fig. 3.1H). In both brain 
and spinal cord, 98 ± 1% of GFP+ cells were also SOX10+ (not shown). In addition, 
immunolabelling with anti-GFP together with monoclonal antibody CC-1, which labels 
differentiated OLs (Fig. 3.2A–C), or anti-OLIG2, which labels all stages of the OL 
lineage (Fig. 3.2D–E), confirmed that the vast majority of OL lineage cells were labelled 
by GFP (94.6 ± 0.7% (n=3 mice) of CC1+ cells and 91.9 ±1.6% of OLIG2+ cells (n=3 
mice) in the corpus callosum between P10 and P13 were GFP+). As expected, there 
was no expression of tdTom in brain or spinal cord in the absence of Cre (not shown). 
In the presence of Cre, the eGFP-STOP cassette was excised and tdTom was 
expressed instead (see Fig. 3.3 and below), thereby fluorescently labelling OLs green 
or red, depending on their origin.  
3.3.2 The postnatal corpus callosum is mainly populated by dorsally derived OLs 
It has been shown previously that NG2-expressing OPCs in the postnatal rat 
cerebellar white matter and corpus callosum fall into two classes—those that express 
voltage-gated Na+ channels and receive synaptic input and others that do not 
(Karadottir et al., 2008). It has also been reported that the postnatal corpus callosum is 
firstly populated by OPCs that migrate from the ventral telencephalon before birth, 
intermingled with OPCs that develop locally within the cortex after birth (Kessaris et al., 
2006). This raised the possibility that the two electrical subtypes of OPCs might 
correspond to the two developmental subgroups. I tested this by patch clamping OPCs 
in Gsh2-Cre:Sox10-GFP/tdTom double-transgenic mice. 
In the telencephalon, Gsh2-Cre is expressed in the lateral ganglionic eminence 
(LGE) and the dorsal part of the medial ganglionic eminence (MGE) (i.e., the region 
coloured red in Fig. 3.3A). The ventral MGE (which expresses Nkx2.1 but not Gsh2) 
makes a negligible contribution to the cortical OL population after P10 (Kessaris et al., 
2006). In Gsh2-Cre : Sox10-GFP/tdTom mice, OL lineage cells derived from the LGE 
and dorsal MGE should have their GFP coding sequences removed by Cre 
recombinase and consequently fluoresce red (tdTom), while those from the developing 
cortex, which do not undergo Cre recombination, fluoresce green (GFP) as 
schematised in Fig. 3.1A. As expected, the cortical grey and white matter contained 
intermingled red- and green-labelled cells, reflecting a mixture of ventrally and dorsally 
derived OL lineage cells (Fig. 3.3C). In these mice, the red cells are undoubtedly 
ventral in origin, but green cells could either be genuinely dorsal in origin or else 
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ventrally derived cells that somehow escaped Cre recombination, e.g., because Cre 
protein is expressed at too low a level to bind the lox recombination sites efficiently. 
This uncertainty was resolved by crossing Sox10-GFP/tdTom to Emx1-Cre mice, which 
express Cre (hence activating tdTom expression) in a reciprocal pattern to Gsh2-Cre, 
i.e., in the cortical VZ but not in the LGE or MGE (i.e. the region coloured red 
in Fig.3.3B). Cells that are labelled red by Gsh2-Cre will remain green in Emx1-Cre and 
vice versa. It follows that the proportion of OL lineage cells that is labelled red by Gsh2-
Cre plus the proportion that is labelled red by Emx1-Cre should equal 100%. We found 
that 23 ± 1% (n = 7 mice) of OL lineage cells in the P12/13 corpus callosum were 
recombined red by Gsh2-Cre and 81 ± 1% (n = 5 mice) by Emx1-Cre (Fig. 3.3C-G). 
Since the sum of these contributions is not significantly different from 100%, we can 
infer that (1) Cre recombination efficiency is close to 100% in both Emx1-
Cre and Gsh2-Cre (i.e., no cells escape the action of Cre) and (2) ∼80% of OL lineage 
cells in the postnatal corpus callosum are generated locally in the cortical VZ, the 
remaining ∼20% migrating in from the LGE and MGE. 
3.3.3 Dorsally and ventrally derived OL lineage cells in the corpus callosum have 
similar electrical properties  
Having determined that the dual reporter system reliably distinguishes ventrally 
and dorsally derived cells, I made electrophysiological recordings from dorsally and 
ventrally defined cells with the morphology of OPCs (dOPCs and vOPCs) in the corpus 
callosum of acute vibratome forebrain slices of Gsh2-Cre:Sox10-GFP/tdTom mice at 
P9–P12 (median age P11). Figure 3.4, A and B, shows representative images and 
current traces obtained from vOPCs (tdTom-expressing, red) and dOPCs (eGFP-
expressing, green). Before recording, the cells were identified by their expression of 
red or green fluorescence (Fig. 3.4A,B, top images). They were then whole-cell 
clamped using an internal solution containing a green or red dye (for the red and green 
cells, respectively: Fig. 3.4A,B, middle images), allowing colocalization of the 
fluorescent reporter protein and the pipette dye to demonstrate that the correct cell had 
been patch clamped (Fig. 3.4A,B, bottom images). OPC status (as opposed to OL) was 
defined by their morphology (recognising that this might include some cells that were 
differentiating and downregulating their voltage-gated Na+ channels: see chapter 4). 
On applying 20 mV voltage steps from a holding potential of −70 mV (Fig. 3.4A, 
B, top traces), depolarization was seen to evoke a transient inward (Na+) current in the 
majority of cells, followed by a more sustained outward (K+) current (Karadottir et al., 
2008). Subtraction of the linearly scaled capacity transient and (ohmic) current evoked 
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by hyperpolarizing steps revealed a clear transient inward Na+ current (INa) that partly 
overlapped with the onset of the K+ current (Fig. 3.4A, B, bottom traces). As previously 
reported (Karadottir et al., 2008), ∼35% of fluorescing cells with OPC morphology 
lacked detectable Na+ current, but the presence or absence of INa did not correlate with 
the developmental origin of the cells (10 of 17 vOPCs and 11 of 15 dOPCs displayed 
Na+ currents; not significantly different, p = 0.63). Some of the INa-negative cells 
presumably were OPCs that were differentiating into mature OLs (De Biase et al., 
2010; Kukley et al., 2010), while others were NG2-expressing OPCs that lacked 
significant Na+ current (Karadottir et al., 2008). 
The capacitance of OPCs (Fig. 3.4C), their membrane resistance near the 
resting potential (Fig. 3.4D), and the net inward current that INa-expressing OPCs 
generated on depolarization from −70 mV to +10 mV (Fig. 3.4E) did not differ 
significantly between dOPCs and vOPCs. Similarly, the responses of INa-expressing 
OPCs to neurotransmitter application did not differ significantly. Kainate and NMDA 
evoked inward currents at −70 mV, while GABA evoked an outward current at −40 mV 
(Fig. 3.4F) but the amplitudes of these currents were indistinguishable between the 
OPCs of different origin (Fig. 3.4G). Thus, although I confirmed the existence of two 
electrical subtypes of cell with OPC morphology in the corpus callosum, I determined 
that these do not correspond to dOPCs versus vOPCs. 
Similarly, the electrical properties of cells with the morphology of mature 
myelinating OLs derived from the ventral VZ (tdTom-expressing vOLs, red) (Fig. 3.5A) 
or dorsal VZ (eGFP-expressing dOLs, green) (Fig. 3.5B) did not differ significantly. 
Their current response to voltage steps was approximately ohmic with slight outward 
rectification (Fig. 3.5A, B), with a membrane resistance at −70 mV that was not 
significantly different between dOLs and vOLs (Fig. 3.5C). dOLs and vOLs were found 
to myelinate a similar range of numbers of internodes (between 2 and 21, the 
distribution of which did not differ significantly: p = 0.45 comparing dOLs and vOLs) 
(Fig. 3.5D). Accordingly, the mean number of internodes was not different for dOLs and 
vOLs (p = 0.2) (Fig. 3.5E). Their responses to kainate and NMDA were also not 
significantly different from one another (Fig. 3.5F, G). 
3.3.4 Dorsally and ventrally derived OL lineage cells in the spinal cord have 
similar electrical properties 
The VZ of the developing spinal cord is composed of a series of discrete 
progenitor domains, known as p3, pMN, p2, p1, and p0 in the ventral half of the cord 
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and dP6 to dP1 in the dorsal half (reading ventral to dorsal) (Fig. 3.6A). Each 
progenitor domain generates a characteristic subset of spinal neurons before switching 
to production of glial cells (astrocytes and/or OPCs). Most OPCs in the spinal cord are 
generated from the pMN domain in the ventral VZ, but a minority are generated outside 
pMN, mainly from the dorsal VZ (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al., 
2005). 
Dorsal OPCs and their differentiated dOL progeny were specifically marked by 
crossing Sox10-GFP/tdTom mice with Msx3-Cre mice (Msx3 is expressed in progenitor 
domains dP1–dP5), with or Gsh2-Cre mice (Gsh2 is expressed in dP3–dP5, Fig. 3.6A). 
In P12/13 double-transgenic animals, Gsh2-derived cells were 10 ± 2% (n = 3 mice) of 
all OL lineage cells in the cord, whereas Msx3-derived cells were 17 ± 1% (n = 5 mice) 
of the total. This is in keeping with the broader expression domain of Msx3 and 
indicates that dP1 and/or dP2 give rise to some OL lineage cells in addition to dP3–
dP5. Thereafter, Msx3-Cre was used to label dorsally derived OPCs and OLs in the 
spinal cord. Msx3-derived OL lineage cells (red) were concentrated in the dorsal and 
dorsolateral funiculi (Fig. 3.6B, C, D), whereas vOPCs (green) were distributed widely 
throughout the cross section of the cord (Fig. 3.6C). This confirms previous reports that 
dOPCs are less migratory than their vOPC counterparts. This could either be an 
intrinsic difference or reflect the fact that dOPCs appear late-after vOPCs have already 
colonized the cord-and are outcompeted by vOPCs for migration- or proliferation-
inducing factors (e.g., platelet-derived growth factor, PDGF-AA). Consistent with the 
latter idea, dOPCs proliferate and migrate more than normal when vOLs are absent 
in Nkx6.1/Nkx6.2 double-null mice (Cai et al., 2005; Vallstedt et al., 2005) and when 
the PDGF-AA supply is increased experimentally (Calver et al., 1998; van Heyningen 
et al., 2001). 
Red (tdTom-expressing, dorsally derived) and green (GFP-expressing, ventrally 
derived) OL lineage cells in the dorsal and dorsolateral funiculi of the P6–P14 spinal 
cord were recorded from (median age P8). Patch-clamped cells were identified as 
OPCs and mature OLs from their morphology and membrane current properties, as 
described previously for recordings in brain slices. Spinal cord OPC-morphology cells, 
like those in brain, fell into two classes, either with or without Na+ currents, and the 
mean capacitance of the cells without INa was larger (Fig. 3.7A). The membrane 
resistance of dOPCs and vOPCs with INa was not significantly different (Fig. 3.7B), and 
this was also true for dorsally and ventrally derived mature OLs. However, the 
resistance of vOPCs without INa was larger than that for dOPCs. This was the only 
electrophysiological difference I found between dOPCs and vOPCs, but it would 
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become insignificant if correction were made for multiple comparisons. The presence 
or absence of INa did not correlate with the developmental origin of the cells, because 
dOPCs and vOPCs were both found either with or without INa (10 of 16 dOPCs and 10 
of 16 vOPCs expressed INa). In INa-expressing cells, the peak inward current (evoked by 
a step from −70 mV to +10 mV) was not significantly different between the two groups 
(Fig. 3.7C). Dorsally and ventrally derived mature OLs myelinated a similar range of 
number of internodes (between 2 and 6, the distribution of which did not differ 
significantly: p = 0.21 comparing dOLs and vOLs) (Fig. 3.7D). Consequently, the mean 
number of internodes did not differ significantly between dOLs and vOLs (p = 0.23) 
(Fig. 3.7E). There were no significant differences between dOPCs and vOPCs 
with INa in their responses to 100 µM GABA (at −40 mV) or to 100 µM kainate or 60 
µM NMDA (at −70 mV) (Fig. 3.7F), nor between dOLs and vOLs in their responses to 
kainate and NMDA (Fig. 3.7G). 
3.3.5 Tract preferences of dorsally and ventrally derived oligodendrocytes in the 
spinal cord 
At P7, the most ventral part (base) of the dorsal columns, where the developing 
cortical spinal tracts (CSTs) run, was devoid of dOPCs/dOLs and contained few 
vOPCs/vOLs compared to other regions of developing white matter (Fig. 3.8B, E). This 
could be because most corticospinal projections have not yet reached the spinal cord; 
the first corticospinal axons reach lumbar (L5) spinal cord at P6–P9, and the CST does 
not achieve its full size until ∼P14 (Bareyre et al., 2005; Gianino et al., 1999). It makes 
sense that OL lineage cells should be excluded from the paths of growing axons, since 
myelin components (several of which are expressed at a low level by OPCs) are known 
to be inhibitory for axon outgrowth. Since neither the CST nor the rubrospinal tracts 
(RSTs) could be specifically labelled at this early age, an anatomical atlas was referred 
to (Watson et al., 2008) to locate these tracts at P7 and P13. At P7, there were only a 
few ventrally derived OL lineage cells in the CST and even fewer dorsally derived cells 
(Fig. 3.8B, E). At cervical levels, for example, only ∼8% of OL lineage cells in the CST 
were dorsally derived, the remaining ∼92% being ventrally derived (Fig. 3.8H). By P13, 
there were many OL lineage cells in the CST, still mainly ventrally derived although the 
dorsal contribution had also increased (Fig. 3.8C, F). In the cervical CST, for example, 
the dorsal contribution had increased from ∼8% to ∼34% (Fig. 3.8H). In neighbouring 
dorsal tracts, such as the fasciculus gracilis and fasciculus cuneatus (which are 
ascending sensory tracts), the opposite was true - at cervical level, ∼63% of labelled 
cells in these tracts were dorsally derived at P13 (data not shown). The RSTs in the 
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dorsolateral funiculi were equally populated by dorsally and ventrally derived OL 
lineage cells at P13 (50 ± 2% were dorsally derived, n = 3 mice). At this stage, only a 
minor proportion of labelled OL lineage cells in the ventral funiculus was dorsally 
derived (10 ± 3%, n = 3 mice). 
These observations suggested that there were some tract preferences of 
dorsally and ventrally derived OLs. To see whether this persisted long-term, adult 
Msx3-Cre:Sox10-GFP/tdTom spinal cords were examined. Unexpectedly, it was found 
that the dorsal funiculus, especially the CST, was populated predominantly by dorsally 
derived OLs at P67 (Fig. 3.8D, G; I show that the cells are mainly OLs and not OPCs 
below in Fig. 3.9N-Q), the reverse of the situation at P7 and P13 (Fig. 3.8B, C, E, F). 
(The locations of tracts are shown in Fig. 3.8A.) This suggests that the dorsal OL 
lineage displaces the ventral lineage between P13 and P67 in this tract. 
If the absolute number of vOLs in the dorsal funiculus did not change between 
P13 and P67, the number of vOLs per section would be expected to decrease ∼1.5-
fold because the length of the spinal cord increases ∼1.5-fold during this time with a 
concomitant increase in volume (see section 2 of this chapter; since cells were counted 
in the whole area of the dorsal funiculus - i.e., a larger area at P67 than at P13 - growth 
in the radial plane is automatically taken into account). However, the number of vOLs 
per section across the whole area of the dorsal funiculus at cervical level decreased 
3.8-fold between P13 and P67 (from 110 ± 9 to 29 ± 4, n = 3 mice) (Fig.  3.8I), which 
cannot be explained simply by the increased length of the cord-the absolute number of 
vOLs must have decreased ∼2.5-fold (i.e., 3.8/1.5). The number of dOLs per section 
remained constant from P13 to P67 (156 ± 17 and 163 ± 26, respectively, n = 3 mice) 
(Fig. 3.8I). Because of the increased length of the cord, the absolute number of dOLs 
must therefore have increased ∼1.5-fold during this period. Thus, the number of dOLs 
rises as the number of vOLs falls, suggesting that vOLs are replaced by dOLs. 
However, it is not simply a matter of one-to-one replacement because the total number 
of vOLs plus dOLs decreased modestly from P13 to P67 (from ∼266 to ∼192 per 
section). 
To confirm the location of the CST, the anterograde tracer BDA was injected 
into the right primary motor cortex of P67 mice (performed by P.Anderson) and we 
examined the spinal cord 12 d later (see section 3.2). In 3 of 3 injected animals, the 
CST was labelled unilaterally on the left. Within the BDA-labelled area, the majority of 
OL lineage cells were dorsal in origin (red) at all rostrocaudal levels (Fig. 3.9A-C). For 
example, 88 ± 3% (n = 3 mice) of labelled OL lineage cells in the cervical CST were 
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dorsally derived (as shown previously in Fig. 3.8H). In addition, the RSTs were also 
labelled by unilateral BDA injection into the red nucleus in the midbrain. This was less 
reproducible - only 2 of 7 injected mice had any RST labelling. Using this BDA labelling 
as a guide, the cells in the region of the RST were counted and it was found that they 
were populated mostly by dorsally derived OLs (79 ± 5%, n = 3 mice; not shown). In 
contrast, ventral and ventrolateral tracts were occupied mainly by ventrally derived 
OPCs and OLs, as expected (Fig. 3.9D, E), although the proportion of dorsally derived 
cells increased with age, from 10 ± 3% (n = 3 mice) at P13 to 24 ± 4% (n = 3 mice) at 
P67. 
At P67, the GFP and tdTom signal intensities in individual cells were reduced 
relative to P13 and the labelled cells were smaller, both effects being more pronounced 
in white matter compared to grey matter and more obvious for GFP than tdTom. The 
sum of GFP+ and tdTom+ cell counts in the dorsal funiculus at P67 amounted to 80 ± 
5% (n = 3 mice) of all SOX10-immunoreactive cells in the dorsal funiculus, which is not 
significantly different (p = 0.22) from the number of SOX10+ OL lineage cells that 
expressed GFP in Sox10-GFP/tdTom spinal cords at P13 (86 ± 4%, n = 4 mice) (Fig. 
3.1H). Similarly, the sum of the GFP+ and tdTom+ cells in adult spinal cord white matter 
amounted to 89 ± 3% (n = 3 mice) of all OLIG2+ cells (Fig. 3.9F-I), and 88 ± 4% (n = 3 
mice) of all CC-1+ cells (Fig. 3.9J-M), indicating that the majority of these cells are 
mature OLs. The sum of the GFP+ and tdTom+ cells in the spinal cord (at P13 and 
P67) did not reach 100%, suggesting that the Sox10-GFP/tdTom transgene does not 
recombine in all OLs in the spinal cord. However, despite this, since a consistent 
number of OLs (86 ± 4% and 80 ± 5%, at P13 and P67, respectively) are labelled with 
either GFP or tdTom at P13 and at P67, this suggests that the expression levels of 
either label do not fall below the levels of detection, and that the OL population can be 
reliably identified at both ages in the Sox10-GFP/tdTom reporter mouse. Also, almost 
all SOX10+ cells in the adult were OLIG2+, confirming them as OL lineage (98.4 ± 0.1% 
(n = 3 mice) of all SOX10+ cells were OLIG2+ and 96.8 ± 0.4% (n = 3 mice) of all 
OLIG2+ cells were SOX10+ in double-immunolabel experiments (Fig. 3.9N-Q), further 
confirming OLs express both markers in the spinal cord in adulthood. 
3.4 Discussion 
Since the demonstration that there are both dorsally and ventrally derived 
populations of OL lineage cells in the spinal cord and brain (Spassky et al., 2001; Cai 
et al., 2005; Fogarty et al., 2005; Vallstedt et al., 2005; Kessaris et al., 2006), an 
outstanding question has been whether these are functionally identical or specialized in 
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some way (Miller, 2005). As the two populations of OLs are specified by different 
signalling pathways - the ventral cells depend on SHH, whereas the dorsal cells are 
SHH independent - it might be expected that the two populations differ. Additionally, 
different subtypes of OPCs and OLs have been described by a variety of criteria, 
including differences in the electrophysiological properties of OPCs (Chittajallu et al., 
2004; Karadottir et al., 2008) in brain regions where these cells develop to produce a 
wide range of OL morphologies (del Rio-Hortega et al., 1921, 1928; Bjartmar et al., 
1994; Weruaga-Prieto et al., 1996; Murtie et al., 2007; Bakiri et al., 2009; Vinet et al., 
2010). In this chapter, I have shown, using a dual reporter mouse, that despite different 
sites of origin, dorsally- and ventrally-derived OL lineage cells are electrically and 
morphologically similar. However, despite being electrically identical, interesting 
differences in the settling positions of OL lineage cells that develop from dorsal and 
ventral regions of the spinal cord were discovered.  
3.4.1 Dorsally and ventrally derived OL lineage cells are electrically similar 
Using the dual-reporter mice, I was able to ask whether the ventrally and 
dorsally derived OL lineages correspond to different electrical subtypes. However, no 
significant electrophysiological differences could be detected between dOPCs and 
vOPCs. Both populations were an approximately 2:1 mixture of cells with or without 
significant voltage-gated Na+ current, and their input resistances were similar. Because 
I defined OPCs solely by their morphology in these experiments, it is possible that, in 
addition to true NG2-expressing OPCs that lack voltage-gated Na+ currents (Karadottir 
et al., 2008 and see chapter 4), some of the INa-negative cells I recorded from were 
already differentiating into OLs and had downregulated NG2 and Na+ channel 
expression before changing their morphology (De Biase et al., 2010; Kukley et al., 
2010). Both vOPCs and dOPCs had a similar membrane capacitance, arguing against 
a consistent morphological difference. vOLs and dOLs also appeared indistinguishable, 
having a similar membrane resistance and myelinating the same number of axons. 
vOPCs/vOLs and dOPCs/dOLs also reacted similarly to the neurotransmitter agonists 
kainate (to activate AMPA and kainate receptors), NMDA and GABA.  
It is possible that other electrical differences between vOPCs and dOPCs could 
exist that were not examined by this study, for example they could differ in terms of the 
synapses they receive from neuronal axons. OPCs derived from different lineages may 
receive synaptic inputs from either excitatory or inhibitory neurons (or both), or the 
properties of these currents could be distinct (e.g. OPCs could receive synaptic inputs 
at different frequencies and/or amplitudes). The fact that both vOPCs and dOPCs 
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responded similarly to the application of excitatory and inhibitory neurotransmitters 
suggests that they express the appropriate receptors to respond to glutamate and/or 
GABA release from neuronal axons. Receiving different synaptic inputs from neuronal 
axons might provide an electrical mechanism by which OPC survival, differentiation 
and subsequent myelination could be controlled by specific tracts. Alternatively 
different molecular cues, which were not examined in this study, could account for the 
myelination of specific tracts as discussed in more detail below. 
3.4.2 Tract preferences of dorsally and ventrally derived OLs 
Interesting differences in the settling positions of OL lineage cells that develop 
from the dorsal versus the ventral VZ of the spinal cord were discovered. Since dorsal 
regions in the spinal cord are largely sensory, while ventral regions are largely motor, 
perhaps the modality of the axon is matched to the source of OLs (Miller, 2005). 
Consistent with previous studies, it was confirmed that vOPCs appear around E12.5 
and migrate widely throughout the cross section of the cord, populating all developing 
white matter tracts, including those in the dorsal funiculus, before dOPCs appear 
around E15.5 (for review, see Richardson et al., 2006). dOPCs were less migratory 
and remained mainly (though not exclusively) in the dorsal half of the cord. Strikingly, 
they appeared gradually to displace ventrally derived cells from dorsal axon tracts. The 
dorsal and dorsolateral funiculi at cervical levels contained similar numbers of ventrally 
and dorsally derived OL lineage cells at ∼P13 (e.g. ∼50% were ventrally derived in the 
RSTs and ∼66% in the CST) (Figs. 3.6B, 3.8H), but, after that, dorsally derived cells 
took over and by P67 comprised >80% of all OL lineage cells in the RST, CST, and the 
dorsal funiculus as a whole. The large majority of ventrally derived OL lineage cells in 
the dorsal funiculus were CC-1+ differentiated OLs even at P13, so the fact that the 
absolute number of vOL lineage cells decreased after P13 while the dOL lineage did 
not change much (in the cervical cord at least, Fig. 3.8I) strongly suggests that dOLs 
have some selective advantage over vOLs in dorsal axon tracts.  
The Sox10-GFP/tdTom dual reporter used in this study failed to detect ∼14% of 
OL lineage cells in the P13 spinal cord using our Sox10-GFP/tdTom reporter - i.e., 
∼14% of SOX10+ OPCs/OLs did not express GFP in the absence of Cre. In the brain, 
the equivalent figure was ∼4%. There is no obvious explanation for why the 
Sox10  transgene is apparently inactive in a proportion of OL lineage cells, or why this 
proportion should be higher in the spinal cord than the brain. In the calculations above, 
the assumption was made that the “missing” ∼14% of cells does not include a 
disproportionate number of either ventrally or dorsally derived OL lineage cells. If all the 
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missing cells happened to be ventrally derived, or all happened to be dorsally derived 
(and if the assumption is made that the same percentage of such cells were missing at 
P67 as at P13), then the calculated decrease in the number of vOLs/section between 
P13 and P67 would still be 3.8-fold, but the final contribution of dOLs to the dorsal 
funiculus would be ∼80% or ∼88% of the total, respectively, rather than ∼85%. Thus, 
although there is no reason to think that the missing cells should be mainly ventrally or 
dorsally derived, even if this were the case the conclusions in this study would not be 
greatly affected. 
Competition for myelination between ventrally and dorsally derived OL lineage 
cells has been previously described in the corpus callosum and overlying cortex 
(Kessaris et al., 2006). In the brain, the fraction of OL lineage cells in the corpus 
callosum that was derived from the most ventral part of the forebrain VZ (Nkx2.1-
expressing) started high but declined rapidly after birth, so that, by P10, <10% of 
OPCs/OLs in the corpus callosum (and even less in the cortex) were Nkx2.1 derived, 
and by P30, there were essentially none, their place being taken by more dorsally 
derived OLs (Kessaris et al., 2006). Many factors could explain the apparent selective 
advantage that dOLs have over vOLs in dorsal axon tracts of the spinal cord observed 
in this study. dOLs might, for example, have a higher affinity than vOLs for dorsal 
axons or they might respond preferentially to survival factors released by dorsal axons. 
The homophilic cell adhesion molecule L1CAM appears to play an especially important 
role in the development and myelination of the CST compared to other spinal tracts 
(Joosten and Gribnau, 1989; Cohen et al., 1998; Dobson et al., 2001; Jakeman et al., 
2006), so it is conceivable that the CST and other dorsal axons might have adhesive 
properties that favour dOLs over their ventral counterparts. Alternatively, inhibitory 
signals could be released from vOLs in the ventral spinal cord, preventing the migration 
and survival of dOLs outside of the dorsal spinal cord. Instead, there might be continual 
turnover of OLs in the dorsal funiculus and the dying OLs might be preferentially 
replaced by differentiating dOPCs.  
At this point, the mechanism by which dOLs come to outnumber vOLs can only 
be speculated about. Whatever the mechanism, there is effectively a competition 
between the ventral and dorsal lineages. Gene expression profiling of vOL and dOL 
lineage cells from our dual reporter transgenic mouse, which was not within the scope 
of this study, may shed light on the mechanism by which dOLs outcompete vOLs.  OLs 
may express different genes or higher levels of particular genes depending on their site 
of origin, for example dOLs may specifically express adhesion molecule genes or 
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survival genes, enabling them to reside within and myelinate dorsal tracts tracts more 
effectively. 
3.4.3 Tract preferences of dorsally and ventrally derived OLs and consequences 
for remyelination 
The finding that dOLs and vOLs compete to myelinate specific tracts within the 
spinal cord raises the question of whether this competition exists in the context of 
remyelination following a demyelinating disease or injury. In a recent study, Zhu et al., 
(2011b) investigated remyelination following focal demyelination of the spinal cord.  In 
response to demyelination at a ventral region of the spinal cord, dOPCs migrated to, 
and proliferated in, the area of lesion, to provide a large number of newly differentiated 
oligodendrocytes (Zhu et al., 2011b). These data suggest that dOLs may provide an 
important source of OPCs for axon remyelination. It is plausible that vOLs 
predominantly myelinate neuronal axons during early development, whereas dOLs 
myelinate axons at later stages in life and play a more important role in myelin turnover 
and injury-induced remyelination. If a tendency exists for dOLs to dominate the 
remyelination process, this finding might influence our strategic approach to myelin 
regeneration in the future. For example in studies where OPCs are transplanted to 
promote remyelination (Windrem et al., 2008), it might be advantageous to transplant 
dOPCs rather than vOPCs or a mixture of the two. 
  
Figure 3.1. Generation and characterization of Sox10-GFP/tdTom dual reporter 
mice. 
A. The DNA sequence displays the intron and exon structure of the Sox10 locus (i). The 
dashed section of DNA shows the Sox10 PAC (Phage Artificial Chromosome) sequence, 
loxP-eGFP-(polyA)4-loxP-tdTom-frt-CmR-frt  (ii), that replaced the DNA between exons 
3 and 5 (i). LoxP sites are represented by black arrows and Flippase recognition target 
(Frt) sites are represented as black circles (ii). The chloramphenicol resistance cassette 
(Cmr), inserted to allow selection of correctly recombined clones in bacteria, was 
removed with flip-recombinase before microinjection into mouse embryos. In the 
absence of Cre recombinase, only  eGFP is expressed since the polyA4 cassette directs 
the cleavage of the RNA transcript upstream of the tdTom (iii). When the 
Sox10-GFP/tdTom dual reporter mice are crossed with Cre mice, in Sox10+ cells that 
express Cre, the eGFP-polyA cassette between the loxP sites is removed, activating the 
expression of tdTom instead (iv). As expected, in the absence of Cre, expression of GFP 
(green) was noted in a majority of SOX10+ cells (red) in the forebrain (B–D) and spinal 
cord (E–G). Boxed areas in B and E are shown at higher magnification in C, D, and F, 
G, respectively. Cell counts at P10–P13 (H) revealed that ~96% (n = 3 mice) of SOX10+ 
cells in the corpus callosum and ~86% (n = 4 mice) of SOX10+ cells in the spinal cord 
white matter were GFP+ (data shown as mean ± SEM).Scale bars: D, G, 20 μm. 
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Figure 3.2. The majority of oligodendrocyte lineage cells express GFP.
GFP+ cells (green) were confirmed to be OL lineage by double immunolabeling spinal 
cord white matter for CC-1, which labels differentiated OLs (red, A–C), or anti-OLIG2, 
which labels all stages of the lineage (red, D–E). Arrows in A–C indicate GFP+ OLs that 
colabel with CC-1; arrowheads indicate GFP+, CC-1-negative OPCs. tdTom was not 
expressed in the absence of Cre (not shown). Cell nuclei were stained with Hoechst 
33258 (Hst, blue). The images in A–E were taken in the corpus callosum at P12. Scale 
bars: F, 25 μm.
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Figure 3.3. The corpus callosum is populated mainly by dorsally derived OLs. 
Gsh2 is expressed only in the LGE and dorsal MGE (A, shown in red), whereas Emx1 is 
expressed in the developing dorsal telencephalon (B, shown in red). In both A and B the 
colours green and red show the predicted fluoresence of OPCs derived from the regions 
shown, in the two mice. In Gsh2-Cre: Sox10-GFP/tdTom animals, the corpus callosum 
(CC) was populated mainly by unrecombined (green) OL lineage cells (C). Consistent 
with this, in Emx1-Cre:Sox10-GFP/tdTom animals, the CC was populated predominantly 
by recombined (red) OL lineage cells (D). Boxes in C and D are shown at higher 
magnification in E and F, respectively. Cell nuclei were poststained with Hoechst 33258 
(Hst, blue). G, Cell counts in the CC at P12–P13 showed that ~20% (n = 6 mice) of the 
red labelled OL population in Gsh2-Cre:Sox10-GFP/tdTom were tdTom+, i.e., derived 
from MGE/LGE, whereas ~80% (n = 5 mice) of red labeled cells in the CC of 
Emx1-Cre:Sox10-GFP/tdTom were tdTom+, i.e., originating in the cortex. Data are 
presented as mean ± SEM. Scale bar: 20 μm. 
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Figure 3.4. Electrophysiological properties of ventrally and dorsally derived OPCs 
in the corpus callosum. 
A, A vOPC expressing tdTom under Sox10 transcriptional control (in 
Gsh2-Cre:Sox10-GFP/tdTom mice; top) was whole-cell clamped with an internal 
solution containing Lucifer yellow (green: middle). Bottom panel shows overlay. Top 
current traces are in response to 20 mV steps from −70 mV. Bottom traces are after 
subtraction of the linearly scaled response to the step to −110 mV. B, As in A but for a 
dOPC expressing eGFP under Sox10 control (in Gsh2-Cre:Sox10-GFP/tdTom mice). C, 
D, Comparison for vOPCs (tdTom) and dOPCs (eGFP), with and without Na+ current, of 
membrane capacitance (C) and membrane resistance (D) at −70 mV. E, Comparison of 
peak net inward current evoked in INa-expressing OPCs by a step from −70 mV to +10 
mV. F, Specimen responses of an OPC to kainate (100 μM) and NMDA (60 μM) at −70 
mV and to GABA (100 μM) at −40 mV. G, Magnitude of drug-evoked currents (as in E) 
for vOPCs and dOPCs expressing INa.
106
tdTom oligodendrocyte  eGFP oligodendrocyte
50 s
50 pA
50 s
50 pA
50s
10
0p
A
10
0p
A
50s
kainate
NMDA
R
m
 (M
Ω
)
0
50
100
150
200
250
tdTom eGFP
p = 0.50
11 10 0
5
10
15
20
10 11
p=0.20
td-Tom LY td-Tom
LY
eGFP Alexa 568
eGFP
Alexa 568
A
D EC
B
-70mV -70mV
+30mV
-110mV
+30mV
-110mV
D
ru
g-
ev
ok
ed
 c
ur
re
nt
 (p
A
)
0
25
50
75
100
125
p = 0.86
kainate
46 8
NMDA
tdTom
eGFP
p = 0.52
11
tdTom eGFP
1n
A
10ms 1
nA
10ms
F G
0
10
20
40
30
50
60
70
0-4 5-9 10-14 15-19 20-24
tdTom
eGFP
N
um
be
r o
f p
ro
ce
ss
es
%
 c
el
ls
 p
er
 b
in
 o
f 5
 p
ro
ce
ss
es
Figure 3.5. Comparison of the electrical properties of ventrally and dorsally 
derived mature oligodendrocytes (vOLs and dOLs) in the forebrain. 
A, A vOL expressing tdTom in Gsh2-Cre:Sox10-GFP/tdTom mice (left) was whole-cell 
clamped with an internal solution containing Lucifer yellow (green: middle); thin green 
parallel processes are internodes. Right panel shows overlay. Current traces are in 
response to 20 mV steps from −70 mV. B, As in A but for a dOL expressing eGFP in 
Gsh2-Cre:Sox10-GFP/tdTom mice; thin red parallel processes are internodes. C, 
Comparison for vOLs (tdTom) and dOLs (eGFP) of membrane resistance at −70 mV. D, 
Percentage of vOLs (tdTom) and dOLs (eGFP) with different numbers of internodal 
processes (10 vOLs and 11 dOLs were studied). E, Mean number of internodal 
processes made by vOLs and dOLs. F, Specimen responses of an OL to kainate 
(100 μM) and NMDA (60 μM) at −70 mV. G, Magnitude of drug-evoked currents (as in F) 
for vOLs and dOLs. P values are from t tests.
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Figure 3.6. Origin and location of spinal dOPCs and vOPCs. 
A, In the developing spinal cord Msx3 is expressed in dorsal domains dP1–dP5, 
whereas Gsh2 is expressed only in dP3–dP5. Hence, Msx3-Cre:Sox10-GFP/tdTom 
mice were used to examine dorsally derived OL lineage cells in the spinal cord. B, A 
schematic diagram of the adult spinal cord showing the tracts and regions examined. 
C-D, At P13, ventrally derived OPCs and OLs (green) are evenly spread throughout the 
spinal cord (C), whereas dorsally derived OL lineage cells (red) are mainly restricted to 
the dorsal and dorsolateral regions of the cord (D). Very few dorsally derived cells were 
observed in the ventral funiculus (VF). Note that the dorsal funiculus (DF) is dominated 
by dorsally derived (red) cells except for the ventralmost part (the contical spinal tracts 
(CSTs)), where ventrally derived (green) cells are more abundant. In the dorsolateral 
funiculus (DLF), where the rubrospinal tracts (RSTs) run, there appears to be an 
accumulation of dorsally derived cells. Cell nuclei were poststained with Hoechst 33258 
(Hst, blue). Scale 250 µm. 
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Figure 3.7. Dorsally and ventrally derived OL lineage cells in the spinal cord have 
similar electrical properties.
A–G, Electrical properties of spinal dorsally and ventrally derived OL lineage cells in 
Msx3-Cre:Sox10-GFP/tdTom mice. A, Membrane capacitance of dorsal 
(tdTom-expressing) and ventral (eGFP-expressing) OPC morphology cells. B, 
Membrane resistance at −70 mV of OPC morphology cells with and without INa and of 
mature OLs. C, Peak inward current evoked by depolarization from −70 mV to +10 mV 
in OPCs with INa. D, Percentage of dOLs and vOLs with different numbers of internodal 
processes (13 dOLs and 22 vOLs were studied). E, Mean number of internodal 
processes made by dOLs and vOLs. F, Drug-evoked currents in OPCs with INa. G, 
Drug-evoked currents in mature OLs. P values are from t tests.
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Figure 3.8. Corticospinal tracts are populated mainly by dorsally derived OL 
lineage cells in adulthood. 
A, A schematic diagram of the adult spinal cord showing the tracts and regions exam-
ined. At P7, the majority of cells in the dorsal funiculus (DF) and especially the cortical 
spinal tract (CST) are ventrally derived (green) (B and E). By P13, the numbers of 
dorsally derived (red) cells increases in the DF (C), but the CST is still mainly populated 
by dorsally derived cells (green, F). This situation reverses by P67, when the entire DF, 
especially the CST (D and G), is populated mainly by dorsally derived OPCs and OLs as 
revealed by cell counts (H). Three sections per spinal level were counted for each 
animal: P7 (n = 2 mice) (B, E), P13 (n = 3) (C, F), and P67 (n = 3) (D, G). I, The absolute 
numbers of GFP+ (ventrally derived) cells/section in the dorsal funiculus (cervical level) 
decrease dramatically between P7 and P67, while tdTom+ (dorsally derived) cells 
increase in number during the same time frame. Scale bars,100 μm. 
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Figure 3.9. The Sox10-GFP/tdTom reporter faithfully identifies OL lineage cells in 
the adult. 
A–C, BDA labeling confirmed that the majority of presumptive OL lineage cells in the 
adult CST are of dorsal origin (tdTom+). The white dotted line separates grey matter 
from white matter and the yellow dotted line outlines the CST. D, E, A cross-sectional 
image of an adult Msx3-Cre:Sox10-GFP/tdTom spinal cord shows that the dorsal 
funiculus (especially the CST) and dorsolateral funiculi (RST) contain mainly dorsally 
derived tdTom+ cells. tdTom+ (F, red) and GFP+ (G, green) cells together account for 
the great majority of OLIG2+ cells (H–I) in the adult spinal white matter. In addition, most 
CC-1+ differentiated OLs (L–M) colabeled for either tdTom (red, J) or GFP (green, K), 
confirming that the Sox10-GFP/tdTom reporter faithfully identifies OL lineage cells in the 
adult cord and also that a significant number of OL lineage cells were not “lost” in 
adulthood because of reduced GFP or tdTom expression. Almost all SOX10+ cells (red, 
N) also colabel for OLIG2 (green, O–Q) and vice versa in the adult spinal cord. Cell 
nuclei were poststained with Hoechst 33258 (Hst, blue). All images were taken from the 
cervical spinal cord. The images in F–Q were taken within the CST. Scale bars: A, 
100 μm; D, 250 μm; I, M, 25 μm; Q, 35 μm. 
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Chapter 4: Properties and fate of oligodendrocyte precursor 
cells in the postnatal mouse brain   
4.1 Introduction 
As reviewed in chapter 1, whether all OPCs are the same is controversial. On 
the one hand it has been suggested that all OPCs express voltage-gated sodium (INa) 
and potassium channels, which are down-regulated when OPCs differentiate to form 
OLs (De Biase et al., 2010; Kukley et al., 2010).  On the other hand, OPCs expressing 
NG2 in the rat cerebellar white matter fall into two classes: one that receives synaptic 
input, expresses INa and can generate action potentials, and another that lacks these 
attributes (Karadottir et al., 2008). Voltage-gated ion channel expression and spiking 
behaviour were also reported to differ between white and grey matter OPCs (Chittajallu 
et al., 2004). Furthermore, while it is undisputed that OPCs proliferate, there is great 
variation in the fraction of OPCs that are reported to be dividing. This has led to 
speculation about the existence of a permanently post-mitotic sub-population of OPCs 
that may have a distinct biological function in the brain. Finally, in addition to generating 
oligodendrocytes throughout the brain, OPCs have also been reported to be the source 
of new projection neurons in one region of the brain, the piriform cortex (Dayer et al., 
2005; Tamura et al., 2007; Rivers et al., 2008; Guo et al., 2010). To resolve these 
issues over the diversity of OPCs, I patch-clamped OPCs in different brain regions to 
investigate their expression of voltage-gated ion channels, their proliferative capacity 
and their cell fate. 
4.2 Methods 
Transgenic mice  
Sox10-GFP and Pdgfrα-H2BGFP knock-in mice (Hamilton et al., 2003; referred 
to as Pdgfrα-GFP mice) which fluorescently label oligodendrocyte lineage cells (see 
below) were used for the electrophysiology experiments described in this chapter. For 
the cell fate tracing experiments described in this chapter, Pdgfrα-CreERT2 BAC 
transgenic mice (Rivers et al., 2008) were crossed with Cre-sensitive reporter mice, 
either 1) homozygous R26R-YFP transgenic mice (Srinivas et al., 2001) to  label OPCs 
and their all of their progeny with YFP or, 2) heterozygous Tau-loxSTOP-lox-mGFP-
IRES-NLS-LacZ-pA (Tau-mGFP) mice (Hippenmeyer et al., 2005) to label any 
differentiating/differentiated oligodendrocytes and neurons generated by OPCs with 
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membrane targeted GFP (mGFP). These transgenic mice are described in detail 
chapter 2, section 13. 
Tamoxifen administration  
Tamoxifen was administered to activate Cre-mediated recombination and 
induce YFP or GFP labelling in oligodendrocyte lineage cells, as described in detail in 
chapter 2, section 13.5. 
Brain slices  
Coronal brain slices or parasagittal cerebellar slices (225 µm thick) were 
prepared from postnatal day 2, P7-P10 (referred to as P9), and P32-P34 (referred to as 
P33) Sox10-GFP or Pdgfrα-GFP mice (as described in chapter 2 section 1). Slices 
were superfused at ~33°C with bicarbonate-buffered solution which contained the 
following (in mM): 126 NaCl, 24 NaHCO3, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, 1 MgCl2, 10 
D-glucose, pH 7.4 (bubbled with 95% O2/5% CO2). 
Patch-clamp recordings  
Whole-cell recordings were made from OPCs that expressed GFP under 
transcriptional control of the Sox10 or Pdgfrα promotor. Some mice were pre-labelled 
with EdU before recording to detect dividing cells, as described in chapter 2 section 
13.7. OPCs were distinguished from differentiated OLs by morphology (OPCs are 
bipolar or stellate cells, OLs have long processes aligned with axons) and by the 
change in membrane current induced by changing the cell membrane potential from 
−110 to +30 mV in 20 mV steps. The steady-state I–V plots are approximately ohmic 
(linear) with mild outward rectification for mature OLs and more outwardly rectifying for 
OPCs (see Fig. 3.4 and 3.5). The peak net inward current (reflecting the difference 
between the inward INa and the subsequently activating voltage-dependent outward K+ 
current) was quantified after subtracting the capacity current and an assumed ohmic 
leak current, which were scaled from the response to hyperpolarising pulses. Voltage 
responses to current injection were recorded from the cell’s resting potential (applying 
20 pA steps for 200 ms).  
Electrodes were pulled from thick-walled borosilicate glass to a resistance of 6–
9 MΩ and filled with a K-gluconate-based solution containing the following (in mM): 130 
K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 BAPTA, 4 MgATP, 0.5 Na2GTP, and 2 
K-Lucifer yellow (or 0.052 Alexa Fluor 568), pH 7.3 (adjusted with KOH). 1 µM TTX 
(Tocris) was added into the superfusion solution to block sodium currents. 
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After recording, the patch electrode was removed from the cell, leaving the 
soma intact.  The slice was then immersion fixed in 4% (w/v) paraformaldehyde (PFA) 
in PBS at 21ºC for a minimum of 1 hour (maximum of 6 hours).  These cells were also 
processed to detect GFP and NG2, with or without EdU, as described in chapter 2, 
section 14. Some slices were briefly fixed for 20 minutes at 21°C to allow 
immunolabelling with anti-PDGFRα (this antibody is fixation sensitive). 
EdU labelling and detection  
In vivo EdU labelling to detect dividing cells was performed by my colleague 
Kaylene Young as described in chapter 2, section 14. 
Tissue preparation and immunohistochemistry  
Immunohistrochemistry was performed on cryosections or brain slices after 
patch-clamp recordings as described in detail in chapter 2, section 14. 
Microscopy and cell counts  
Images were collected on an Ultraview confocal microscope (Perkin Elmer) or 
LSM 510 (Zeiss) as Z stacks with 1 µm spacing.  For quantification, 8 or more low 
magnification (20x objective) fields were collected within each anatomical region of 
interest, for each coronal brain section, including all layers of the medial motor cortex 
(Ctx), layer II of the anterior piriform cortices (aPC), and the corpus callosum (CC).  
Cells were counted manually, viewing each image in Adobe Photoshop or Image J. For 
post-electrophysiological confocal imaging of individual cells, the Alexa Fluor 568 dye-
filled cell was located within the section and scored for EdU and NG2 expression, blind 
to the electrophysiology data for that cell.  Fluorescence intensities and cell body 
diameters were measured in photomicrographs using Image J software. 
Calculation of cell cycle time 
For a homogeneous population of cycling cells, the fraction of cells that label 
with EdU (“labelling index”) is expected to increase linearly with the duration of 
BrdU/EdU exposure until all dividing cells are labelled (phase 1, Fig. 4.10B: 
Nowakowski et al., 1989). After this the labelling index cannot increase further and a 
plateau is reached (phase 2, Fig. 4.10B). The rate at which cells incorporate EdU is 
given by the slope (m) of phase 1 and was calculated by performing a linear regression 
analysis. The maximum labelling index (phase 2 plateau value) is known as the “growth 
fraction” (GF), which is expressed as a percentage of the total cell population. This was 
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calculated using only points at late times in the labelling curve, that were deemed not 
statistically significant from each other by ANOVA and were not already included in the 
linear regression analysis. The value of GF presented is the average from all mice that 
were analysed at the plateau. From these data, the length of the cell cycle Tc = GF/m 
was calculated (Nowakowski et al., 1989). Since Tc depends on the reciprocal of m, its 
standard error (s.e.Tc) is not symmetrical about the mean. However, for simplicity s.e. 
of Tc is shown as ± half of the full range, calculated as follows:  
s.e.Tc = [{(GF + s.e.GF) / (m – s.e.m)} – {(GF - s.e.GF) / (m + s.e.m)}] / 2  
Statistics  
The statistical analysis is described in detail in chapter 2, section 15. 
4.3 Results 
4.3.1 Using transgenic mice to identify OL lineage cells in the postnatal brain 
To investigate whether oligodendrogenic OPCs present throughout the 
postnatal mouse brain have electrical properties similar to the potentially neurogenic 
OPCs in the anterior piriform cortex (aPC), putative OPCs were identified by their 
intrinsic fluorescence in brain slices from Pdgfrα-GFP (Hamilton et al., 2003) or Sox10-
GFP (Kessaris et al 2006) trangenic mice. Sox10-GFP transgenic mice have been 
previously shown to reliably label all oligodendrocyte lineage cells with GFP (Kessaris 
et al., 2006), but do not label OPCs specifically. As PDGFRα is expressed by OPCs 
but not by differentiated OLs (Nishyama et al., 2009), it might be expected that OPCs 
should be specifically labelled in the Pdgfrα-GFP mice. Pdgfrα-GFP transgenic mice 
have been previously used to identify embryonic OPCs (Hamilton et al., 2003) but the 
specificity of the GFP expression was not characterised postnatally. Therefore 
postnatal day 9 (P9) and P33 coronal brain sections from Pdgfrα-GFP mice were co-
immunolabelled for GFP and the OL lineage marker OLIG2 (Fig. 4.1A-C).  In the motor 
cortical area (henceforth called the motor cortex or Ctx), corpus callosum and anterior 
piriform cortex, more than 96% of all GFP+ cells also expressed OLIG2 (Fig. 4.1G). As 
NG2-immunolabelling is intense in OPCs but is lost as they differentiate into OLs 
(Nishyama et al., 2009), additional sections were immunolabelled for GFP and NG2 
(Fig. 4.1D-F) to determine what proportion of the GFP+ cells are OPCs.  At P9 ~93% of 
GFP antibody-labelled cells also labelled for NG2.  However by P33 only ~70% of all 
GFP+ cells in the motor cortex, ~30% of those in the corpus callousm, and ~60% in the 
anterior piriform cortex also expressed NG2 (Fig. 4.1G), suggesting that GFP persists 
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even after OPCs have turned into more mature oligodendroglial cells (which I represent 
as: OLIG2+ NG2neg). Therefore, in the postnatal brain of Pdgfrα-GFP transgenic mice, 
GFP labelling identifies cells of the OL lineage (OLIG2+) but does not distinguish 
between OPCs and recently-differentiated OLs. 
4.3.2 Expression of voltage-gated sodium channels defines two populations of 
OL lineage cell in the postnatal mouse brain    
To investigate the electrophysiological properties of OL lineage cells, I whole-
cell patch-clamped cells in white matter areas (corpus callosum (CC), and cerebellar 
white matter (CB WM)) and grey matter areas (motor cortex (Ctx), anterior piriform 
cortex (aPC), and cerebellar grey matter (CB GM)) of the postnatal brain.  Identified by 
their GFP expression, OL lineage cells in the brain of postnatal Pdgfrα-GFP or Sox10-
GFP mice could be divided into two broad classes of cell.  One class (termed INa+) 
produced a transient inward current after depolarisation beyond -30 mV (Fig. 4.2A-C), 
which was blocked by tetrodotoxin (TTX) (Fig. 4.3A), indicating that it was mediated by 
voltage-gated sodium channels (INa). This transient inward current was followed by 
activation of a more sustained outward, presumably K+ current (IK) (Fig. 4.2A-C) since 
in rat OPCs this has been shown to be abolished when internal K+ is replaced with Cs+ 
(Karadottir et al., 2008). In contrast, the other cell type (termed INaneg) showed an 
essentially time-independent current-voltage (I-V) relationship at negative potentials, 
but often an outward (presumably K+) voltage-gated current on depolarisation (Fig. 
4.2D-F). When TTX was applied to this cell class, the I-V relationship remained 
unchanged (Fig. 4.3B), excluding the possibility that the K+ conductance was masking 
a voltage-gated Na+ current in these cells (n=3).   
Owing to the rapid kinetics of INa, it partly overlaps with the transient capacity 
current, so the net inward current was quantified after subtracting the linearly scaled 
capacity transient and ohmic leak current that was evoked by a hyperpolarising pulse 
(Fig. 4.2, lower traces). The resulting peak inward current represents a combination of 
inward INa and outward IK. To assess how the overlap of these currents alters the 
apparent magnitude of the voltage-gated Na+ current, TTX was applied to some cells to 
isolate IK (Fig. 4.3A). Subtraction of IK in these cells from the total inward current 
resulted in a 2.5-fold increase in the amplitude of the net inward current (n=3) (Fig. 
4.3A).  
In the corpus callosum, the proportion of OPCs (defined by morphology) that 
expressed INa did not change significantly throughout development, being ~60-80% at 
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P2, P9 and P33 (Fig. 4.4A; 118 cells were studied in total).  In contrast, the proportion 
of OPCs (defined by morphology) that expressed INa, in the motor cortex (Ctx) and 
cerebellar grey matter (CB GM), significantly decreased from ~80% early in 
development (P2, P9) to ~30% later in development (P33) (both P<0.001; Chi2 test) 
(Fig. 4.4B; in total 141 cells in the Ctx, and 64 cells in the CB GM were studied).  
Interestingly, ~20% of OPCs (defined by morphology) lacked INa expression as early as 
P2, in both white and grey matter, suggesting that OPCs lacking INa are formed early in 
development, just after birth.  
4.3.3 INa cells show regenerative action potential-like waves but do not express 
neuronal markers 
It has been reported that some OPCs can fire action potentials in response to 
depolarisation (Chittajallu et al., 2004; Karadottir et al., 2008; Ge et al., 2009).  In my 
study, depolarising current injection resulted in passive membrane responses in INaneg 
GFP+ cells (Fig.  4.5F), while INa+ GFP+ cells exhibited a range of action potential-like 
waves in response to depolarising current pulses (Fig. 4.5A-E).  Early in development 
(P9) the majority of INa+ GFP+ cells (69/87) in both the grey and the white matter 
showed a single regenerative depolarisation (Fig. 4.5A-C). Single action potential-like 
events were also detected in 21 of 37 INa+ GFP+ cells in the white and the grey matter 
later in development (P33).  A minority of INa expressing cells (3/124) exhibited 
repetitive action potential-like waves on depolarisation (Fig. 4.5D-E). Similar 
regenerative responses have been reported for OPCs in white (Chittajallu et al., 2004; 
De Biase et al., 2010) and grey matter regions (Chittajallu et al., 2004; Ge et al., 2009; 
De Biase et al., 2010) of the postnatal mouse brain. 
Although INa+ GFP+ cells could generate action potential-like events, they were 
not like typical neuronal action potentials or those described for INa+ OPCs in the rat 
cerebellar white matter (Karadottir et al., 2008).  The action potential-like events had a 
higher threshold for activation (-21 ± 1.5 mV) than action potentials in neurons, their 
amplitudes increased somewhat with larger current injections (Fig. 4.5D-E), unlike 
neuronal action potentials, and the timescale of the spikes (4.3 ± 0.7 ms, measuring 
the duration at half of the amplitude) was longer than those for most neurons (for 
examples see Fig. 4.5D-E). This probably reflects the lower ratio of INa current 
magnitude to cell input resistance in mouse OPCs (mean peak inward current <300 pA, 
Fig. 4.9 below) than was previously found for rat OPCs (mean peak inward current ~ 
1000 pA, Karadottir et al., 2008) and suggests that mouse INa+ cells do not have a 
sufficient density of INa to fire bone fide action potentials. 
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As INa+ GFP+ cells were detected in all brain regions, including the white matter 
of the corpus callosum, it seemed unlikely that the excitability of the INa+ GFP+ cells 
analysed was a result of ectopic GFP expression by immature neurons or cortical 
interneurons.  However, as some OPCs reportedly express immature neuronal markers 
such as TOAD-64 (turned on after division-64), doublecortin, Tuj1 and HuC/D 
(Belachew et al, 2003; Chittajallu et al, 2004; Tamura et al., 2007), suggesting that they 
might turn into neurons in various brain regions (reviewed by Richardson et al., 2011), I 
investigated this possibility by immunolabelling coronal brain sections from P9 and P33 
Pdgfrα-GFP transgenic mice to detect GFP and a variety of neuronal markers (Fig. 
4.6). At both ages, GFP-expressing cells in the motor cortex did not detectably express 
parvalbumin (Fig. 4.6A, M), somatostatin (Fig 4.6B, M), neuropeptide Y (Fig 4.6C, M), 
calbindin (Fig. 4.6D, M), reelin (Fig.  4.6E, M) and PSA-NCAM (Fig. 4.6L, M). While the 
vast majority of GFP-expressing cells also lacked calretinin labelling (Fig. 4.6F, M) and 
NeuN (Fig. 4.6I, M), a small number of cells that exhibited faint GFP expression were 
found to express calretinin (Fig. 4.6G, H, M) or NeuN (Fig. 4.6J, K, M) strongly, and so 
are presumed to be neurons.  In the motor cortex, these presumptive neurons were 
located in the superficial cortex, concentrated near the brain mid-line.  Even if the 
calretinin- and NeuN-expressing GFP+ cells are separate populations, at P33 they 
would together still comprise only ~2% (and ~4% at P9) of all GFP+ cells.  Consistent 
with the findings in the motor cortex, GFP+ cells in the anterior piriform cortex of P33 
Pdgfrα-GFP transgenic mice rarely expressed neuronal markers – a small number co-
labelled for PSA-NCAM (4/1820 GFP+ cells examined; 4/606 PSA-NCAM+ cells 
examined) and only 0.7% ± 0.2% of GFP+ cells co-expressed NeuN. 
The finding that GFP (driven by an OL-lineage cell promoter) is expressed by a 
small number of cells expressing neuronal markers is reminiscent of a study from 
Belachew et al. (2003), who suggested that the brightly-labelled GFP+ NG2+ OPCs that 
they observed in CNPase-GFP transgenic mice were able to generate faintly-labelled 
GFP+ interneurons in the postnatal mouse hippocampus.  These data might suggest 
either that some interneurons are generated from OPCs, and that the GFP 
fluorescence is residual and indicative of their origin, or that a small subset of cortical 
neurons have a very low level of Pdgfrα promoter activity and so become labelled with 
GFP.   
By counting the number of neurons labelled for calretinin and NeuN, it was 
deduced that the GFP-labelled cells account for 11% ± 0.7% of calretinin-expressing 
and 0.14% ± 0.02% of NeuN-expressing neurons in the motor cortex at P9, and 14% ± 
2% of calretinin-expressing and 0.2% ± 0.02% of NeuN-expressing neurons in the 
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motor cortex at P33.  The GFP+ neurons expressed low levels of GFP, which was ~8 
times lower in intensity (averaged over the nucleus) than was detected in NG2+ OPCs 
(GFP+ neurons 10.6 ± 1.0, OPCs 84.3 ± 0.1 arbitrary units) and ~3 times less than was 
detected in NG2neg OLs (35.0 ± 5.0 arbitrary units). The GFP+ neurons were difficult to 
detect even by antibody labelling, so it is highly unlikely that they would have been 
selected for patch-clamping based on their intrinsic GFP fluorescence. Furthermore, 
patch-clamp recordings were performed in brain hemi-sections, therefore cells 
immediately bordering the cortical mid-line (where the GFP+ neurons tend to 
congregate) were not targeted, and the calretinin and NeuN expressing cells were too 
few in number (<5%) to account for the significant number of GFP+ cells that I classify 
as excitable INa+ GFP+ cells (77% and 61% of the GFP+ cells that were studied 
expressed INa in the motor cortex, at P9 and P33, respectively). I conclude that the 
great majority of the GFP+ INa+ cells that I recorded from were genuine OPCs and not 
neurons. 
4.3.4 All GFP+ cells that express NG2 strongly are proliferative and express INa  
Based on GFP expression I was able to identify OL lineage cells, however I 
found that they were heterogeneous in terms of INa expression in all brain regions 
examined. The morphology of the Alexa Fluor 568-filled cells suggested that the 
expression of INa might be an OPC trait, while a lack of INa might be an OL trait.  
Morphology proved to be more useful for identifying putative OPCs in the white matter 
than in the grey matter.  In white matter, GFP positive cells with OPC-like morphology 
(Fig. 4.7A) (INa+ GFP+ cell) could be easily distinguished from OLs with myelinating 
processes (Fig. 4.7B, INaneg GFP+ cell).  OPCs were defined as having bipolar or stellate 
morphology and OLs as having multiple long processes aligned with axons. This 
distinction was less obvious in grey matter (Fig. 4.7C, INaneg GFP+ cell), because axons 
do not fasciculate in the grey matter as they do in white matter tracts, and myelin 
internodes are not all parallel with one another but oriented in various directions (Murtie 
et al., 2007; Vinet et al., 2010). Consequently, in the grey matter, on the basis of 
morphology alone some GFP+ differentiated OLs might easily be mistaken for OPCs.  
In order to identify OPCs unambiguously in both grey and white matter it was 
necessary to perform post-recording immunohistochemistry for NG2. In the following 
section I correlated cell proliferation with expression of NG2 and INa in different brain 
regions. 
Individual GFP+ cells in the corpus callosum, motor cortex and anterior piriform 
cortex were whole-cell patch-clamped to determine whether or not they exhibited INa 
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and then dye-filled with Alexa Fluor-568.  Dye filling not only revealed the cellular 
morphology but also permitted identification of the recorded cell after NG2 
immunolabelling. Three categories of dye-filled cells were identified: (1) cells 
expressing NG2 strongly (NG2+ cells) which I defined to be OPCs (Fig. 4.8A, C and E), 
(2) cells expressing low levels of NG2 limited to the soma or the base of some 
processes (NG2low cells) that were presumed to be early differentiating OLs (Fig. 4.8G), 
and (3) cells with no detectable NG2 (NG2neg cells) that were assumed to be OLs (Fig. 
4.8I).   
At both P9 and P33 and in all brain regions examined, I found that the NG2+ 
GFP+ cell population (Fig. 4.8A, C, E) was the same as the population of INa+ GFP+ 
excitable cells (Fig. 4.8.B, D, F).  As expected, these NG2+ INa+ presumed OPCs were 
found to co-express PDGFRα (5 cells examined in the motor cortex, 7 cells in the 
anterior cortex) confirming them as OPCs. The magnitude of the net inward current 
generated by OPCs on depolarization from -70 mV to 10 mV was ~130-320 pA in all 
areas (Fig. 4.9A) and tended to decrease with age, falling by 21%, 61% or 31% from 
P9 to P33 in the CC, Ctx or aPC, respectively (Fig. 4.9A).  Similarly, in all brain areas a 
reduction in membrane resistance (Fig. 4.9B) and peak outward current (Fig. 4.9C) 
was observed with age, whereas no consistent change in cell capacitance (a measure 
of cell size) could be detected with age (Fig. 4.9D).  OPCs were consistently larger in 
grey matter than in white matter, irrespective of age (Fig. 4.9D).  The resting 
membrane potential of OPCs ranged from between ~-85 and -94 mV (at P9, the resting 
membrane potential of OPCs was -94 ± 3.8 mV, -93 ± 2.6 mV, -92 ± 1.6 mV, in the 
corpus callosum (n=14), motor cortex (n=14) and anterior piriform cortex (n=10), 
respectively. At P33, the resting membrane potential of OPCs was -89 ± 1.9 mV, -86 ± 
3.3 mV, -85 ± 2.3 mV, in the corpus callosum (n=22), motor cortex (n=18) and anterior 
piriform cortex (n=17), respectively) at each age and in each brain region.  These data 
suggest that the intrinsic membrane properties of OPCs are subject to change during 
development but that INa expression is a universal property of OPCs in all brain areas 
throughout postnatal life.   
The second category of GFP+ cells, NG2low cells, had limited expression of NG2 
(Fig. 4.8G).  These cells had little to no INa (Fig. 4.8H; mean net inward current 
24 ± 5pA in 9 cells) and are referred to as NG2low INalow cells. They were assumed to 
correspond to early differentiating OLs that are down-regulating their INa and NG2 
expression, as previously described (De Biase et al., 2010; Kukley et al., 2010). The 
final category of GFP+ cells (NG2neg OLs) lacked both NG2 labelling (Fig. 4.8I) and INa 
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expression (Fig. 4.8J) and therefore correspond to pre-myelinating or myelinating OLs 
(44 cells; NG2neg INaneg OLs), which I refer to collectively as OLs.   
A number of studies have indicated the presence of a post-mitotic population of 
OPCs (defined by NG2 immunolabelling) within the postnatal mouse brain (reviewed by 
Richardson et al., 2011).  In the piriform cortex, these post-mitotic OPCs have been 
suggested to comprise a substantial fraction (~50%) of the OPC population and to 
differentiate over time, providing a source of new projection neurons (Rivers et al., 
2008; Guo et al., 2010). To assess the electrophysiological properties of dividing 
oligodendrogenic OPCs and the putative non-dividing neurogenic OPCs, the thymidine 
analogue EdU was administered to Pdgfrα-GFP mice for 5 days prior to making patch 
clamp recordings at P9, and for 12-13 days prior to making patch clamp recordings at 
P33.  In addition to NG2-immunolabelling, slices were processed to detect EdU.  These 
dosing regimens were selected to label all the proliferating OPCs in the white and grey 
matter of the brain, which were predicted from Psachoulia et al., (2009) to be 
approximately half of all OPCs.  Unexpectedly, given this prediction, the vast majority 
of GFP+, NG2+, INa+ OPCs that I analysed were EdU+, and so were proliferating, 
irrespective of brain region or age.  At P9, ~90% of NG2+ INa+ OPCs had divided in the 
previous five days (motor cortex, 8/9 OPCs; corpus callosum, 12/13 OPCs).  At P33, 
70-100% of all GFP+, NG2+, INa+ OPCs were EdU-labelled in all regions (motor cortex, 
17/24 OPCs; corpus callosum, 4/4 OPCs; aPC, 29/31 OPCs) (Fig. 4.8A-F).  In contrast, 
none of the NG2low INalow cells analysed in the motor cortex of P33 mice (following ~13 
days of EdU administration) had incorporated EdU (Fig. 4.8G, 9 cells analysed), 
consistent with in vitro data from Sugiarto et al. (2011), which suggested that, following 
an asymmetric OPC division, one cell begins to down regulate mitogenic proteins, 
commits to differentiating and will no longer incorporate BrdU, while the other cell 
maintains the expression of mitogenic proteins, remains an OPC and re-enters the cell 
cycle. This supports the idea that the NG2low INalow cells are early differentiating OLs, 
formed from a cell division that occurred more than 13 days earlier.  
The large fraction of individual OPCs that were EdU+ following these patch-
clamp recordings accurately reflected the total fraction of EdU+ OPCs quantified in 
each brain region when confocal analysis was performed of large numbers of OPCs 
immunolabelled for NG2.  In motor cortex at P9, 90% ± 2% of NG2+ OPCs were EdU+ 
and at P33, 83% ± 1% of NG2+ OPCs were EdU+, indicating that the high fraction of 
OPCs identified as proliferating was not the result of a cell selection bias when patch-
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clamping, but instead indicated that a larger proportion of OPCs underwent cell division 
than was previously detected by Psachoulia et al. (2009) and Guo et al. (2010).   
These data undermine previous reports, based on BrdU-cumulative labelling, 
that there is a post-mitotic population of OPCs in the brain (Rivers et al., 2008; 
Psachoulia et al., 2009, Guo et al., 2010; Simon et al., 2011).  This in turn raises 
questions about the origins of new projection neurons in the anterior cortex, which were 
previously thought to derive from OPCs but which do not incorporate BrdU (Rivers et 
al. 2008; Guo et al., 2010) even after a long labelling period and thus are unlikely to be 
derived from dividing precursors such as OPCs. However, the EdU labelling 
experiments on motor cortex described above left open the possibility that there might 
be a local population of post-mitotic OPCs specifically in the anterior pirifrom cortex.  
To test this, EdU was administered to P21 and P60 mice via their drinking water for 
various time periods up to 35 days.  Coronal brain sections were immunolabelled for 
PDGFRα and NG2 to detect OPCs, and were co-stained for EdU (Fig. 4.10A).  When 
administering EdU from P21 the proportion of OPCs in the anterior piriform cortex that 
became EdU+ was found to increase linearly with time (r2 > 0.96) at a rate of 7.6% per 
day, until >98% of all OPCs were stably labelled after ~13 days (Fig. 4.10B).  From P60 
the fraction of EdU-labelled OPCs was found to increase linearly with time (r2 > 0.97) at 
a rate of 3.15% per day until >98% of OPCs were labelled after ~30 days.  From these 
data the cell cycle time for OPCs in the anterior piriform cortex was calculated as being 
approximately 12.9 ± 0.8 days at P21 and 31.3 ± 1.7 days at P60 (using the methods 
described section 2 of this chapter).  These data show that all OPCs (defined by strong 
NG2 and PDGFRα expression) in the anterior piriform cortex are mitotically active, as 
in other regions of the forebrain.  
4.3.5 OPCs generate exclusively OLs in the postnatal mouse brain 
To determine what cell types are produced by OPCs in the corpus callosum, 
motor cortex and anterior piriform cortex, OPCs were labelled and traced using two cell 
tracing methods simultaneously: (1) extended EdU exposure to label all proliferating 
cells (including all OPCs and their differentiating progeny) and (2) Cre-lox fate mapping 
using Pdgfrα-CreERT2 mice.  EdU was administered via the drinking water to Pdgfrα-
CreERT2 : R26R-YFP mice continuously after P25 to pre-label all proliferating OPCs.  
Tamoxifen was then administered to these same mice on four consecutive days (P45-
P48 inclusive) in order to activate Cre-mediated recombination and induce YFP 
expression in PDGFRα-positive OPCs (see experimental time line, Fig. 4.11A). 
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The identity of the starting population of YFP-labelled cells was confirmed by 
immunolabelling sections of Pdgfrα-CreERT2 : R26R-YFP mouse brains at P45+6, two 
days after the final dose of tamoxifen.  Sections were immunolabelled for YFP and 
different combinations of OLIG2, NG2, PDGFRα, PSA-NCAM, NeuN or the microglial 
marker Iba1 (Fig. 4.11B, D).  In the aPC, ~90% of all YFP+ cells co-labelled for OLIG2 
(>500 YFP+ cells counted), most of which were OPCs, as 88% ± 4% of YFP+ cells also 
co-labelled for NG2 (>600 YFP+ cells counted) and 89% ± 1% co-labelled for PDGFRα 
(>400 YFP+ cells counted) (Fig. 4.11D).  At P45+6, <1% of YFP+ cells in the anterior 
piriform cortex co-labelled for NeuN (>500 YFP+ cells counted). These data confirmed 
that tamoxifen induced the YFP-labelling of OPCs but an insignificant number of NeuN+ 
neurons.  In addition to OPCs,  a population of YFP+ PSA-NCAM+ cells were also 
detected in the aPC (Fig. 4.11B), which constituted 11% ± 6% of all YFP+ cells (>400 
YFP+ cells counted).  The YFP+ PSA-NCAM+ cells were smaller than OPCs, having cell 
bodies 5.2 ± 0.3 µm in diameter compared with 10.1 ± 0.5 µm for YFP+ NG2+ OPCs (20 
cells measured in each case). These very small YFP+ cells were also distinguished 
from OL lineage cells in the same region in that they did not express OLIG2 (Fig. 
4.11C).  Despite their small size, the YFP+ PSA-NCAM+ cells were not microglial cells 
as they did not express Iba1; indeed, no YFP+ Iba1+ cells were found in the anterior 
piriform cortex (>400 YFP+ cells counted, Fig. 4.11D).  Importantly, the YFP+ PSA-
NCAM+ cells did not become EdU-labelled even when EdU was administered for 90 
days (from P25 to P115; Fig. 4.12F).  Therefore OPCs are the only EdU+ YFP+ double-
labelled cells within the anterior piriform cortex, allowing their fate to be followed 
specifically in vivo.     
Pdgfrα-CreERT2 : R26R-YFP  mice were labelled with EdU from P25, tamoxifen 
was administered from P45-P48 (Fig. 4.11A) and the mice were analysed on P115 
(P45+70). Coronal brain sections were double-immunolabelled for YFP and NG2 
(OPCs), CC1 (OLs) or NeuN (neurons) (Fig. 4.12A-E).  The sections were also 
processed to detect EdU.  The vast majority of YFP+ cells in the corpus callosum and 
motor cortex were OL-lineage cells that expressed NG2 or CC1.  However, as 
previously reported (Rivers et al., 2008), YFP+ neurons accumulated in the anterior 
piriform cortex where they were about as numerous as YFP+, CC1+ OLs (Fig. 4.11E).  
As expected, essentially all of the YFP+ OPCs were EdU+ in all brain regions examined 
(Fig. 4.12A, F) (<2% of YFP+ OPCs escaped EdU-labelling).  Therefore, all the 
differentiated progeny of YFP+ EdU+ OPCs would be expected to inherit both markers.  
This was true for YFP+ CC1+ OLs in the corpus callosum, motor cortex and anterior 
piriform cortex, which were clearly also EdU+ (<4% of YFP+ CC1+ OLs escaped EdU-
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labelling) (Fig. 4.12B-D, F), identifying them as cells that were generated from OPCs at 
some point between P45 and P115.  However this was not true for the YFP+ NeuN+ 
neurons that accumulated in the anterior piriform cortex over the same time period.  
None of the YFP+ NeuN+ neurons had incorporated EdU (Fig. 4.12E, F) (>1000 YFP+, 
NeuN+ cells counted in 5 mice), indicating that they are not the progeny of YFP+, EdU+ 
OPCs in the postnatal mouse brain.  This suggests that the YFP+ anterior piriform 
cortex neurons were generated after P45 (when tamoxifen was given) by direct 
differentiation of precursor cells, as yet unidentified, that had were no longer 
proliferating and indeed must have undergone their final division before P25 (i.e. before 
EdU was administered).   
4.3.6 YFP+ PSA-NCAM+ cells in the anterior piriform cortex are post-mitotic cells 
that are born before P25 
The YFP+ EdUneg PSA-NCAM+ cells that were identified in the anterior piriform 
cortex of P45+6 Pdgfrα-CreERT2 : R26R-YFP  mice could be the source of the YFP+ 
EdUneg anterior piriform cortex neurons detected at P45+70.  None of the rare YFP+ 
PSA-NCAM+ cells remaining in the anterior piriform cortex at P45+70 (Fig. 4.11B) were 
EdU+ (Fig. 4.12F), indicating that, like the YFP+ NeuN+ cells, they were not the progeny 
of YFP+ EdU+ OPCs.  In fact no PSA-NCAM+ cells detected in the anterior piriform 
cortex at any age had incorporated EdU (>150 PSA-NCAM+ cells examined in 3 mice), 
indicating that they were born before EdU exposure began on P25.  Therefore these 
cells, which were previously suggested to be an intermediate between OPCs and 
projection neurons (Guo et al., 2010), are actually a post-mitotic population that is not 
generated after P25 from proliferating OPCs nor from proliferating neural stem cells.  At 
P45+70, PSA-NCAM+ cells represented only 0.5% ± 0.1% of all YFP+ cells within the 
aPC (>1200 YFP+ cells examined in n=3 mice; Fig. 4.11E).  This fraction is 20-fold less 
than at P45+6 (Fig. 4.11D), reflecting their dilution by the accumulating number of YFP+ 
OLs and neurons. Rivers et al. (2008), determined that YFP+ NeuN+ cells are added to 
the aPC of Pdgfrα-CreERT2 : R26R-YFP transgenic mice at a rate of ~0.18 cells per 
30 µm coronal brain section per day, from 30 days after tamoxifen administration.  This 
equates to ~7 YFP+ neurons per section by P45+70 ((70 days - 30 days) x 0.18 per day 
= 7.2).  In this study, the total number of YFP+ PSA-NCAM+ cells per 30 µm coronal 
brain section fell from ~7 cells per section at P45+6 to an average of ~1 cell per section 
at P45+70 (average number in 12 sections across 3 mice from each timepoint), which 
suggests that YFP+ PSA-NCAM+ cells either die or differentiate over time.  Interestingly 
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the fall of ~6 YFP+ PSA-NCAM+ cells/section, can be seen to almost match the number 
of YFP+ NeuN+ neurons added to the aPC in the same time frame. 
4.4 Discussion 
OPCs were originally assumed to be a homogeneous class of immature 
oligodendroglial cell, but have since been subdivided according to their electrical 
properties (Chittajallu et al., 2004; Karadottir et al., 2008), gene expression profiles 
(Gensert and Goldman, 2001; Mallon et al., 2002; Lin et al., 2009), proliferation rates 
(Psachoulia et al., 2009), response to injury (Keirstead et al., 1998; Lytle et al., 2009) 
and their abilities to differentiate into myelinating OLs (Mallon et al., 2002; Dimou et al., 
2008) or other types of cells including neurons (Guo et al., 2010; Rivers et al., 2008; 
Zhu et al., 2008).  There continues to be much debate over how many sub-types of 
OPC there might be, and the most appropriate way to classify them.  To advance 
understanding of this issue, experiments were performed examining both the 
histological and electrophysiological properties of OPCs. In summary, these data 
determined that all postnatal OPCs defined by strong expression of the NG2 
proteoglycan: (1) co-express the mitogenic receptor PDGFRα, (2) express INa and are 
electrically excitable, (3) are mitotically active and incorporate EdU, and (4) generate 
differentiated OLs but not neurons.  
4.4.1 OPCs in the postnatal mouse brain are excitable but do not fire action 
potentials  
Injecting current into OPCs led to regenerative action potential-like 
depolarization waves, consistent with previous studies in mice (Chittajallu et al., 2004; 
Ge et al., 2009; De Biase et al., 2010). These action potential-like waves differed from 
neuronal action potentials and the action potentials previously described for OPCs in 
the rat cerebellar white matter (Karadottir et al., 2008), as they required a larger 
depolarization for activation, their amplitudes increased with larger current injections 
and the timescale of the waves was longer. These regenerative events could be 
induced in OPCs in all brain areas, and at all developmental stages investigated, 
suggesting they are a universal property of OPCs.  
The likelihood that a cell will generate an action potential is determined by the 
magnitude of the voltage-gated sodium current and the effective cell membrane 
resistance (which can be adversely reduced by the conductance of the seal between 
the patch electrode and the cell membrane (Bakiri et al., 2009)). Thus, the difference in 
spiking behaviour I observed in mouse OPCs compared to rat OPCs (Karadottir et al., 
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2008) might reflect the fact that mouse OPCs have a 6-fold lower ratio of INa magnitude 
to membrane resistance than was previously found for rat INa OPCs (Karadottir et al., 
2008). It is conceivable that, even in mouse OPCs, more robust spiking behaviour 
would be observed in vivo in the absence of shunting by the seal between the patch 
electrode and the cell.   
I observed significant variation among OPCs in the amount of current required 
to initiate Na+ spikes (for the most excitable cells the minimum current needed was 
60 pA), in part reflecting differences in input resistances of the cells (Bakiri et al., 2009).  
White matter OPCs have been reported to receive ~140 synapses (Kukley et al., 
2007), for each of which the miniature excitatory post-synaptic current (EPSC) at the 
resting potential is ~6 pA (Kukley et al., 2007; Kukley et al., 2010), implying that 10 
simultaneous EPSCs would be needed to trigger this response in vivo (60 pA/ 6 pA). 
This is likely to happen more frequently in development when synchronized neuronal 
firing occurs in the cortex (Mao et al., 2001), hippocampus (Mohns and Blumberg, 
2008), cerebellum (Watt et al., 2009) and retina (Demas et al., 2003; Meister et al., 
1991).  However, whether or not full action potentials are produced by mouse OPCs in 
vivo, activation of their voltage-gated sodium channels is likely to amplify excitatory 
synaptic inputs, raising intracellular calcium levels to regulate OPC development, so 
the expression of INa by OPCs might play a key role in regulating the developmental 
myelination of active circuits. 
4.4.2 Is excitability a regulator of OPC proliferation?  
All OPCs have INa, proliferate and generate OLs in vivo (Figs. 4.8-4.12).  
However the rate of OPC proliferation and OL production varies significantly between 
brain regions, with OPCs in the white matter dividing more rapidly than those in the 
grey matter (Power et al., 2002; Psachoulia et al., 2009; Rivers et al., 2008; Dimou et 
al., 2008; Simon et al., 2011).  Many factors regulate OPC proliferation, such as PDGF-
AA, basic fibroblast growth factor (FGF2), and sonic hedgehog (Collarini et al., 1992; 
Pringle et al., 1989; Zhu et al., 1999). Furthermore the expression of NG2 by OPCs has 
been reported to enhance ligand binding to PDGFRα and the fibroblast growth factor 
receptor (Goretzki et al., 1999). In the presence of growth factors, OPCs can proliferate 
in the absence of neurons (e.g. Collarini et al., 1992). However, there is evidence that 
neuronal activity also influences OPC proliferation in vivo. For example, injecting TTX 
into the eye, to block action potentials in retinal ganglion neurons, causes a large 
decrease in OPC proliferation in the optic nerve (Barres and Raff, 1993). This inhibitory 
effect of TTX could be alleviated by supplying exogenous PDGF-A to the optic nerve, 
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suggesting that electrical activity stimulates release of PDGF-A within the nerve, or 
enhances the responsiveness of OPCs to PDGF-A (Barres and Raff, 1993). There is 
also other evidence that links growth factor signalling and electrical activity. PDGFRα 
signalling maintains the expression of delayed outward-rectifying K+ channels by OPCs 
(Chittajallu et al., 2005) and block of K+ channels as a consequence of glutamatergic 
signalling to OPCs may inhibit their proliferation and lineage progression (Knutson et 
al., 1997). 
I considered whether OPC proliferation rate might correlate with the density of 
voltage-gated potassium channels (Knutson et al., 1997).  The cell cycle time for OPCs 
in the corpus callosum of the P21 mouse brain is ~3 days, which is significantly shorter 
than the cell cycle time for OPCs in the motor cortex (~18 days; Young, Psachoulia and 
Richardson, unpublished) or aPC (~ 13 days, see Fig. 4.10B). Perhaps coincidentally, 
in P33 mice the peak outward K+ current was 2-fold larger in the corpus callosum 
compared to the other regions (Fig. 4.9D), consistent with a potential role for K+ 
currents in promoting a higher proliferation rate in white matter compared to that in  
grey matter areas at late developmental times.   
4.4.3 OPCs generate OLs but not neurons in the postnatal mouse forebrain.   
It has been reported previously that OPCs generate new neurons in the 
postnatal mouse brain (Rivers et al., 2008; Guo et al., 2010).  In this study very small 
numbers of YFP+, NeuN+ neurons were observed throughout the forebrain of Pdgfrα-
CreERT2 : R26R-YFP mice at short times post-tamoxifen but, in most brain areas, these 
neurons did not accumulate with time post-tamoxifen, as one would predict if they were 
produced continually from YFP+ precursors and survived long-term. Similar 
observations were made using an independently-generated Pdgfrα-CreERT2 line (Kang 
et al., 2010) and an Ng2-CreER line (Zhu et al., 2011a), prompting the suggestion that 
the rare labelled neurons were the result of sporadic activation of the CreER 
transgenes in a subset of neurons (Kang et al., 2010; Zhu et al., 2011a).  However, in 
this study YFP+-labelled neurons were also observed in the anterior piriform cortex (but 
not the posterior piriform cortex; KM Young and WD Richardson, unpublished) that 
survived and accumulated for months following tamoxifen treatment, confirming the 
earlier results of Rivers et al. (2008).  A similar accumulation of mGFP+ neurons was 
also observed with time in the aPC of Pdgfrα-CreERT2 : Tau-mGFP transgenic mice 
(Fig. 4.13), demonstrating that this is not an artefact of the particular reporter mouse 
used. 
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  It is difficult to understand how this could come about unless these 
particular neurons are produced continuously in the postnatal aPC from a pool of 
precursors that become YFP-labelled at the time of tamoxifen treatment.  In the earlier 
studies, the YFP-labelled neurons were consistently BrdU-negative, even after 
extended BrdU exposure, as were ~50% of OPCs, suggesting that a sub-population of 
mitotically quiescent OPCs might differentiate directly into new aPC neurons without an 
intervening cell division. Now, using an alternative thymidine analogue (EdU), all OPCs 
in the forebrain were found to be mitotically active (see Fig. 4.10) and therefore OPCs 
cannot be the source of new neurons in the anterior piriform cortex, which are 
consistently EdU-negative (Fig. 4.12F). Therefore, these data now agree with Kang et 
al. (2010) who found that all OPCs, but no neurons, incorporated BrdU after a long 
labelling period. Nevertheless, the fact that YFP+ neurons accumulate in the anterior 
piriform cortex after tamoxifen treatment of the Pdgfrα-CreERT2 : R26R-YFP mice still 
requires explanation, as does the apparent discrepancy between our line of Pdgfrα-
CreER mice and the line made and used by Kang et al. (2010), who did not see an 
accumulation of neurons in the piriform cortex.  It is conceivable that our line, but not 
theirs, marks an unidentified population of Pdgfrα-expressing neurogenic 
precursor/stem cells that either resides in the CNS or arrives there via the blood.  
Further experiments, e.g. with Pdgfrα-CreER knock-in mice, will be required to resolve 
this. 
In summary, these data show that OPCs throughout the postnatal brain are 
electrically excitable, proliferative and are the precursors of new oligodendrocytes, but 
not neurons, at least over the time period I have examined, i.e. after P25.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. In Pdgfra-GFP mice GFP labels oligodendroglial cells in the postnatal 
brain.
A-F. Cryosections from P9 and P33 Pdgfra-GFP mice were immunolabelled to detect 
GFP (green) with either OLIG2 (red; A-C) or NG2 (red; D-F). Double-labelled cells are 
indicated by a yellow arrow, single labelled cells by a white arrow. Sections were also 
stained with Hoechst 33258 (Hst; blue) to detect cell nuclei. G. The proportions of GFP+ 
cells that co-expressed each marker were quantified for the motor cortex (Ctx), corpus 
callosum (CC) and the anterior piriform cortex (aPC). The proportion of GFP+ cells that 
co-expressed NG2 fell significantly from P9 to P33 (ANOVA; P< 0.01). Scale bars: 20 
µm.
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Figure 4.2. Two types of GFP+ OL lineage cell in the postnatal mouse brain.
A-F. Cells expressing GFP driven by the Pdgfrα promoter (green) were whole-cell 
patch-clamped and filled with Alexa Fluor-568 dye (red) (top image in columns A-F). 
Current responses (second panel of A-F) were recorded for GFP+ cells with and without 
INa (A-C and D-F, respectively), to 20 mV steps from -70 mV to -110 mV and to +10 mV. 
Voltage-gated currents were isolated by subtracting the capacity transient and ohmic 
leak current scaled linearly from that seen in response to evoked by a hyperpolarizing 
pulse (bottom sets of traces). Representative data, at either P9 (A-D) or P33 (E, F) from 
GFP+ cells in the corpus callosum (CC) (A, D), cortical grey matter (Ctx) (B, E) and 
anterior piriform cortex (aPC) (C, F) are shown. Scale bars: 50 μm 
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Figure 4.3. INa currents in GFP+ cells are blocked by TTX.
A, Left: Capacity transient and ohmic leak - subtracted responses of a GFP+ cell with INa, 
to 20 mV steps from -70 mV (to -110 mV and to +10 mV). Middle: 1 μM TTX blocked the 
inward Na+ current.. Right: Subtracting the voltage-gated K+ current isolated in TTX from 
the total voltage-gated current gave the voltage-gated Na+ current. B, Left: Capacity 
transient and ohmic leak - subtracted responses of a GFP+ cell without INa, to 20 mV 
steps from -70 mV (to -110 mV and to +10 mV). Right: TTX did not change the current 
response of the cell to voltage steps. Traces are representative of 3 GFP+ cells without 
INa. 
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AFigure 4.4. Two classes of OPC morphology cell can be detected early in 
development, and in all brain regions examined.
A,B,The percentage of OPCs that exhibit INa in white matter areas (A) (corpus callosum),  
and grey matter areas (B) cortex (Ctx); and cerebellar grey matter (CB GM) throughout 
development. Note that no significant difference could be detected in the proportion of 
cells expressing INa in the corpus callosum during development, however the proportion 
of cells expressing INa significantly decreased in the motor cortex (P= 0.27 x 10
-3) and in 
the cerebellar grey matter (P= 6.1 x 10-5) between P9 and P30. These P values were 
obtained from a Chi2 analysis with Yates small number correction.
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Figure 4.5. INa+ GFP+ cells generate action potential-like events in response to 
current injection. 
A-F, Responses of white and grey matter GFP+ cells to depolarizing current injection 
(-20, 0, 20, 60, 100, 160, 220 and 260 pA of current was injected).  A-C, Current-clamp 
recordings for GFP+ cells with INa, at P9, in the corpus callosum (CC) (A), cortical grey 
matter (Ctx) (B) and anterior piriform cortex  (aPC) (C). D-E, Current-clamp recordings 
from GFP+ INa cells, which produce repetitive action potential-like waves in the corpus 
callosum at P33 (40, 140 pA was injected) (D), and cerebellar white matter (CB WM) at 
P9 (40, 80, 120 pA was injected) (E). Red boxes indicate the region of the trace that has 
been enlarged. F, Current-clamp recording of a GFP+ cell without INa, at P9 (-20, 0, 20, 
60, 100, 160, 220 and 260 pA of current was injected), in the corpus callosum; similar 
responses were seen in cells lacking INa in all other brain areas examined.
B C
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Figure 4.6.  A small proportion of calretinin+ interneurons express GFP in the 
medial motor cortex of Pdgfrα-GFP transgenic mice. 
A-L, Cryosections from P9 and P33 Pdgfrα-GFP transgenic mice were co-stained to 
detect GFP (green) and a variety of neuronal markers (red): parvalbumin (PV; A), 
somatostatin (SST; B), neuropeptide Y (NPY; C), calbindin (cb; D), reelin (E), calretinin 
(crt; F-H), NeuN; (I-K) and PSA-NCAM (L). M, The number of single labelled GFP+ cells 
(white arrowheads in A-L), single labelled neuronal cells (white arrows) and co-labelled 
cells (yellow arrows) was counted. The table gives the proportion of GFP+ cells that 
co-expressed each neuronal marker. This was quantified in the motor cortex for 3 mice 
and is expressed as the average percentage ± s.e.m. The total number of GFP+ cells 
examined is also given. The only neuronal markers expressed by subsets of cortical 
GFP+ cells were calretinin and NeuN. Scale bars:15 μm (A, C-E, H, J-L) or 10 μm (B, F, 
G, I). 
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Figure 4.7. Morphology of PDGFRα-GFP expressing OPCs.
A-C GFP was mainly expressed by cells with typical OPC morphology in white and grey 
matter (e.g. dye-filled OPCs in the corpus callosum (CC) (A) and anterior piriform cortex 
(aPC) (C)), but GFP could also be occasionally detected in cells that were more 
advanced in their differentiation, with more oligodendrocyte-like morphology including 
myelinating internodes (e.g. dye-filled GFP expressing cell in the corpus callosum (CC) 
with some myelinating internodes labelled with white arrows, B). Scale bars: 30 µm.
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Figure 4.8. Characterisation of NG2+ expression, INa expression and proliferation in 
GFP+ OPCs. 
A-J, Images of dye fills of whole-cell patch-clamped GFP+ cells in corpus callosum (CC), 
cortical grey matter (Ctx) and anterior piriform cortex (aPC), and labelling for NG2 and 
EdU (left panel), together with current responses to depolarizing voltage steps in 20 mV 
increments from -70 mV (right panel). Cells fell into one of three groups: A-F, NG2+ INa+ 
mitotic (EdU+) OPCs; G-H, NG2low INalow early differentiating OLs; and I-J, electrically 
passive OLs (NG2neg, INa
neg). Scale bars: 20 μm.
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Figure 4.9. All NG2+ OPCs express INa. 
A-D, The average electrophysiological data for NG2+ OPCs (mean ± s.e.m.) at P9 
(corpus callosum (CC) n=20, motor cortex (Ctx) n=15, anterior piriform cortex (aPC) 
n=14 cells) and P33 (corpus callosum (CC) n=22, motor cortex (Ctx) n=17, anterior 
piriform (aPC) n=41 cells) are shown, including: A, peak inward current on depolariza-
tion from -70 mV to +10 mV, B, membrane resistance at -70 mV; C, peak outward 
current (on depolarization from -70 mV to +10 mV), and D, membrane capacitance at 
-70 mV. 
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Figure 4.10. All NG2+ OPCs in the anterior piriform cortex proliferate and 
incorporate EdU. 
A, Coronal brain sections containing the anterior piriform cortex (aPC) immuno-labelled 
to detect PDGFRα (red) and NG2 (green) in order to identify OPCs, and then developed 
to visualize EdU incorporation (blue).  B, The proportion of OPCs (PDGFRα+ NG2+) that 
had incorporated EdU as a function of EdU administration time (mean ± s.e.m., n=3 mice 
for each timepoint).  Scale bar: 35 μm. 
A B
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AFigure 4.11. Characterisation of OPC cell fate in the postnatal mouse brain after 
activating Cre recombination to label OPCs with YFP. 
A, Pdgfrα-CreERT2 : R26R-YFP transgenic mice received EdU from P25 to label 
dividing cells, as well as tamoxifen from P45-P48 to activate Cre recombination to label 
OPCs, and were perfusion fixed at P51 (P45+6) and P115 (P45+70).  B, 
Immunolabelling of the anterior piriform cortex (aPC) of P45+6 Pdgfrα-CreERT2 : 
R26R-YFP transgenic mice for NG2 (blue), GFP (green) and PSANCAM (red) shows 
OPCs (centre and top right) as well as a small GFP+ cell (arrow head) that also labels for 
PSANCAM. C, Immunolabelling of the anterior piriform cortex of P45+6 Pdgfrα
-CreERT2 : R26R-YFP transgenic mice for OLIG2 (blue), GFP (green) and NeuN (red). 
White arrowheads indicate unidentified YFP+ cells in the anterior piriform cortex that lack 
OLIG2 expression. D, Proportions of YFP+ cells in anterior piriform cortex (aPC) of 
P45+6 Pdgfrα-CreERT2 : R26R-YFP mouse brains that were either OPCs (NG2+), OLs 
(CC1+), neuroblasts (PSANCAM+, PSAN), neurons (NeuN+) or microglia (Iba1+) (mean ± 
s.e.m, n=3 mice). E, Proportions of YFP+ cells in the corpus callosum (CC), motor cortex 
(Ctx) and anterior piriform cortex (aPC) of P45+70 Pdgfrα-CreERT2 : R26R-YFP mice 
that were OPCs (NG2+), OLs (CC1+) or neurons (NeuN+) (mean ± s.e.m, n=3 mice), and 
proportion in aPC that were PSANCAM+. Scale bars: 30 µm.
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Figure 4.12. OPCs generate new OLs but not neurons in the postnatal mouse 
brain. 
A-F, Pdgfrα-CreERT2 : R26R-YFP transgenic mice received EdU from P25 to label 
dividing cells, tamoxifen from P45 -P48 to activate Cre recombination to induce YFP 
expression in OPCs, and were perfusion fixed at P51 (P45+6) and P115 (P45+70). A, 
Immunolabelling of the anterior piriform cortex (aPC) for NG2 (red), GFP (green) and 
detection of EdU (blue). B-D, immunolabelling of the corpus callosum (CC) (B), cortex 
(Ctx) (C) and  anterior piriform cortex (aPC) (D) for CC1 antigen (red) to define mature 
oligodendrocytes, GFP (green) and detection of EdU (blue).  E, Immunolabelling of the 
aPC for NeuN (red), GFP (green) and detection of EdU (blue).  F,  Percentage of YFP+ 
OPCs (YFP+ NG2+), YFP+ OLs (YFP+ CC1+) and YFP+ neurons (YFP+ NeuN+ or YFP+ 
PSAN+) that incorporated EdU (mean ± s.e.m, n=3 mice). All YFP+ oligodendrocyte 
lineage cells incorporate EdU, but YFP+ neurons never incorporate EdU. White arrows 
indicate triple-labelled cells.  Yellow arrows indicate double-positive, but EdU-negative 
cells. Scale bars:30 µm. 
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Figure 4.13. GFP+ neurons accumulate in the aPC of postnatal Pdgfrα-CreERT2 : 
Tau-mGFP transgenic mice. 
 A-C, Pdgfrα-CreERT2 transgenic mice were crossed with a different reporter mouse that, 
following recombination, expresses a membrane targeted form of GFP (mGFP) under 
the control of the neuronal and oligodendroglial Tau promoter (Tau-mGFP reporter mice; 
Hippenmayer et al., 2005).The double heterozygous Pdgfrα-CreERT2 : Tau-mGFP 
transgenic mice received tamoxifen from P45-P48 to induce recombination in PDGFRα
+ cells, and were analysed at P45+ 14, 27, 70 and 150 days, by immunolabelling coronal 
brain sections to detect mGFP (green) and NeuN (red). Cell nuclei were stained with 
Hoechst 33258 (Hst; blue).  A, A maximum intensity projection of a confocal image stack 
through a 30 μm brain section, demonstrating the location of mGFP+ NeuN+ neurons 
(white arrows) in layer II of the anterior piriform cortex (aPC). B, A single-scan (1 μm) 
confocal image through a mGFP+ NeuN+ neuron. C, Numbers of mGFP+ NeuN+ cells in 
the aPC of each 30 μm coronal brain section, showing a significant accumulation of 
mGFP+ neurons with time.  However this was smaller in magnitude than a previous 
report examining Pdgfrα-CreERT2 : R26R-YFP transgenic mice (Rivers et al, 2008), and 
likely reflects a difference in the recombination efficiencies of the two reporter lines.
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Chapter 5: The effects of GABA on OPCs, mature 
oligodendrocytes and myelination 
5.1. Introduction 
During development or during plasticity and remyelination in the adult, the 
proliferation of oligodendrocyte precursor cells (OPCs) must generate the appropriate 
number of myelinating cells to ensheath the length of axon that needs to be 
myelinated. OPC proliferation and myelination are coordinated by communication 
between the axons to be myelinated and the developing oligodendrocyte lineage cells. 
As reviewed in chapter 1, this has long been known to involve growth factors such as 
PDGF-AA (Richardson et al., 1988; Barres & Raff, 1993) and neurotrophin-3 (Barres et 
al., 1994b). More recently, however, it has been discovered that OPCs receive 
excitatory and inhibitory synaptic input mediated by glutamate and GABA (Bergles et 
al., 2000; Lin & Bergles, 2004; Kukley et al., 2007, 2008; Ziskin et al., 2007; Káradóttir 
et al., 2008; Ge et al., 2009), raising the question of whether these neurotransmitters 
also regulate OPC development and myelination. In this chapter, I investigated the 
properties of GABA-evoked currents in oligodendrocyte lineage cells, and how 
GABAergic signalling regulates their proliferation, differentiation and myelination. 
5.2. Methods 
Transgenic mice and myelination assay 
Sox10-GFP transgenic mice (described in detail in chapter 2, section 13.1-13.3) 
in which GFP is expressed in oligodendrocyte lineage cells (Kessaris et al., 2006), 
were used in an neocortical organotypic slice model of myelination (Rinholm et al., 
2011) as described below.  
Acute brain slices 
Parasagittal cerebellar brain slices (225µm thick) were prepared from P7-P14 
rats (as described in chapter 2, section 1). Slices were superfused at ~33°C with 
bicarbonate buffered solution which contained the following (mM): 126 NaCl, 24 
NaHCO3, 1 NaH2PO4, 2.5 KCl, 1 MgCl2, 2.5 (or 2 for EPSC experiments) CaCl2, 10 D-
glucose, pH 7.4 (bubbled with 95% O2/5% CO2).  
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Patch-clamp recordings 
The electrophysiology of oligodendrocyte lineage cells was studied in acute 
parasagittal cerebellar slices, to mimic, as best as possible, the in vivo situation. 
Oligodendrocyte lineage cells were identified from their dye-fill morphology and I-V 
relations, and for some cells from post-recording antibody labelling, as described by 
Káradóttir et al. (2005, 2008). They were whole-cell clamped with pipettes with a series 
resistance of 8-20 MΩ. The electrophysiology of neurons was studied in the 
organotypic slice cultures used to study myelination. Neurons were identified from their 
dye-fill morphology and I-V relations, and were whole-cell clamped with pipettes of 
series resistance 5-15 MΩ. Electrode junction potentials were compensated. I-V 
relations were from responses to 200 msec voltage steps.  
Electrodes were pulled from thick-walled borosilicate glass to a resistance of 6-
9 MΩ for oligodendrocyte lineage cells and 2-5 MΩ for neurons. Electrodes were filled 
with Cs-gluconate (for oligodendrocytes) or K-gluconate (for OPCs and neurons) based 
solution containing (mM): 130 Cs- or K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 
BAPTA, 4 MgATP, 0.5 Na2GTP, 2 K-Lucifer yellow (pH 7.3).  
Synaptic currents were recorded in neurons at -40mV, analysed using Clampfit 
10.1, and were defined to occur if their amplitude was >3 times the standard deviation 
of the current noise in a period without visible synaptic currents and their 10-90% 
decay time was longer than their rise time.  
Organotypic cortical slice cultures and myelination assay 
An assay for myelination was employed using brain slices in which 
transgenically labelled oligodendrocyte lineage cells fluoresce green, and neuronal 
axons and myelin are identified and quantified with immunofluorescence (Rinholm et 
al., 2011). This allowed assessment of whether changes in myelination reflected 
changes in the number of oligodendrocyte lineage cells, of axonal density or of the 
myelinating activity per oligodendrocyte lineage cell.  
Coronal cortical slices from 8 day old transgenic mice were cut, and then 
cultured as described in chapter 2, section 2.3. After 2 weeks in culture the slices were 
fixed and immunolabelled with markers for myelin (MBP primary, and AlexaFluor 555 
secondary antibodies) and axons (NF200 primary and Cy5.5 secondary antibodies: this 
emission is recoloured blue in the figures). Images (confocal Z stacks) were taken of 
myelination within the grey matter of the cortex, covering layers I-VI.  
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Myelination was quantified (using Metamorph or Image J) either by measuring 
(averaged over an 920 by 920 µm area) the peak intensity of MBP labelling divided by 
that of the axon labelling (NF200) in the confocal stack image with the largest intensity 
in each stack, to obtain a measure of myelination per axon (Rinholm et al., 2011), and 
then averaging over 2-6 stacks from each slice, or by counting the fraction of axons 
myelinated in four contiguous regions (Fig. 5.8, 30 µm by 25 µm). The amount of 
myelin per length of axon was measured by placing a 3 µm by 3 µm square over the 
first (from the top left corner) myelinated axon found crossing the top edge of each of 
the regions shown in Fig. 5.8 and integrating the MBP intensity over this 3 µm square 
area. Internode length (Fig. 5.10) was measured between two nodes of Ranvier, one at 
least of which was within a 92 µm by 160 µm region, and the internode was followed to 
its end even if that was outside the initial observation region. These internode lengths 
defined by MBP labelling are approximately 1 µm shorter than the length that would be 
measured from the centre of one node to the centre of the next. Measurements were 
also made of the number of nodes of Ranvier per field of view (Fig. 5.10), and the 
length of nodes of Ranvier (Fig. 5.10). 
Immunohistochemistry and EdU labelling 
Immunohistochemistry, in vitro EdU labelling and EdU detection were 
performed on organotypic slices as described in detail in chapter 2, section 14.  
Statistics 
The statistical analysis is described in detail in chapter 2, section 15. 
5.3. Results 
5.3.1 GABA-evoked currents in oligodendrocyte lineage cells 
In acute brain slices, superfused GABA (100 µM) evoked a current in 
oligodendrocyte lineage cells in rat cerebellar white matter (Fig. 5.1 and 5.2) and 
mouse corpus callosum (chapter 3). In OPCs, this current was strongly inhibited by 
GABAzine (Fig. 5.1A, C). Applying GABAzine in the absence of superfused GABA had 
very little effect on the membrane current, suggesting there is little tonic GABA release 
onto these cells, at least in cerebellar slices (Fig. 5.1B). The magnitude of the GABA-
evoked current did not differ significantly (Fig. 5.1D) between OPC-morphology cells 
that expressed or had down-regulated their voltage-gated Na+ current (in contrast a 
decrease of glutamate-gated current is seen in cells lacking Na+ currents: Káradóttir et 
al. (2008)). With the pipette [Cl]i chosen to set ECl to -87 mV, the GABA-evoked current 
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reversed at around -50 mV (Fig. 5.1D), which is more positive than the resting 
potential, so GABA would depolarize cells that were not voltage-clamped, as shown 
previously by Lin & Bergles, (2004). This positive value may largely reflect a 
contribution of HCO3- to the reversal potential (Kaila et al., 1989) which, for a 
permeability ratio of PHCO3/PCl of 0.44 as is found in neurons (Fatima-Shad & Barry, 
1993), will shift the reversal potential to -64 mV. Blocking accumulation of Cl- inside the 
cell by NKCC1 transporters (Tyzio et al., 2011) using 100 µM bumetanide, moved the 
reversal potential negative by only 3.9+2.5 mV in 19 cells (10 with and 9 without 
voltage-gated Na+ current, p= 0.14) (Fig. 5.1E), implying that operation of NKCC1 is not 
the main cause of the depolarised reversal potential. 
GABA also evoked a current in cerebellar myelinating oligodendrocytes, which 
was strongly blocked by GABAzine (Fig. 5.2A). This current was unaffected by blocking 
GABAB receptors with CGP35348 (50 µM, Fig. 5.2B, I) or GABAC receptors with 
TPMPA (100 µM, Fig. 5.2C, I), and the GABAB agonist baclofen (40 µM) generated no 
current in 8 cells (data not shown). Inhibiting GAT-1 GABA transporters with 100 µM 
SKF-89976A (Fig. 5.2D, I), blocking ionotropic glutamate receptors with 25 µM NBQX 
and 50 µM AP5 (Fig. 5.2E, I), or blocking action potentials with 1 µM TTX (Fig. 5.2G, I), 
all had no effect on the GABA-evoked current (Fig. 5.2I). Thus, the current is not an 
uptake current, and is not a result of GABA depolarising neurons and triggering action 
potential evoked release of glutamate or some other agent. Furosemide, a GABAA 
receptor α6 subunit blocker (Korpi et al., 1995), reduced the GABA-evoked current by 
33±6% (p=1.6X10-3) (Fig. 5.2F, I), suggesting that the GABAA receptors in 
oligodendrocytes may contain the α6 subunit. However, this percentage block is far 
smaller than the almost 100% block found for tonic GABA receptor mediated currents 
in the nearby cerebellar granule cells (Rossi et al., 2003). 
Unlike in OPCs, the GABA-evoked current in mature oligodendrocytes was 
inward at all potentials (Fig. 5.2H). This may suggest that the long cell processes are 
not well voltage-clamped by the pipette at the soma, so that at the ends of the 
processes the voltage remains below the reversal potential even when the soma is 
depolarised. Alternatively, GABA may generate an inward current in part by 
suppressing an outward K+ current (Pastor et al., 1995), or part of the current may be 
generated by K+ released when GABA depolarizes other cells in the slice (cf. Cheung 
et al., 2009). However, blocking K+ channels (with 5mM 4-aminopyridine and 5 mM 
BaCl2, or 5 mM 4-aminopyridine and 5 mM BaCl2 together with 100 nM apamin and 20 
mM TEA) had no effect on GABA-evoked currents in 12 mature oligodendrocytes (data 
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not shown). Despite uncertainty over the reason for the lack of reversal of the current at 
positive potentials, these data indicate that the GABA-evoked current is mediated by 
GABAA receptors (Berger et al., 1992; Pastor et al., 1995).  
5.3.2 GABAA receptors are not activated on myelinating oligodendrocytes during 
ischaemia 
The role of GABA in the response of oligodendrocyte lineage cells to 
pathological conditions like ischaemia was investigated, since GABA is known to be 
released in the white matter during ischaemia (Shimada et al., 1993). Application of a 
solution mimicking ischaemia (described in detail in chapter 2, section 2) evoked a 
slowly developing inward current (Fig. 5.3A). However, unlike application of glutamate 
receptor blockers which reduce ischaemia-evoked currents in oligodendrocytes and 
OPCs (Karadottir et al., 2005 and 2008), GABAzine did not reduce the ischaemia-
evoked inward current (Fig. 5.3A, B). These data suggest that ischaemia-evoked 
GABA release does not greatly activate GABAA receptors on these cells, and does not 
significantly contribute to the ischaemic current. 
5.3.3 Oligodendrocyte development in cultured cortical slices  
To test the role of GABA in regulating oligodendrocyte development, 
organotypic brain slices were made from the frontal cortex of postnatal day 8 (P8) 
Sox10-GFP transgenic mice (Kessaris et al., 2006), in which oligodendrocyte lineage 
cells express GFP. Fixing slices after different durations in culture, and labelling with 
antibodies for neurofilament 200 (NF) and for myelin basic protein (MBP), allowed the 
imaging of neuronal processes as blue, oligodendrocyte lineage cells as green, and 
myelin as red (Fig. 5.4A).  
Myelination develops over a period of about 2 weeks in these cultured slices 
(Fig. 5.4A, D). Initially many oligodendrocyte lineage cells are visible but, as neuronal 
processes develop, these become fewer in number as a result of cell death, and 
gradually myelin basic protein appears. Larger magnification pictures of the cultures 
(Fig. 5.4B, C) reveal that the great majority of the MBP is expressed in close apposition 
to neurofilament-labelled processes (only 11% of MBP labelled processes were not 
clearly wrapping neurofilament labelled axons, and these may be processes 
connecting internodes to the oligodendrocyte somata, or processes wrapping axons in 
which the neurofilament labelling was too weak to see). Thus, very few 
oligodendrocytes express MBP before they myelinate, and labelling is concentrated in 
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myelin around axons. Nodes of Ranvier are visible as gaps in the MBP labelling around 
axons (Fig. 5.4B and see below). 
By counting the number of GFP expressing cells, and using the total 
fluorescence of NF antibody and MBP antibody as measures of the amount of neuronal 
processes and of myelin present (Rinholm et al., 2011), the progress of myelination in 
the cultures can be assessed as in Fig. 5.4D. During the first few days in culture the 
number of oligodendrocyte lineage cells increases as OPCs proliferate, which is 
followed by a decrease to below the initial number as cells die. After about a week in 
culture the number of neuronal processes reaches a plateau, while myelination 
continues to occur for at least another week. As a quantitative measure of the amount 
of myelin formed per neuronal process, the ratio of the MBP fluorescence to NF 
fluorescence was calculated (shown for different cortical layers in Fig. 5.4E). More 
detailed analyses of the percentage of axons myelinated and the myelin per individual 
axon are given below. 
5.3.4 GABA, but not glutamate, regulates the number of oligodendrocyte lineage 
cells 
To test the effect of endogenously released glutamate and GABA on the 
number of oligodendrocyte lineage cells generated, as a result of the balance between 
OPC proliferation and death, the NMDA receptor blocker MK-801 (50 µM), the 
AMPA/KA receptor blocker NBQX (25 µM), or the GABAA receptor blocker GABAzine 
(50 µM) were included in the culture medium from days 3 to 14 in vitro. Blocking NMDA 
receptors led to a 40+12% decrease (p=0.02) of the amount of neurofilament labelling 
in the cultures, probably because neurons need a basal level of NMDA receptor 
activation to survive (Hardingham & Bading, 2003), which precluded a meaningful 
analysis of whether NMDA receptors regulate myelination. However, deleterious effects 
on neurons were not observed when blocking AMPA/KA or GABAA receptors. When 
present from 3-14 days in vitro NBQX, which blocks excitatory synaptic transmission 
from axons to OPCs (Kukley et al., 2007; Ziskin et al., 2007), had no effect (Fig. 5.5A, 
B; p=0.99) on the number of oligodendrocyte lineage cells present at DIV14, nor on the 
amount of labelling for neurofilament or MBP (reduced by 3+11% (p=0.81) and 
increased by 4+6% (p=0.75) respectively, not shown). In contrast GABAzine, which 
blocks inhibitory synaptic transmission to OPCs (Lin & Bergles, 2004; Káradóttir et al., 
2008), dramatically increased the number of oligodendrocyte lineage cells (Fig. 5.5A). 
Having NBQX present with the GABAzine (to reduce any neuronal excitability increase 
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produced by blocking GABAA receptors) did not significantly affect the increase 
produced by GABAzine (the increase was 0.5% larger, p=0.93, not shown).   
 Counting the number of GFP-labelled cells showed that GABAzine 
increased the number of oligodendrocyte lineage cells more than 2.6-fold in this 
particular experiment (p=3x10-5, Fig. 5.5B; the mean increase over 7 independent sets 
of cultures was 1.76+0.08 fold (p= 1.1x10-15, first 2 bars in Fig. 5.5G). Furthermore, this 
increase did not just lead to a larger population of OPCs that went on to die before or 
after differentiating into mature oligodendrocytes (as was seen previously by Calver et 
al. (1998) when increasing OPC proliferation with PDGF-A oversupplied from an 
integrated transgene). Using APC (adenomatous polyposis coli) antibody to define 
mature myelinating cells (Bhat et al., 1996) it was found that, by 2 weeks in culture, 
GABAzine had produced a large fractional increase in the number of mature (APC-
expressing) oligodendrocytes (increased by 73%, Fig. 5.5C, D) as well as in the 
number of APC-negative NG2-expressing OPCs (increased by 48%, Fig. 5.5E, F). 
Since GABAzine increases the number of cells it follows that endogenous GABA, 
acting via GABAA receptors, normally acts to decrease the number of oligodendrocyte 
lineage cells, including mature oligodendrocytes.  
Applying muscimol (10 µM), a GABAA receptor agonist, from days 3-14 in vitro 
had the opposite effect to GABAzine on the number of oligodendrocyte lineage cells 
present at DIV14 (Fig. 5.5G). Muscimol decreased the number of cells by 23+6% 
(p=0.0004, 32 slices). Thus, increases and decreases of GABAA receptor activation 
can bidirectionally alter oligodendrocyte lineage cell number. 
The increase of the number of oligodendrocyte lineage cells produced by 
GABAzine did not depend on NKCC1 transporters accumulating Cl- in the cell to shift 
positive the reversal potential for GABAA receptors (Lin & Bergles, 2004; Tyzio et al., 
2011). NKCC1 was blocked with bumetanide (100 µM, present from 3-14 days in vitro), 
which on its own did not affect the number of oligodendrocyte lineage cells (p=0.2,  4th 
bar in Fig. 5.5G). In the presence of bumetanide, adding GABAzine or muscimol 
produced a 1.71+0.12 fold increase (p=2x10-7) or a 28+5% decrease (p=0.02), 
respectively, in the number of oligodendrocyte lineage cells present, i.e. changes that 
were not significantly different to those seen in the absence of bumetanide (Fig. 5.5G).  
In contrast to the effects of blocking or activating GABAA receptors, blocking 
GABAB receptors with 50 µM CGP35348 or activating them with 10 µM baclofen had 
no effect on the number of oligodendrocyte lineage cells present (decreased by 
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12+8%, p=0.15, and increased by 2+8%, p=0.81, respectively, Fig 5.5G), unlike a 
previous report for pure OPC cultures (Luyt et al., 2007) in which activation of GABAB 
receptors increased OPC proliferation. 
5.3.5 GABA regulates the proliferation and death of oligodendrocyte lineage cells 
GABAzine could increase the number of oligodendrocyte lineage cells either by 
blocking a GABA-mediated suppression of OPC proliferation (as was previously 
suggested for neural precursor cells: LoTurco et al., 1995), or by blocking GABA-
evoked cell death (Fig. 5.4D shows less GFP-labelled cells at 10-14 days in vitro than 
at 3-7 days in vitro, so some death of oligodendrocyte lineage cells is occurring). To 
investigate this GABAzine was applied from 3-6 days in vitro, i.e. the period in Fig. 
5.4D when OPC proliferation dominates). At day 6, NG2-expressing OPCs accounted 
for the majority of the oligodendrocyte lineage cells (68.5+2.8% in control slices and 
74.6+2.4% in GABAzine treated slices, not significantly different, p= 0.11). By DIV6, 
GABAzine had evoked a similar percentage increase in the number of oligodendrocyte 
lineage cells (1.72+0.04 fold, p=8x10-7, Fig. 5.5H) as when it was applied from 3-14 
days in vitro (1.76+0.08 fold, Fig. 5.5G).  
Using the thymidine analogue EdU to define dividing cells (Chehrehasa et al., 
2009), I found that GABAzine significantly increased the fraction of OPCs (NG2-
expressing cells) that were dividing (from 70.6+2.8% in control slices to 93.4+0.7% in 
GABAzine treated slices, p=4.0x10-9) between days 4 and 6 in vitro (Fig. 5.6A, B, C). In 
addition, I assessed the number of oligodendrocyte lineage cells undergoing apoptotic 
cell death at day 6 in vitro by labelling slices for cleaved caspase-3 (Sánchez-Gómez et 
al., 2003; Fig. 5.6D, E). GABAzine significantly reduced the proportion of Sox10-GFP 
cells undergoing apoptosis (from 1.9 +0.2% in control slices to 1.2+0.1% in GABAzine 
treated slices, p=0.003, Fig. 5.6F). Thus, GABAzine regulates the number of 
oligodendrocyte lineage cells by increasing their proliferation and by decreasing their 
death, implying that endogenous GABA release normally suppresses proliferation and 
increases cell death. It is unclear whether these are two separate actions of GABAA 
receptors or whether GABA alters a single developmental pathway to switch the cell 
from a proliferative state to a state where more of them die. 
5.3.6 Endogenous GABA release decreases myelination 
The increased number of APC-expressing cells in Fig. 5.5C-D indicates the 
possibility that GABA could control, not only the number of OPCs produced, but also 
the amount of myelination carried out. Figure 5.7 analyses the effect on myelination in 
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cortical slices of blocking the effects of endogenous GABA on GABAA receptors with 
GABAzine, or of activating GABAA receptors with muscimol (10 µM, present from days 
3-14 in vitro). As in Fig. 5.5B, GABAzine greatly increased the number of GFP-
expressing oligodendrocyte lineage cells present (by 1.83+0.09 fold, p=2x10-14, Fig. 
5.7A, B) while muscimol decreased the number present by 25+7% (p=3x10-4). In 
contrast to this effect on oligodendrocyte lineage cells, neurofilament labelling was 
unaffected by either GABAzine or muscimol (Fig. 5.7C, D), showing that GABAA 
receptor activation has little effect on the growth of neuronal processes.  
The changes in the number of oligodendrocyte lineage cells induced by 
exposure to GABAzine or muscimol produced significant alterations in myelination. 
Total MBP fluorescence was increased by 42+19% by GABAzine (p=0.01, Fig. 5.7E, F) 
and decreased by 33+7% by muscimol (p=1x10-4). As a simple index of myelination per 
neuronal process, the summed fluorescence of the MBP present was normalised by 
the summed fluorescence of the neurofilament present. GABAzine increased this index 
by 26+10% (p=0.03, Fig. 5.7G, H) while muscimol decreased it by 37+6% (p=9x10-4).  
 To determine whether the increase of myelination was due to a larger 
fraction of axons becoming myelinated, or to more myelin wrapping each axon, the 
fraction of neurofilament-labelled axons that were wrapped with MBP in four contiguous 
30 µm x 25 µm rectangular areas per image were counted (Fig. 5.8A). This revealed 
that GABAzine increased by 25+6% (p=0.003) the fraction of axons myelinated, without 
producing a significant change in the number of axons present (Fig. 5.8B, C). In 
addition, by selecting only axons that were myelinated, and measuring the MBP 
fluorescence associated with a standard length of such axons (Fig. 5.8D), it was found 
that GABAzine also increased the amount of myelin labelling per length of myelinated 
axon by 28+11% (p=0.03, Fig. 5.8E). This might reflect an increase in the average 
thickness of the myelin around each axon, or an increase in the diameter of the axon 
(accurate measurement of which is beyond the resolution of the images) without an 
increase in myelin thickness, or both. Any of these scenarios would increase the 
conduction velocity of the underlying axon. Thus, GABAzine increases both the fraction 
of axons myelinated and the amount of myelin per axon, implying that endogenous 
GABA release normally has the opposite effects. 
5.3.7 The effects of GABA are not via altered neuronal activity 
The effects of endogenous GABA release on the number of oligodendrocyte 
lineage cells and on myelination could be mediated directly by the GABAA receptors I 
have demonstrated in Fig. 5.1 and 5.2 to be present on oligodendrocyte lineage cells. 
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Alternatively, blocking neuronal GABAA receptors might change neuronal activity, which 
could alter myelination by changing the release of growth factors (see Introduction) or 
of glutamate (Wake et al., 2011). I therefore assessed action potential activity in the 
cultured slices (after 8 days in vitro) by whole-cell patch-clamping neurons in the grey 
matter of the cortex and quantifying the frequency of TTX-suppressible synaptic 
currents they received at -40 mV. Prolonged application of GABAzine did not 
significantly change the action potential evoked EPSC rate (0.97+0.79 Hz in 12 cells in 
control slices, 1.13+0.64 Hz in 10 cells in GABAzine treated slices, p=0.88; Fig. 5.9). 
This lack of a large long-term effect of GABAzine could reflect homeostatic alteration of 
cell properties to regulate firing rate but, surprisingly, even at the onset of GABAzine 
application there was no significant change of EPSC rate (decreased from 1.46+0.84 to 
0.98+0.44 Hz in 12 cells, including both spontaneous and action potential evoked 
EPSCs, p=0.57), possibly because GABA has both excitatory and inhibitory actions at 
this stage of development (Mohajerani & Cherubini, 2005) perhaps in different cell 
types (Sauer et al., 2012).  
5.3.8 Endogenous GABA increases internode length 
The large decrease in the number of oligodendrocyte lineage cells produced by 
endogenous GABA release (i.e. the opposite of the GABAzine effect in Fig. 5.5B) 
implies that there will be fewer OPCs competing to myelinate the same number of 
axons which, in addition to resulting in less axons becoming myelinated as described 
above, may result in each oligodendrocyte having to make longer internodes to 
myelinate the same length of axon. To analyse this, nodes of Ranvier were identified 
using antibody to ankyrin G, or as gaps in the MBP-labelling of the GFP-filled 
myelinating processes of oligodendrocytes (Fig. 5.10A). 
GABAzine increased (p=0.02), while muscimol decreased (p=0.02), the mean 
number of nodes in each 146 µm square field of view (Fig. 5.10B). The 47% increase in 
node density produced by GABAzine is nearly 2-fold larger than the 25% increase in 
the number of axons myelinated (Fig. 5.8B), implying that GABAzine decreases the 
separation of nodes along axons, i.e. decreases the internode length. GABAzine and 
muscimol did not alter the lengths of the nodes themselves, whether quantified as the 
length of the gap between MBP-labelled processes (Fig. 5.10C), as the length between 
the ends of GFP-filled processes (Fig. 5.10D, which is shorter than the gap between 
the MBP labelling, because MBP is not expressed in the last 0.5 µm of the myelinating 
processes), or as the length of the ankyrin labelling of the axon (Fig. 5.10E). 
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The lengths of internodes were measured by tracing them from one node of 
Ranvier to the next. All internodal segments were measured that had one end in 92 µm 
by 160 µm regions (Fig. 5.10F), and the internodes were then followed to their ends 
even if they were outside the initial region. The resulting distribution of internode 
lengths differed significantly between control slices and GABAzine-exposed slices (Fig. 
5.10G, p=3x10-7 by Kolmogorov-Smirnov test), corresponding to a 13% decrease of 
mean internode length (from 52.7+1.2 to 46.6+1.7 µm, p=0.003) in GABAzine treated 
slices (Fig. 5.10H). In fact there is more shift of the distribution of internode lengths at 
shorter lengths, and the Gaussian fits to the distributions in Fig. 5.10G predict a 21% 
decrease of mean length in GABAzine. Thus, endogenous GABA release normally 
increases internode length. 
5.4 Discussion 
5.4.1 GABA evokes a current in all oligodendrocyte lineage cells 
Application of GABA evoked currents in cells at all stages of the 
oligodendrocyte lineage, which were mediated by activation of GABAA receptors (Fig. 
5.1 and Fig. 5.2). These data contradict previous work reported by Kirchhoff and 
Kettenmann (1992) suggesting that GABA responses disappear as OPCs differentiate 
into mature oligodendrocytes. OPCs are more spatially compact than mature cells, 
facilitating the control of the cell’s voltage and intracellular Cl-, and they displayed a 
reversing GABA-evoked I-V relationship. However, the reversal potential of the GABA-
evoked current was more positive than the value of ECl (-87 mV) and slightly more 
positive than the reversal potential of -64 mV predicted assuming a significant HCO3- 
permeability of the channel (Fatima-Shad and Berry, 1993) from the Cl- and HCO3- 
concentrations present in the solutions inside and outside the cell. Immature neurons 
are known to maintain a high [Cl-]i because of the expression of the Cl- accumulating 
transporter NKCC1, and a low level of the Cl- extruding transporter KCC2, and 
therefore GABA exerts a depolarising rather than a hyperpolarising response in the 
immature brain ((Ben-Ari, 2002) but see Rheims et al. (2009) and Tyzio et al. (2011) for 
further discussion). Similarly, activation of GABAA receptors in OPCs has been 
reported to induce membrane depolarisation since the intracellular concentration of Cl- 
is also high (Lin and Bergles, 2004). However, in OPCs, blocking NKCC1 with 
bumetanide did not significantly change the reversal potential of GABA-evoked 
currents (Fig. 5.1E). 
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The depolarisation evoked by GABAA receptors generates a [Ca2+]i elevation by 
activating voltage gated Na+ channels, raising [Na+]i and thus reversing Na+/Ca2+ 
exchangers (Tong et al., 2009). Interestingly, this unique Ca2+ signalling pathway has 
been shown to be involved in OPC migration (Tong et al., 2009). The data in this 
chapter suggest a further functional role of GABA in regulating OPC cell number and 
myelination, which will be discussed in more detail below. 
In contrast to the OPCs, mature oligodendrocytes showed an inward current in 
response to GABA application at all potentials (Fig. 5.2). Previously, this has been 
attributed to GABA both activating a Cl- influx through GABAA receptors and 
suppressing an inward rectifier K+ conductance (Pastor et al., 1995). However, blocking 
K+ channels with agents such as BaCl2 which blocks inward rectifiers, indicated that the 
latter effect was not occurring in these experiments. In addition, application of 
glutamate receptor blockers and TTX had no effect on the GABA-evoked current in 
mature cells, further suggesting that GABA is not acting via an indirect pathway, 
activating neurons which release glutamate or K+ onto oligodendrocytes. Finally, no 
evidence was found for the presence of GABAB or GABAC receptors in mature cells, 
which could contribute to the GABA-evoked current. In summary, these data indicate 
that the GABA-evoked response is mediated by GABAA receptors located on the 
oligodendrocytes, and the unusual I-V relationship may be a direct consequence of the 
complex morphology of these cells resulting in poor voltage-control of voltage and 
perhaps [Cl-]i in the long processes. 
GABAergic signalling to oligodendrocyte lineage cells could also play a role in 
pathological conditions. GABA is released in the white matter during ischaemia 
(Shimada et al., 1993) which may activate the GABAA receptors present on 
oligodendrocytes and their precursors. It is currently unclear whether GABA release 
exerts a beneficial effect by limiting depolarisation produced by glutamate release 
(Lutz, 1992) or a harmful effect since Cl- influx facilitates water influx leading to cell 
swelling (Allen and Attwell, 2004). However, my data demonstrate that GABAA 
receptors are not significantly activated on myelinating oligodendrocytes during 
ischaemia, as application of GABAzine did not block or reduce ischaemia-evoked 
currents (Fig. 5.3). Interestingly, a suppression of GABAA responses during ischaemia 
has been reported for neurons (Allen et al., 2004).  
5.4.2 Regulation of oligodendrocyte lineage cell number by GABA 
Proliferation of oligodendrocyte precursor cells has been suggested to occur for 
a period that is regulated by an intrinsic clock (Raff et al., 1988) or to be controlled by 
154 
 
the availability of growth factors (Calver et al., 1998; van Heyningen et al., 2001), while 
differentiation of OPCs has been suggested to require a critical density of OPCs 
(Rosenberg et al., 2008). The data presented in this chapter reveal a previously 
unknown factor exercising a major influence on the number and density of 
oligodendrocyte lineage cells in situ in cerebral cortical slices, i.e. release of the 
neurotransmitter GABA.  
Blocking the effects of endogenous GABA on GABAA receptors, using 
GABAzine, nearly doubled the number of oligodendrocyte lineage cells that are 
produced and survive, while increasing activation of GABAA receptors with exogenous 
muscimol reduced the number (Fig. 5.5G). In contrast, blocking glutamatergic 
excitation with NBQX had no effect on the number of oligodendrocyte lineage cells, and 
GABAzine produced the same increase in oligodendrocyte lineage cell number in the 
presence of NBQX (Fig. 5.5A-B, and associated text). This result, and the fact that 
GABAzine did not have a significant effect on neuronal activity, suggest that the actions 
of GABA are not mediated by an alteration of neuronal firing or a subsequent change of 
glutamate release acting on AMPA/KA receptors in OPCs, but reflect a direct action of 
GABA on oligodendrocyte lineage cells.  
Endogenously released GABA reduces the number of oligodendrocyte lineage 
cells by two possibly linked mechanisms. First, it suppresses OPC proliferation (since 
GABAzine increases proliferation: Fig. 5.6A-C), as was previously suggested to occur 
for neural precursor cells (LoTurco et al., 1995). Second, it increases the death of 
oligodendrocyte lineage cells (since GABAzine decreases that death: Fig. 5.6D-F), cell 
death is known to occur both at the OPC stage and after differentiation into pre-
myelinating oligodendrocytes (Barres et al., 1992; Trapp et al., 1997). As a result, the 
number of oligodendrocyte lineage cells which are produced and survive is determined 
not only by an endogenous clock and/or the availability of growth factors (Raff et al., 
1988; Calver et al., 1998; van Heyningen et al., 2001), but also by locally released 
GABA.  
The suppressive effect of GABA on the proliferation of neural precursor cells 
was suggested to be produced by membrane depolarization (LoTurco et al., 1995). 
However, although GABAA receptors are excitatory during early development (Lin & 
Bergles, 2004; Tyzio et al., 2011), the effects of GABA on oligodendrocyte 
development did not depend on NKCC1 transporters creating a high [Cl-]i to make the 
reversal potential of GABA evoked currents more positive (Fig. 5.1E), since blocking 
NKCC1 with bumetanide did not alter the effect of GABAzine (Fig. 5.5G).  
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5.4.3 Regulation of myelination by GABA 
Activation of GABAA receptors by endogenous GABA does not just decrease 
the number of OPCs produced, but also decreases the number of mature myelinating 
cells (Fig. 5.5C-D). As a result of this, blocking GABA’s action with GABAzine led to an 
increase in myelination per axon (Fig. 5.7H), both because more axons become 
myelinated and because each myelinated axon has more myelin (Fig. 5.8C-E). 
GABAzine also decreased the mean internode length (Fig. 5.10). Although the 
mechanisms determining internode length are not understood at all, a simple 
explanation for why GABAzine decreases the internode length is that, when the 
number of OPCs is increased (Fig. 5.5E, F), there are more cells competing to 
myelinate the fixed number of axons present (Figs. 5.7C, D; 5.8B), so each ends up 
myelinating a shorter axon segment.  
The GABA that regulates OPC development in these experiments is 
presumably released by interneurons in the grey matter (Lin & Bergles, 2004; Vélez-
Fort et al., 2010). GABA released from inhibitory projection axons at synapses onto 
OPCs in some white matter tracts (e.g. from cerebellar Purkinje cell axons: Káradóttir 
et al., 2008) could have a similar influence in the white matter. OPCs themselves may 
modify the GABA concentration that they experience, because they express plasma 
membrane GABA transporters (Cahoy et al., 2008) and have even been suggested to 
release GABA by reversal of these transporters (Gallo et al., 1991). In addition the 
structure of interneuron–OPC synapses changes during development, so that at later 
times the peak GABA concentration experienced by the OPCs is reduced (Vélez-Fort 
et al., 2010), perhaps reducing the influence of GABA on OPC proliferation.  
For grey matter OPCs, the timing of excitatory synaptic input is similar to that in 
nearby neurons (Mangin et al., 2008) suggesting that, if the same is true for inhibitory 
synaptic currents, then OPC development will be locally regulated by nearby 
interneurons. Consequently, the activity of interneurons could tune the conduction 
speed of nearby axons, and a differential density or activity of interneurons along the 
path of a set of axons might lead to a spatial variation of the fraction of axons that 
become myelinated, or a spatial variation of the internode length in the axons that do 
become myelinated. A spatial variation of internode length has been reported for axons 
in the auditory system (Seidl et al., 2010). 
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5.4.4 GABA actions on oligodendrocyte lineage cells and consequences for 
physiology and pathology in the brain 
The effects of GABAzine show that release of endogenous GABA decreases 
myelination and increases internode length. This offers two separate ways in which 
GABA can tune the arrival time of action potentials. If, as a result of GABA release 
during development, some axons are prevented from becoming myelinated, then that 
will delay the arrival of action potentials at the ends of those axons. However, for axons 
that do become myelinated the longer internode length will, at least for the relatively 
short internodes characterised in Fig. 5.10, increase the conduction speed, because 
the internode length will be below the optimal length needed to maximise conduction 
speed (Brill et al., 1977). Further work is necessary to establish whether either of these 
mechanisms serves to tune the conduction speed of myelinated axons in order to 
beneficially influence information processing. 
These data also have potential clinical implications, for brain cancer and for 
promoting remyelination. The reduction of oligodendrocyte precursor proliferation by 
GABA could explain an experimentally observed inverse correlation between the 
density of GABAA receptors and the malignancy of glioma cells (Jussofie et al., 1994; 
Labrakakis et al., 1998) some of which may develop from OPCs (Patt et al., 1996). This 
would suggest that pharmacologically increasing GABAergic signalling in gliomas may 
reduce cell proliferation and increase cell death, and hence reduce their malignancy. 
Furthermore, the fact that GABA modulates myelination during normal development 
raises the possibility that it may do the same during remyelination by adult OPCs in 
pathologies like multiple sclerosis and spinal cord injury. Excitatory axons make 
synapses onto adult OPCs during remyelination (Etxeberria et al., 2010), raising the 
possibility that the same might occur for inhibitory axons in the grey matter or in white 
matter tracts containing inhibitory axons. If this does occur, local block of GABAA 
signalling might serve to increase the number of OPCs available to carry out 
remyelination. 
 
 
 
 
 
20pA
100s
GABA GABA GABAA
GABAzine
2pA
50s
GABAzine
-140 -100 -20 20 60
300
200
100
-100
INa OPCs
no INa OPCs
mV
pA
0
200
150
100
-50
20 60-40-140
Control
GABAzine
pA
mV
C
B
D
Co
nt
ro
l
Co
nt
ro
l
Bu
m
et
an
ide
Bu
m
et
an
ide
INa OPCs no INa OPCs
p=0.52 p=0.89
E
E
re
v f
or
 G
A
B
A 
(m
V
) 0
-10
-20
-30
-40
-50
-60
-70
Figure 5.1. GABA evokes a current via GABAA receptors in OPCs.
A, GABA (100 μM) evoked an outward current at depolarised potentials which was 
effectively blocked by the GABAA receptor blocker GABAzine (10 μM). B, GABAzine did 
not affect the baseline current in OPCs. C, Mean GABA-evoked IV relationship for OPCs 
with and without GABAzine (10μM). D, Mean GABA-evoked IV relationship for OPCs 
with INa (closed circles) and without INa (no INa) (open circles), which reverse at a more 
positive potential than the predicted ECl (-87 mV), possibly because of a contribution of 
HCO3
- to the current. E, Blocking accumulation of Cl- inside the cell by NKCC1 
transporters with 100 μM bumetanide did not significantly change the reversal potential 
in OPCs with or without INa. Numbers of cells are shown on the bars.
10 910 9
157
A CB
D
GABA GABA GABA
GABAzine
10pA
100s
50pA
120s
TPMPA
GABA GABA GABA
20pA
100s
GABA GABA GABA
Furosemide
mV
-120-100 -80 -60 -40 -20 20 40
-0.4
-0.8
-1.2
-2.0
normalised
current
0
20
40
60
80
100
120
GA
BA
zin
e
CG
PTT
X
NB
QX
 + A
P5
TP
MP
A
SK
F
Fu
ros
em
ide%
 re
m
ai
ni
ng
cu
rr
en
t (
pA
)
G H
5 4 6 4 8 46
p=
3.
5X
10
-6
p=
9.
6 
X
10
-3
Figure 5.2. GABA evokes a current mediated via GABAA receptors in mature 
oligodendrocytes.
A-G, Current response at -74 mV of cerebellar oligodendrocytes to 100 μM GABA, and 
the effect on the current of a GABAA receptor blocker (A: 10 μM GABAzine ), a GABAB 
receptor blocker (B: 50 μM CGP35348), a GABAC blocker (C: 100 μM TPMPA), a GAT-1 
transporter blocker (D: 100 μM SKF-89976A), blockers of AMPA/KA and NMDA 
receptors (E: 25 μM NBQX and 50 μM D-AP5) , a GABAA receptor α6 subunit blocker (D: 
100μM furosemide), and an action potential blocker (G: 1 μM TTX). H, I-V relation for 
GABA-evoked current in 14 oligodendrocytes (normalised to the value at -70 mV). I, 
Percentage of current remaining unblocked in the blockers shown, number of cells are 
shown on the bars and p values (Holm-Bonferroni corrected for multiple comparisons) 
are shown where the changes were significant.
CGP
GABA GABA GABA
GABA GABA
SKF-89976A
40pA
80s
GABA GABA GABA
NBQX & AP5
100s
20pA
E F
I
GABA GABA
TTX
20pA
100s
20pA
100s
158
A B
5min
40pA
GABAzine
Ischaemia
p=0.9
0
20
40
60
80
100
120
Co
ntr
ol
GA
BA
zin
eA
m
pl
itu
de
 o
f i
sc
ha
em
ia
-e
vo
ke
d 
in
w
ar
d 
cu
re
nn
t (
pA
)
11 11
Figure 5.3. The ischaemia-evoked inward current in mature oligodendrocytes is 
not affected by blocking GABAA receptors.
A, Membrane current at -74 mV in a mature oligodenddrocyte during simulated 
ischaemia (glucose and O2 were replaced with sucrose and N2, and antimycin and 
iodoacetate were added to the recording solution to block ATP production by glycolysis 
and oxidative phosphorylation). GABAA receptors were blocked (with 10 μM GABAzine) 
during the period when the ischaemia-evoked current sags back somewhat from its 
initial peak. B, Blocking GABAA receptors with 10 μM GABAzine did not significantly  
reduce the ischaemic-evoked inward current in mature oligodendrocytes. Numbers of 
cells are shown on the bars.
159
0.8
1.0
1.2
2000
3000
G
FP
+
ce
lls
/m
m
2
1.2
1.6 layers IV and V
layers I-III
layer VI
whole area
DIV3 DIV7 DIV10
GFP,MBP,NF200A
pia
corpus callosum
DIV14
CB
0.0
0.2
0.4
0.6
N
F2
00
 o
r M
B
P
 fl
uo
re
sc
en
ce
MBP
NF200
0
1000
GFP+ cells
0
0.4
0.8
2
M
B
P
 / 
N
F2
00
days in vitro
MBP,
1411852
days in vitro
141185
D
200μm
2μm
E
10μmNF200 MBP,NF200
Figure 5.4. Development of myelination in cultured cortical slices.
A, Cortical slices from mice with oligodendrocyte lineage cells expressing GFP (under 
control of the Sox10 promoter, green) after different numbers of days in vitro (DIV). Blue 
is antibody to neurofilament 200 (NF200) and shows axons; red is antibody to myelin 
basic protein (MBP). Slice orientation is approximately with the pial surface at the top 
and the corpus callosal surface at the bottom. Band of heavy myelination at DIV14 is in 
layers IV-V (the Baillarger lines corresponding to the stria of Gennari in the striate 
cortex). B, Higher magnification view of cultures showing neurofilament in axons, some 
of which are wrapped with MBP containing myelin (green GFP channel not shown). Gap 
in the MBP covering one axon is a node of Ranvier (indicated by the white arrow). C, A 
myelinated axon imaged in cross section, showing MBP closely opposed to the 
neurofilament labelled axon. D, Mean values of numbers of GFP expressing cells/mm2 
(green, right axis) and mean fluorescence (left axis) of NF200 (blue) and MBP (red) 
averaged over 920 µm by 920 µm images (8-15 images at different ages). E, 
Development with time of the amount of myelin per axon, quantified as ratio of MBP to 
NF200 fluorescence averaged over the different cortical layers indicated.
NF200
160
Control GABAzinepia
corpus callosum
A
C
GFP,MBP,NF200
APC,GFP,MBPAPC,GFPAPC
0
50
100
150
A
P
C
- , 
S
ox
10
-G
FP
+
ce
ll 
co
un
t (
%
 o
f c
on
tro
l)
p=0.006
APC,NG2 APC,NG2,GFPAPC
50
100
150
200 p=9x10-6
D
FE
22 17
22 17
G
0
50
100
150
200
49
Bumetanide
Co
n Gz
Co
n Gz
A
P
C
+ , 
S
ox
10
-G
FP
 +
 c
el
l c
ou
nt
 (%
 o
f c
on
tro
l)
Co
n Gz
Mu
sc
0
Co
n Gz
CG
P Ba
c
Mu
sc
36 32 26 27 27 18 12
0
50
100
150
200
250
S
ox
10
-G
FP
+   c
el
l 
co
un
t (
%
 o
f c
on
tro
l)H
Co
n Gz
6 3
DIV6
p=1.1x10-15 p=2x10-7
p=4x10-4 p=0.02
20µm
20µm
p=8x10-7
S
ox
10
-G
FP
+   c
el
l 
co
un
t (
%
 o
f c
on
tro
l)
Figure 5.5. Blocking GABAARs increases the number of oligodendrocyte lineage 
cells.
A, Cortical slices at DIV14 after culture in control conditions, or with GABAA or AMPA/KA 
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Figure 5.7. Endogenous GABA release decreases myelination.
A, C, E, G, Cortical slices at DIV14 after culture in control conditions, or with GABAzine 
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Figure 5.10. Endogenous GABA release increases internode length.
A, Myelinated axon node of Ranvier labelled for ankyrin G (Ank G), myelin basic protein 
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Chapter 6: Other pilot PhD projects  
The experiments described in this chapter detail two less developed research 
projects I performed during my PhD. In this chapter I investigate nitric oxide signalling 
to oligodendrocyte lineage cells (section 6.1) and activity-dependent nodal plasticity 
(section 6.2), and each project will be described in turn. 
6.1 Nitric oxide regulation of the membrane properties of 
oligodendrocyte lineage cells and myelination 
6.1.1 Introduction 
Nitric oxide (NO) signalling regulates many processes in the central nervous 
system, including cell proliferation, neuronal development, and learning and memory 
(Contestabile and Ciani, 2004; Bicker, 2005; Garthwaite, 2008). In the absence of 
pathology, NO is synthesised by nitric oxide synthase (NOS), an enzyme found in 
neurons (nNOS) and endothelial cells (eNOS) (Seidel et al., 1997). The canonical 
pathway for NO signal transduction is via activation of guanylyl cyclase (GC) to 
produce cGMP, which in turn regulates the function of protein kinases, 
phosphodiesterases, and ion channels (reviewed by Garthwaite, 2008). NO can 
thereby affect neuronal function by modulating neuronal excitability and firing rate 
(Ahern et al., 2002; Frick and Johnston, 2005; Steinert et al., 2008; Artinian et al., 
2010). 
In addition to modulating neuronal activity, NO has been reported to influence 
the properties of oligodendrocytes. In particular, a recent study suggested that inhaled 
NO (a controversial therapy used to treat hypoxic respiratory failure in neonates) 
increased myelination in neonatal mice, by increasing OPC proliferation and 
differentiation (Olivier et al., 2010). A subpopulation of oligodendrocyte lineage cells 
are reported to express GC for cGMP synthesis (Tanaka et al., 1997), and some OPCs 
exhibit a small hyperpolarisation-activated inward current (Ih) produced by 
hyperpolarisation activated cyclic nucleotide-modulated cation channels (HCN), which 
can be modulated by the cGMP level (Lin and Bergles, 2002). In a study by Garthwaite 
et al. (2006), NO derived from vascular endothelial cells was reported to activate GC in 
axons, raising the cGMP level, and causing membrane depolarisation by activating 
HCN channels. Conceivably the depolarisation of axons observed could reflect a 
primary action of NO on oligodendrocytes. 
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NO is reported to play a role in the pathology of many diseases involving 
oligodendrocytes, including multiple sclerosis (Smith and Lassmann., 2002; Li et al., 
2011) and periventricular leukomalacia (Baud et al., 2004). There is abundant evidence 
that NO production is significantly raised in multiple sclerosis lesions (Smith and 
Lassmann, 2002). This increase in NO is due to an upregulation of inducible NOS by 
reactive microglia/macrophages. The increased levels of NO can react with superoxide 
to form peroxynitrite, which is a highly toxic reactive nitrogen species, and leads to the 
death of oligodendrocytes (Zhang et al., 2006a). These reactive nitrogen species have 
been recognised to play a crucial role in the formation of white matter lesions in 
disease models of multiple sclerosis (Hooper et al., 1997; Volpe et al., 2003).  
In contrast, NO is reported to be protective against cell injury because NO is a 
weak oxidant and reacts more readily as an antioxidant by neutralizing other free 
radicals (Rosenberg et al., 1999). NO has also been suggested to prevent 
oligodendrocyte death by increasing cGMP production and activating cGMP-dependent 
signalling pathways which, in turn, can inhibit mitochondrial pore transition and 
apoptosis in response to certain types of excitotoxic injury (Benjamins and Nedelkoska, 
2007). Collectively, these studies suggest that NO may play either a harmful or 
protective role in oligodendrocyte injury and further work will be required to improve our 
understanding of this issue.  
In this chapter I report work investigating the membrane effects of NO signalling 
in both OPCs and oligodendrocytes, by applying an NO donor, or decreasing 
endogenous NO production, and recording any resulting changes in membrane 
currents. In addition, I investigated the effects of NO on myelination using the 
organotypic cortical slice model of myelination described in chapter 5.   
6.2.2 Methods 
Transgenic mice 
Sox10-GFP transgenic mice (described in detail in chapter 2, section 13.1-13.3) 
in which GFP is expressed in oligodendrocyte lineage cells (Kessaris et al., 2006), 
were used for patch-clamp recording and in an organotypic slice model of myelination 
(Rinholm et al., 2011, and chapter 5). 
Brain slices 
Coronal forebrain or parasagittal brain slices (225 µm thick) were prepared from 
P6-9 Sox10-GFP transgenic mice (as described in chapter 2 section 1). Slices were 
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superfused at ~37°C with bicarbonate buffered solut ion which contained the following 
(mM); 126 NaCl, 24 NaHCO3, 1 NaH2PO4, 2.5 KCl, 1 MgCl2, 2.5, CaCl2, 10 D-glucose, 
pH 7.4 (bubbled with 95% O2/5% CO2).  
Nitric oxide donors 
Diazeniumdiolate NO donors were used with varying NO release half-lives. For 
patch-clamp recordings the NO donor PAPA-NONOate was used, as it has a short NO 
release half-life of 15 min (37°C), at pH 7.4. PAPA -NONOate was chosen for patch-
clamp recordings to look at fast time scale responses to NO. For organotypic slice 
culture experiments the NO donor DETA-NONOate was used, as it has a longer NO 
release half-life of 20 hours (37°C), at pH 7.4. DE TA-NONOate was chosen for culture 
experiments because it produces NO for long time periods, enabling assessment of the 
effect of prolonged increases in NO levels.  
Patch-clamp recordings 
 The electrophysiology of oligodendrocyte lineage cells was studied in 
acute coronal forebrain and parasagittal cerebellar slices. Oligodendrocyte lineage 
cells were identified from their GFP-fluorescence, dye-fill morphology and I-V relations. 
They were whole-cell clamped with pipettes with a series resistance of 8-20 MΩ. 
Electrodes were pulled from thick-walled borosilicate glass to a resistance of 6-
9 MΩ for oligodendrocyte lineage cells. Electrodes were filled with K-gluconate based 
solution containing (mM): 130 K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 BAPTA, 
4 MgATP, 0.5 Na2GTP, 2 K-Lucifer yellow (pH 7.3).  
Organotypic cortical slice cultures and myelination assay 
An assay for myelination in brain slices was used in which oligodendrocyte 
lineage cells fluoresce green, and neuronal axons and myelin are identified and 
quantified with immunofluorescence (Rinholm et al., 2011). This allowed assessment of 
whether changes in myelination reflected changes in the number of oligodendrocyte 
lineage cells, axonal density or the myelinating activity per oligodendrocyte lineage cell. 
The myelination assay is described in detail in chapter 5.  
Immunohistochemistry  
Immunohistochemistry was performed on organotypic slices as described in 
chapter 2, section 14 and chapter 5.  
170 
 
Statistics 
The statistical analysis is described in detail in chapter 2, section 15. 
6.2.3 Results 
In cortical and cerebellar brain slices of Sox10-GFP transgenic mice, 
application of an NO donor (1 and 10 µM PAPA-NONOate) did not evoke a current in 
OPCs (Fig. 6.1A, n=10 cells) or in myelinating oligodendrocytes (Fig. 6.1B, n=3 cells). 
Data in Fig. 6.1A, B are shown at -40 mV, but no current change was seen at any 
voltage. Additionally, blocking endogenous nitric oxide production by inhibiting nitric 
oxide synthase (NOS) (with 100 µM N(G)-methyl-L-arginine (L-NMMA)) did not evoke a 
current in OPCs (Fig. 6.1A, n=10 cells) or in myelinating oligodendrocytes (Fig. 6.1B, 
n=3 cells). These data suggest that NO signalling does not evoke detectable 
membrane currents in oligodendrocyte lineage cells. 
NO exerts its biological effects by activating GC and increasing cGMP levels, 
which can modulate HCN ion channels (Ingram and Williams, 1996). HCN channels 
respond to hyperpolarisation by activating with a time constant of ~100 ms, producing a 
slowly activating Ih current (Wilson and Garthwaite, 2010). I investigated HCN channel 
expression in OPCs by applying a series of long hyperpolarising voltage steps to try to 
activate Ih currents. However, no significant current with the time course of Ih could be 
detected in OPCs in the corpus callosum (n=4 cells) or motor cortex (n=4 cells) (Fig. 
6.1C). 
 To test the possible role of NO in regulating oligodendrocyte development 
and myelination, organotypic slices were made from the frontal cortex of postnatal day 
8 Sox10-GFP transgenic mice (Kessaris et al., 2006), as described in detail in chapter 
5. Slices were fixed after 14 days in culture, and labelling with antibodies to 
neurofilament 200 (NF) and myelin basic protein (MBP), allowed for the imaging of 
neuronal processes as blue, oligodendrocyte lineage cells as green, and myelin as red 
(Fig. 6.2A).  
Myelination developed over a period of 2 weeks, as seen in chapter 5. By 
measuring the total fluorescence of GFP expressing cells, the number of 
oligodendrocyte lineage cells was assessed (Rinholm et al., 2011), and by using the 
total fluorescence of NF antibody and MBP antibody as measures of the amount of 
neuronal processes and of myelin present, the progress of myelination was assessed. 
To test the effect of endogenously released NO on the number of oligodendrocyte 
lineage cells generated, NOS blockers (100 µM L-nitroarginine (L-NNA), or 50 µM 
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N(G)-methyl-L-arginine (L-NMMA)) were included in the culture medium from days 3 to 
14 in vitro. Blocking NOS had no significant effect on the number of oligodendrocyte 
lineage cells (Fig. 6.2A, B; p=0.4 and p=0.06 for L-NNA and L-NMMA, respectively), 
nor on the amount of myelination, measured as the ratio of total MBP to total NF 
fluorescence (Fig. 6.2A, C; p=0.6 and p=0.7 for L-NNA and L-NMMA, respectively). In 
addition, a NO donor (100 µM or 200 µM DETA-NONOate) was included in the culture 
medium from days 3 to 14 in vitro, to increase the concentration of NO exogenously. 
Increasing NO levels had no significant effect on the number of oligodendrocyte 
lineage cells (Fig. 6.2A, B; p=0.3 and p=0.07 for 100 µM and 200 µM DETA-NONOate, 
respectively), nor on the amount of myelination, measured as the ratio of MBP to NF 
(Fig. 6.2A, C; p=0.9 and p=0.6 for 100 µM and 200 µM DETA-NONOate, respectively). 
Although the effects of L-NMMA and DETA-NONOate come close to statistical 
significance, L-NMMA decreases the NO level while DETA-NONOate increases it, yet 
both drugs decreased the number of oligodendrocyte lineage cells present, ruling out 
an effect of NO. These data contradict a previous report by Olivier et al. (2010; see 
section 6.1.1), and suggest that NO signalling does not significantly affect the number 
oligodendrocyte lineage cell generated or myelination. 
6.2.4 Discussion 
It is well established that the transmitter NO can modulate the activity of 
neurons within the CNS, however the role of NO in brain development is poorly 
understood. In particular, very little is known about NO signalling to oligodendrocyte 
lineage cells and how this signalling affects oligodendrocyte lineage development and 
myelination. Therefore, I investigated NO-evoked membrane currents in 
oligodendrocyte lineage cells and the effects of NO on myelination. 
 My data suggest that neither endogenous nor exogenous NO evoke detectable 
currents in oligodendrocyte lineage cells. Additionally, OPCs in the corpus callosum or 
motor cortex were not found to express Ih currents mediated by HCN channels (an ion 
channel which can be modulated by cGMP), unlike OPCs in the hippocampus which 
are reported to express small Ih currents (Lin and Bergles, 2002). Furthermore, unlike 
the neurotransmitter GABA which decreases oligodendrocyte lineage cell number and 
myelination (see Chapter 5), increasing or decreasing NO levels did not significantly 
change the number of oligodendrocyte lineage cells generated, nor myelination. This 
finding contradicts a previous report by Oliver et al. (2010), in which rodent pups were 
exposed to inhaled NO, which increased OPC proliferation and myelination. However, 
NO also plays an important role in the regulation of blood flow (reviewed by Toda and 
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Okamura 2003), and it is therefore possible that exposure to inhaled NO increases 
blood flow to white matter tracts which results in an increase in myelination.  Finally, 
NO signalling may play an important role in oligodendrocyte injury, which was not 
investigated in this chapter. 
6.2 Activity dependent myelination and nodal plasticity 
6.2.1 Introduction 
Information transmission in the brain is generally considered to be modulated 
primarily in the grey matter, where dendrites integrate inputs from many presynaptic 
neurons, and the postsynaptic cell bodies ‘decide’ how or whether to convert this 
chemical information into an electrical signal. In the white matter, this electrical signal – 
already at the all-or-none stage – is simply propagated, with no scope for changes in 
information content until the next synaptic junction. However, this view is becoming 
outdated with increasing evidence that the timing of the action potential arrival at 
synapses is critical to information processing in the brain. Importantly, this timing can 
be regulated by myelin in the white matter, which determines action potential 
conduction speed. During development, for example, myelination is adjusted to ensure 
that cortical inputs from different thalamic nuclei arrive at the same time (Salami et al., 
2003). During experience-dependent auditory maturation, the internode length is 
increased in longer brainstem pathways to ensure coincident input arrival with 
information arriving on shorter brainstem pathways, in order to allow sound localisation 
(Seidl et al., 2010). Finally, during learning in humans, there is evidence for increased 
myelination with increased piano practice (Bengtsson et al., 2005) and juggling (Scholz 
et al., 2009).  
These are long-term changes, but it also seems possible that a mechanism 
could exist for altering conduction speed in the short-term, given the importance of 
input arrival time for several fast information integrating processes in the grey matter, 
for example, spike-timing dependent plasticity (STDP) (Markram et al., 1997; Bi and 
Poo, 1998) and dendritic sequence discrimination (Branco et al., 2010). My colleague, 
Lee Cossell has shown theoretically that an effective and energetically efficient way of 
quickly fine-tuning conduction speed would be to exo- or endocytose membrane at the 
nodes of Ranvier, thus decreasing or increasing conduction speed, respectively, by 
altering the nodal capacitance. Similarly, it was recently shown that the axon initial 
segment (AIS) – which has similar structural and functional features to the node of 
Ranvier – can change in size and position in an activity- and calcium-dependent 
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manner (Grubb and Burrone, 2010; Kuba et al., 2010). Myelinated axons experience 
activity-evoked calcium increases, possibly through influx at the node (Zhang et al., 
2006b), which might promote the insertion or removal of membrane and Na+ channels 
at the node, I therefore investigated whether, in response to activity, nodes might 
undergo adjustments, which affect the conduction speed of action potential 
propagation. 
6.2.2 Methods 
Optic nerve preparation 
Optic nerves were removed from P21 rats (when myelination should be around 
70% complete, Foster et al., 1982), as described in detail in chapter 2, section 2.1.4. 
Optic nerves were superfused at ~33°C with bicarbon ate-buffered solution which 
contained the following (in mM); 126 NaCl, 24 NaHCO3, 1 NaH2PO4, 2.5 KCl, 1 MgCl2, 
2.5, CaCl2, 10 D-glucose, pH 7.4 (bubbled with 95% O2/5% CO2).  
Compound action potential recordings  
To record the optic nerve compound action potential (CAP), the optic nerve was 
stimulated using a suction electrode filled with bicarbonate-buffered solution as 
described above. The optic nerve was stimulated using a using 0.2 ms, 2–8 V pulses, 
at 0.033 Hz (a low stimulus strength was used to avoid activation of the small number 
(Tennekoon et al., 1977) of unmyelinated axons present at this age). The CAP was 
recorded as a current using an Axon Axopatch 200B patch clamp with a second 
suction electrode at least 2 mm from the stimulating electrode. The suction electrode 
technique is described in detail in chapter 2, section 12. 
CAPs were recorded for 20 minutes in bicarbonate-buffered solution to 
establish a stable baseline recording before application of high [K+] (15mM KCl) to 
depolarise the optic nerve for 10 minutes. This procedure mimics, but more briefly, the 
depolarisation protocol of Grubb and Burrone (2010) which altered the AIS structure.  
Following depolarisation, CAPs were recorded for a further 20 minutes in bicarbonate-
buffered solution to assess recovery and any lasting changes in conduction velocity. 
Optic nerves were included in the analysis if the amplitude of the CAP recovered to 
within 10% of the control amplitude (n=6 nerves). 
Statistics 
The statistical analysis is described in detail in chapter 2, section 15. 
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6.2.3 Results 
CAPs were recorded from the optic nerves of P21 rats (when myelination 
should be around 70% complete; Foster et al., 1982). The time from the stimulus 
artefact to the peak of the CAP was measured, and a change in this latency was 
interpreted as a change in conduction velocity. To depolarise the axons I superfused 
optic nerves with high [K+] (15 mM KCl; Grubb and Burrone, 2010) for 10 minutes (Fig. 
6.3A). This significantly decreased the CAP amplitude (p=0.0031, in 6 control and 6 
high [K+] treated nerves) and increased the CAP latency (p= 7.0 x10-6, in 6 control and 
6 high [K+] treated nerves) i.e. decreased the conduction velocity (Fig. 6.3A-C), which 
was probably due to depolarisation producing sodium channel inactivation. To assess 
any long lasting changes in conduction velocity, I selected only those nerves that 
recovered to within 10% of their original amplitude (n=6 for control, and high [K+] 
conditions) (Fig. 6.3C). In optic nerves treated with high [K+], the latency of the mean 
CAP recovered by ~95% (Fig. 6.3B). However, the latency of the mean CAP the 
control optic nerves also decreased to ~95% of their original latency (Fig. 6.3B) after 
recording for 30 minutes. Indeed, no significant difference could be detected in the 
conduction velocity of CAPs between control and nerves treated with high [K+] (p= 
0.67), suggesting that nodal plasticity is not occurring in this preparation. 
In addition to depolarising optic nerves with high [K+], more physiological 
electrical stimulation trains were also applied to optic nerves to look for nodal plasticity. 
Several stimulation trains, including a train similar to that shown to shift the AIS (Grubb 
and Burrone, 2010) (20 Hz bursts of 5 pulses every 5 s), a train used to induce STDP 
(Markram et al., 1997) (20 Hz bursts of 5 spikes for 1 min) and more vigorous tetanic 
stimulation classically used to induce LTP (100 Hz for 10 sec) were applied to optic 
nerves (data not shown). These types of electrical stimulation evoked a pattern of 
changes to the CAP similar to that seen with depolarisation with high [K+]: a decrease 
in amplitude and increase in latency during stimulation, followed by recovery to original 
values, with no observable lasting change in conduction velocity. 
6.2.4 Discussion 
Depolarisation of the myelinated optic nerve (with either high [K+], or 
physiological stimulation found to induce various types of neuronal plasticity), did not 
change action potential conduction velocity, which suggests that nodal plasticity is not 
occurring in this preparation. However, this does not rule out the idea that the action 
potential conduction velocity might be regulated on a fast timescale at the node of 
Ranvier. It is possible that this novel form of plasticity may occur but was below the 
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threshold for detection in the optic nerve preparation, where there are different cell 
classes present with different conduction speeds, making accurate measurement of 
individual axons speeds impossible. Alternatively, nodal plasticity may require a 
feedback signal from the postsynaptic cell, which was not present in the optic nerve 
preparation. Such a feedback mechanism is attractive, given that it is within the 
postsynaptic cell that the action potential timing is critical. Further work in acute brain 
slices, looking at the input arrival times to a single postsynaptic cell whilst stimulating 
presynaptic inputs from a myelinated nerve, at different times relative to applying a 
postsynaptic depolarisation, may allow determination of whether this kind of nodal 
plasticity exists. 
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Figure 6.1. Nitric oxide-evoked currents can not be detected in oligodendrocyte 
lineage cells.
A,B, Application of a nitric oxide donor (10 μM PAPA-NONOate) or inhibiting 
endogenous nitric oxide production by blocking nitric oxide synthase (100 μM 
N(G)-methyl-L-arginine (L-NMMA)) did not evoke a detectable current in OPCs (A, n=10 
cells) or in mature oligodendrocytes (B, n=3 cells) clamped to -30 mV. C,D, Expression 
of hyperpolarisation-activated cyclic nucleotide-modulated cation (HCN) channels, 
which can be modulated by nitric oxide, was investigated in OPCs. A series of 
hyperpolarising voltage steps (from a holding potential of -45 mV, hyperpolarising 
voltage steps in 10 mV increments from -55 mV to -115 mV) were applied to activate 
HCN channels, however no detectable HCN channel conductance was observed in 
OPCs in the corpus callosum (CC) (C, n=4 cells) or motor cortex  (Ctx) (D, n=4 cells).
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Figure 6.2. Nitric oxide does not affect oligodendrocyte cell number or  
myelination.
A, Cortical slices at DIV14 after culture in control conditions, or with a nitric oxide donor 
(100 µM or 200 µM DETA-NONOate), or with a nitric oxide synthase inhibitor (100 µM 
L-nitroarginine (L-NNA), or 50 µM N(G)-methyl-L-arginine (L-NMMA)) present from 
DIV3-14, showing labelling for Sox10-GFP (green), neurofilament (blue) and MBP (red). 
B, Quantification (averaged over the whole image) of the GFP fluorescence. C, 
Quantification of  the ratio of labelling for MBP to that for NF200. Numbers on the bars 
represent the number of slices analysed.
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Figure 6.3. Investigating node of Ranvier plasticity in the optic nerve.
A, Compound action potentials (CAP) were recorded from P21 (when ~70% of 
myelination has occurred) optic nerves using suction electrodes (the experimental 
set-up is described in detail in chapter 2, section 12). CAPs were recorded every 3 
seconds, and their peak latency and peak amplitude were measured across conditions 
(at points marked by asterisk in A, in relation to the baseline value immediately 
preceding the artefact). Left: A representative trace of a CAP recorded during control 
conditions (in bicarbonate-buffered solution). Middle:  a representative trace of a CAP 
recorded after application of 15 mM K+ for 10 minutes to depolarise the nerve. During 
depolarisation the CAP amplitude decreased and the latency of the peak increased. 
Right: a representative trace of a CAP recorded 20min after removal of 15 mM K+ (in 
bicarbonate-buffered solution). The amplitude and latency of the CAP peak recovered 
and was not disimilar to the CAP recorded before depolarisation.  B, C, Mean latency (B) 
and amplitude (C) as a percentage of the inital CAP recording (n=6 optic nerves in 
control and 15 mM K+ conditions). 
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Chapter 7: Final discussion 
In this section, I will review the main results I have obtained throughout my PhD 
and suggest future experiments which could further the research I have carried out. 
7.1 Dorsally- and ventrally-derived oligodendrocytes have similar 
electrical properties but myelinate preferred tracts 
7.1.1 Discussion 
 Oligodendrocytes are generated from both dorsal and ventral germinal regions 
in the embryonic forebrain and spinal cord, under the influence of different inductive 
signals. Since the discovery of dorsally- and ventrally-derived populations of 
oligodendrocytes, an important question has been whether they are functionally 
identical or differ functionally in some way. Using a dual-reporter mouse, I have shown 
that, despite different sites of origin, dorsally- and ventrally-derived oligodendrocyte 
lineage cells are electrically and morphologically similar.  
However, despite being electrically identical, interesting differences in the 
settling positions of oligodendrocyte lineage cells that develop from dorsal and ventral 
regions of the spinal cord were discovered. These data suggest that competition exists 
between dorsally- and ventrally-derived oligodendrocytes for the myelination of specific 
tracts. In a recent study, Zhu et al. (2011b) demonstrated that dorsally-derived OPCs 
were able to migrate to, and produce new oligodendrocytes in, a focal lesion in the 
ventral spinal cord. These data suggest that dorsally-derived OPCs could provide an 
important source of new oligodendrocytes for axon remyelination after injury. At this 
point, the mechanism by which dorsal oligodendrocytes outnumber ventral 
oligodendrocytes in either myelination or remyelination can only be speculated about, 
and further experiments detailed below may shed light on this mechanism. 
7.1.2 Suggestions for further work 
Despite examining many of the electrical properties and morphological 
properties of dorsally- and ventrally-derived oligodendrocyte lineage cells, they 
appeared to be electrically and morphologically identical. It is possible that other 
electrical differences between dorsally- and ventrally-derived oligodendrocyte lineage 
cells could exist that were not examined by this study. For example, dorsal OPCs and 
ventral OPCs could differ in terms of the synapses they receive from neuronal axons. 
Conceivably OPCs derived from different lineages may receive synaptic inputs from 
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either excitatory or inhibitory neurons (or both), or the properties of these currents 
could be distinct (e.g. OPCs could receive synaptic inputs at different frequencies or 
with different amplitudes). The fact that both dorsal and ventral OPCs responded 
similarly to the application of excitatory and inhibitory neurotransmitters suggests that 
they express the appropriate receptors to respond to glutamate and/or GABA release 
from neuronal axons. Receiving synaptic inputs with different properties from neuronal 
axons could provide an electrical mechanism by which OPC survival, differentiation 
and subsequent myelination could be controlled by specific tracts. Therefore, it would 
be interesting to examine and compare the properties of the synaptic input to dorsal 
and ventral OPCs. 
Alternatively, different molecular cues which were not examined in this study 
could account for the myelination of specific tracts. For example, dorsally- and 
ventrally-derived oligodendrocyte lineage cells may express different genes or higher 
levels of particular genes depending on their site of origin. In the context of this study, 
dorsally-derived oligodendrocyte lineage cells may specifically express adhesion 
molecules or survival genes, which enable them to reside within and myelinate the 
dorsal tracts in the spinal cord more effectively. In order to assess such differences, 
gene expression profiling of dorsally- and ventrally-derived oligodendrocyte lineage 
cells from the dual reporter mouse could be carried out. 
At present, it is well established that newly born mature oligodendrocytes are 
generated from OPCs throughout life (Rivers et al., 2008; Psachoulia et al., 2009). 
Activity dependent changes in myelination have also been suggested to occur in the 
human brain in adulthood. For example, when people learn motor tasks such as piano 
playing (Bengtsson et al., 2005), changes in myelination have been observed. 
However, although I have shown that all OPCs proliferate, it is not known whether 
dorsally- and ventrally-derived OPCs can both contribute towards the production of 
these newly born oligodendrocytes in adulthood. It would be of interest to assess 
whether dorsally- or ventrally-derived OPCs, or a mixture of both, generate these new 
oligodendrocytes, which could contribute to myelin turnover and activity-dependent 
changes in myelination in the adult brain. 
Furthermore, the finding that dorsally-derived oligodendrocyte lineage cells 
compete to myelinate specific tracts within the spinal cord raises the question of how 
such a competition operates in the context of remyelination. During remyelination, 
OPCs must proliferate and differentiate in order to generate new oligodendrocytes to 
repair demyelinated axons. It has been suggested that dorsally-derived OPCs can 
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migrate to, and produce new oligodendendrocytes in a focal lesion in the spinal cord 
(Zhu et al., 2011b). It would be interesting to investigate the signalling mechanisms 
which induce dorsally-derived OPCs proliferate, and differentiate more effectively into 
myelinating oligodendrocytes after injury, when compared to their ventrally-derived 
counterparts. In addition, transplantation of OPCs has been shown to promote 
remyelination (Windrem et al., 2008), therefore it would be of interest to see whether 
transplanted dorsally-derived or ventrally-derived OPCs dominate during the 
remyelination process. 
7.2 Properties and fate of oligodendrocyte precursor cells in the 
postnatal mouse brain 
7.2.1 Discussion 
OPCs were originally assumed to be a homogeneous class of immature 
oligodendroglial cell, but have since been subdivided according to their electrical 
properties (Chittajallu et al., 2004; Karadottir et al., 2008), gene expression profiles 
(Gensert and Goldman, 2001; Mallon et al., 2002; Lin et al., 2009), proliferation rates 
(Psachoulia et al., 2009), response to injury (Keirstead et al., 1998; Lytle et al., 2009) 
and their abilities to differentiate into myelinating OLs (Mallon et al., 2002; Dimou et al., 
2008) or other types of cells including neurons (Guo et al., 2010; Rivers et al., 2008; 
Zhu et al., 2008). There continues to be much debate over how many sub-types of 
OPC there might be, and the most appropriate way to classify them. To advance 
understanding of this issue, I performed experiments examining both the histological 
and electrophysiological properties of OPCs. In summary, these data determined that 
all postnatal OPCs defined by strong expression of the NG2 proteoglycan: (1) co-
express the mitogenic receptor PDGFRα, (2) express INa and are electrically excitable, 
but do not fire bona fide action potentials, (3) are mitotically active and incorporate 
EdU, and (4) generate differentiated OLs but not neurons. 
In addition, two further classes of oligodendrocyte lineage cell were observed. 
One group of cells expressed low levels of NG2 and little to no INa, which were 
assumed to correspond to early differentiating OPCs, that are down-regulating their INa 
and NG2 expression, as previously described (De Biase et al., 2010; Kukley et al., 
2010). This group likely corresponds to the no INa OPCs reported by Karadottir et al. 
(2008). The other group of cells lacked both NG2 labelling and INa expression, and 
therefore correspond to pre-myelinating or myelinating oligodendrocytes. Taken 
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together, these data suggest that OPCs are in fact a homogenous population of cells, 
which downregulate their expression of NG2 and PDGFRα, and voltage-gated 
channels as they differentiate into myelinating oligodendrocytes. At this point, these 
data point to a link between Na+ and/or K+ channel expression and OPC proliferation 
and differentiation, but further work, as suggested below, is required to fully understand 
the these voltage-gated channels in OPCs.  
 7.2.2 Suggestions for further work 
I have demonstrated that injecting current into OPCs led to regenerative action 
potential-like depolarisations in all brain areas and developmental stages examined, 
consistent with previous studies in mice (Chittajallu et al., 2004; Ge et al., 2009; De 
Biase et al., 2010). It is likely that activation of voltage-gated Na+ channels in OPCs 
acts to amplify excitatory synaptic inputs to OPCs, raising intracellular Ca2+ levels to 
regulate OPC development. Expression of INa in OPCs might also play a key role in 
regulating the developmental myelination of active circuits and activity-dependent 
myelination in the adult brain. It would be interesting to conditionally knock-out voltage-
gated Na+ channels in OPCs during developmental myelination and in adulthood. 
Following the deletion of Na+ channels, any changes in the properties of OPCs could 
be assessed, such as their ability to proliferate and differentiate, along with the amount 
of myelin that they make.  
Voltage-gated K+ channel expression by OPCs has been suggested to regulate 
growth-factor mediated proliferation (Knutson et al., 1997; Chittajallu et al., 2005). 
Therefore, I considered whether OPC proliferation rate might correlate with the density 
of voltage-gated K+ channels expressed by OPCs. The cell cycle time for OPCs in the 
corpus callosum is reported to be significantly shorter than the cell cycle time for OPCs 
in the motor cortex (Psachoulia et al., 2009). Coincidentally, the peak outward K+ 
current was 2-fold larger in the corpus callosum compared to the motor cortex, 
consistent with a potential role for K+ currents in promoting proliferation. The function 
role of K+ channel expression in OPCs could be assessed in vivo, by conditionally 
knocking out these channels during development and in adulthood. After the deletion of 
these channels the development and differentiation of OPCs could be compared with 
that in OPCs expressing K+ channels, along with any changes in the myelination that 
the cells produce. 
In addition to the differentiation of OPCs into oligodendrocytes which myelinate 
neuronal axons, several groups have previously reported that OPCs generate new 
neurons in the postnatal mouse brain (Rivers et al., 2008; Guo et al., 2010). In this 
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study, lineage tracing experiments using Pdgfrα-CreERT2:R26-YFP transgenic mice, 
demonstrated the labelling of newly formed YFP+ oligodendrocytes and neurons. The 
neurons accumulated in the anterior piriform cortex of the brain, consistent with 
previous studies (Rivers et al., 2008; Guo et al., 2010). It was assumed that these 
neurons are produced continuously from a pool of precursors in the piriform cortex that 
become YFP-labelled after tamoxifen treatment. In the earlier studies, the YFP-labelled 
neurons were consistently BrdU-negative, even after extended BrdU exposure, leading 
the authors to speculate that a subpopulation of mitotically quiescent OPCs might be 
differentiating into the new neurons in the piriform cortex (Rivers et al., 2008; Guo et 
al., 2010). In this study, using an alternative thymidine analogue (EdU), all OPCs were 
found to be mitotically active, and so cannot be the source of the new neurons in the 
piriform cortex, which were again found to be consistently mitotically inactive. These 
data now agree with a study by Kang et al. (2010) who, using an independently 
generated line of Pdgfrα-CreERT2 mice, failed to detect any newly generated long-term 
surviving neurons, derived from OPCs, in the piriform cortex or elsewhere in the 
forebrain. The fact that YFP expressing neurons (which are not generated by OPCs) 
accumulate in the Pdgfrα-CreERT2:R26-YFP in this study, but not in the Kang et al. 
(2010) study, still requires explanation. It is possible that the transgenic mouse line 
used in this study, but not theirs, marks an unidentified population of Pdgfrα-expressing 
neurogenic precursor/stem cells that either resides in the CNS or arrives via the blood. 
Experiments identifying this population of Pdgfrα-expressing neurogenic 
precursor/stem cells and following their fate, would confirm whether or not new neurons 
are being produced in the adult piriform cortex (that are not generated by OPCs), a 
brain area in the olfactory bulb circuitry, which is known to be highly plastic with new 
neurons being added to the olfactory neuroepithelium of the nose and to the olfactory 
bulb, in adulthood (Young et al., 2007). Further experiments, for example using a 
Pdgfrα-CreER knock-in transgenic mouse line, would be required to resolve this. 
7.3 The effects of GABA on OPCs, mature oligodendrocytes, and 
myelination 
7.3.1 Discussion 
Myelination is controlled by interactions between developing axons and OPCs, 
which are in part mediated by growth factors. However, OPCs also receive excitatory 
and inhibitory input from neuronal axons, raising the question of whether 
neurotransmitters also regulate OPC development and myelination. In this thesis, I 
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confirm earlier reports that GABA evokes a current, which is mediated by GABAA 
receptors, in all oligodendrocyte lineage cells. Using a cerebral cortical slice model of 
myelination, I investigated whether GABAergic signalling can regulate the OPC 
proliferation, differentiation, and myelination. Interestingly, GABA acting on GABAA 
receptors halves the number of OPCs, thereby controlling the number of myelinating 
cells available to ensheath axons. GABA reduces the number of OPCs by two separate 
mechanisms, firstly, it suppresses OPC proliferation, and secondly, it increases the 
death of oligodendrocyte lineage cells. As a result of the reduced number of OPCs, 
GABA reduces the fraction of axons myelinated, reduces the amount of myelin on 
axons that do become myelinated, and increases the length of the myelin internodes 
wrapped around the axons. 
At present, the function of GABAergic input to OPCs is not well understood, but 
these data indicate that GABA plays a role in OPC development and myelination. 
However, these data contradict previous studies reporting that GABA had no effect on 
OPC development (Gallo et al., 1996; Yuan et al., 1998). Instead, the GABA-mediated 
suppression of OPC proliferation observed here is more similar to that previously 
reported for neural precursor cells (LoTurco et al., 1995).  
In this study, the effects of endogenous GABA release on the number of the 
oligodendrocyte lineage cells and on myelination could be mediated directly by GABAA 
receptors present on oligodendrocyte lineage cells, or alternatively blocking neuronal 
GABAA receptors might change neuronal activity, which could alter myelination 
indirectly by changing the release of growth factors or glutamate (Wake et al., 2011). In 
support of the idea that GABA acts directly on OPCs, in this study GABAzine (which 
blocks GABAA receptors) did not have a significant effect on neuronal activity, 
suggesting that the actions of GABA on oligodendrocyte lineage cells are not mediated 
by an alteration of neuronal firing and a subsequent release of growth factors and/or 
glutamate. Further experiments, which are detailed below, could be carried out to 
determine whether GABA is acting directly on OPCs. 
7.3.2 Suggestions for further work 
Firstly, in order to demonstrate that the GABA-mediated effect on OPCs is 
dependent on the synaptic release of GABA, the myelinating slice cultures could be 
treated with botulinum toxin, which cleaves the synaptic release protein SNAP-25 to 
inhibit vesicle fusion and neurotransmitter release (Wake et al., 2011; Welch et al., 
2000). Secondly, the synaptic currents in OPCs could be assessed, to demonstrate 
that following treatment with GABAzine, the GABAergic synaptic input to OPCs is 
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reduced. Furthermore, GABA receptors could be specifically knocked-out of OPCs 
using a conditional GABAA receptor knock-out mouse, or alternatively siRNAs could be 
cell specifically introduced via viral infection to knock-out GABAA receptors in OPCs in 
the myelinating cultures. Following the deletion of GABAA receptors from OPCs, 
changes in OPC proliferation, differentiation and myelination could be assessed. 
Collectively, data from these experiments would further test the idea that GABA release 
from neurons is acting directly on the GABAA receptors on OPCs to regulate their 
proliferation, differentiation and myelination. 
Another question that remains unanswered is: how does GABA regulate the 
proliferation of OPCs in order to control the number of OPCs available to myelinate 
axons? Studies investigating the GABAA receptor regulation of neural stem cell 
proliferation provide a hint of the mechanism by which GABA may regulate OPC 
proliferation. Like neural stem cells (LoTurco et al., 1995), GABA appears to reduce the 
proliferation of OPCs. In neural stem cells, GABA, acting on GABAA receptors, signals 
through S-phase checkpoint kinases of the phosphatidylinositol-3-OH kinase-related 
kinase (PIKKs) family, to regulate the cell cycle and proliferation (Andang et al., 2008; 
Fernando et al., 2011). In particular, GABA acts through the PIKK protein, ATR, which 
activates another PIKK protein, ATM, by phosphorylation. Then, ATM phosphorylates 
histones (in particular the H2AX-variant) in the cell nucleus, resulting in decreased 
DNA synthesis, a slower progression through S-phase of the cell cycle, and a slower 
rate of cell proliferation (Andang et al., 2008; Fernando et al., 2011). It would be of 
interest to investigate whether GABA regulates OPC proliferation by a similar 
mechanism. In order to assess this, the organotypic slice cultures could be immuno-
labelled with an antibody to the phosphorylated form of H2AX (γ-H2AX), and the 
proportion of OPCs expressing γ-H2AX in control slices could be compared with 
proportion of γ-H2AX expressing OPCs in slices treated with either GABAzine or 
muscimol. In addition, ATR phosphorylation of ATM could be blocked using a specific 
ATR kinase inhibitor (Andang et al., 2008), to assess whether the GABAA receptor 
dependent reduction in the number of proliferating OPCs is regulated by a similar 
mechanism to that in neural stem cells.   
At present, it is not clear whether blocking GABAA receptors increases the 
overall number of axons myelinated, or just accelerates myelination. It would be of 
interest to assess whether eventually, after a longer time period in culture, the control 
slices would reach a similar level of myelination. Furthermore, the speed of 
developmental myelination could be assessed in mice in which GABAA receptors have 
been specifically knocked-out of OPCs. 
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GABA not only reduces the fraction of axons myelinated, but also appears to 
reduce the amount of myelin on the axons that do become myelinated. This GABA-
mediated change in myelin thickness could be assessed further by performing electron 
microscopy on the organotypic slice cultures and measuring the g-ratio of the 
myelinated axons. In addition to increasing the fraction of myelinated axons, and the 
amount of myelin, GABA also increased the length of the internodes. Presumably, the 
increase in internode length was due to the large decrease of the overall number of 
oligodendrocyte lineage cells produced, implying that there will be fewer OPCs 
competing to myelinate the same number of axons, which results in each 
oligodendrocyte having to make longer internodes to myelinate the same length of 
axon. This increase in internode length could increase the action potential conduction 
velocity. However, there is an optimal internode length that maximises conduction 
speed (Brill et al., 1977). Indeed, if axons become myelinated with internodes that are 
much longer than the optimal length, the conduction velocity can actually decrease, 
due to less voltage transmission from one node to the next, so that the Na+ 
conductance at the next node takes longer to activate (Brill et al., 1977). It would be of 
interest to assess the extent to which the GABA-mediated change in internode length 
affects the conduction velocity of myelinated axons, and whether this change tunes the 
conduction speed in order to beneficially influence information processing. The 
conduction velocity could be measured experimentally by looking at the input arrival 
times at a single post-synaptic cell whilst stimulating the presynaptic inputs from a 
defined position on a myelinated axon. Alternatively, the action potential conduction 
velocity could be assessed in myelinated axons with the use of voltage-sensitive dyes. 
Using either technique, the conduction velocity could be compared in neurons in 
control slices with neurons in slices treated with GABAzine. 
Finally, the fact that GABA can modulate developmental myelination raises the 
possibility that it may do so during remyelination. In support of this, excitatory axons 
have been reported to make synapses onto OPCs during remyelination (Etxeberria et 
al., 2010). Therefore, it is possible that inhibitory axons in the grey matter or in white 
matter tracts may make synapses with OPCs during remyelination. It would be 
interesting to look at GABAergic signalling to OPCs following a lesion, to assess 
whether blocking GABAergic signalling can increase the number of OPCs available to 
myelinate neuronal axons after injury.  
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7.4 Conclusion 
The experiments performed in this thesis investigated the electrical properties 
of OPCs, and how signalling to these cells regulates their proliferation, differentiation 
and myelination. Firstly, I have demonstrated that oligodendrocyte lineage cells derived 
from different embryonic sites are electrically similar, however, despite having 
indistinguishable electrical properties, dorsally-derived oligodendrocytes myelinated 
specific tracts in the spinal cord. Secondly, I have shown that OPCs in different brain 
regions have similar properties in terms of their expression of voltage-gated ion 
channels, precursor proteins and proliferative capacity. Finally, having determined that 
all OPCs apparently have similar membrane properties, I investigated whether the 
inhibitory neurotransmitter GABA can regulate OPC proliferation, differentiation and 
myelination. Endogenously released GABA was found to reduce the number of 
oligodendrocyte lineage cells formed, reduce the amount of myelin per axon and 
increase internode length. These results demonstrate that GABA, presumably released 
from inhibitory interneurons, can regulate OPC development and myelination. 
However, further work is required to shed light on the functional role of voltage-gated 
ion channels in OPCs and how expression of these channels modulates OPC 
proliferation, differentiation and myelination. 
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